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General introduCtion, aiMs, and outline of the thesis
1.1  Sex chromosomal disorders: phenotypic spectrum, incidence, diagnosis, and 
treatment options
1.2  Sex chromosome aneuploidy: emergence, X inactivation, genetics, and counsel-
ing aspects
1.3  Fetal investigation: screening and diagnostic tests, non-invasive and invasive 
tests, targeted or genome-wide testing, and incidental findings
1.4   The right to inform and to be informed about incidental findings, and ethical and 
policy dilemmas
1.5 Aims of this study and outline of the thesis
Parents-to-be are generally eager to know more about their fetus. There may be various 
reasons for early prenatal assessment by ultrasound, for instance: viability judgment, sex 
determination, or possible increased risk of a genetic anomaly. However, a salient issue 
regarding early fetal assessment is the potential risk of discovering incidental findings 
that may have important medical or social implications unrelated to the reason for test-
ing. 
Incidental findings come unforeseen to the parents; nevertheless, they may some-
times be a benefit. An early finding of a fetal anomaly, whether intended or incidental, 
allows parents and medical professionals to perform additional tests and take appropri-
ate measures. Sex chromosomal aneuploidies (SCAs) may be diagnosed as incidental 
findings in prenatal diagnostic testing procedures. These SCAs cause syndromes little 
known to most parents, and their postnatal phenotypes are variable. Some individuals 
may suffer from health, fertility, or behavioral disturbances; others may go through life 
without ever knowing they have a chromosomal abnormality. However, these inciden-
tal findings of fetal SCA may give rise to difficult dilemmas in decision-making about 
whether or not to continue the pregnancy.
The studies in this thesis analyze and discuss the different aspects of parental attitudes 
and dilemmas, as well as professional opinions about the benefit or disadvantage of an 
incidental finding of a fetal SCA.
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1.1 CharaCteristiCs of sex ChroMosoMal disorders
Phenotypic spectrum
Sex chromosomal aneuploidies (SCAs) encompass both full-blown and mosaic numeri-
cal aberrations, which may influence the individual’s phenotype to a greater or lesser 
extent. Sex chromosomal aneuploidies give rise to syndromes that interfere with normal 
male or female sexual development, preventing the testicles or ovaries from function-
ing normally and reducing the levels of testosterone and estrogen1-5, even though it is 
known that SCA individuals may go through life without knowing they have a genetic 
anomaly.6-8 A multidisciplinary approach to the screening and treatment of the domains 
of risk is strongly recommended.1,2,3 
45,X, Turner syndrome
In 1938 American endocrinologist Dr Henry Turner first described the main character-
istics of the syndrome. These included small stature, lack of sexual development and 
webbed neck.9 In 1959 the genetic background was demonstrated as 45,X. Several 
health risks that occur during childhood, puberty, or adult life threaten general health 
and life expectancy. Approximately 3% of the expected conditions are diagnosed prena-
tally; approximately 20% at birth because of lymphedema with or without a congenital 
heart defect; 43% in the pediatric population because of otologic problems and small 
stature; approximately 30% in adolescence because of pubertal delay or small stature; 
and 3% after the age of 18 years because of secondary amenorrhea or infertility.10,11
Early otologic disease with adult deafness12,13 is a major problem. Growth disturbance 
with small stature, osteoporosis,14,15 cardiovascular, aortic,16,17 auto-immune18 and meta-
bolic disease1,19 may occur. Some mosaic 45,X girls may exhibit a relatively normal growth 
and may spontaneously enter puberty. There is an increased cancer risk.20 Psychosocial 
problems may vary from low self-esteem or slight autistic traits to important psychiatric 
disease such as psychosis and schizophrenia.2,21 All full-blown 45,X women are infertile; 
those with mosaic 45,X have a serious risk of premature ovarian insufficiency.22 Assisted 
reproduction techniques (ART) with oocyte donation enable procreation. 
47,XXY, Klinefelter syndrome
Klinefelter syndrome was first described by Harry F. Klinefelter in 1942 as a clinical entity 
characterized by gynecomastia, small testes, absent spermatogenesis and increased 
levels of FSH.23 The general health of 47,XXY individuals may be normal, but the existing 
hypergonadotropic hypogonadism and the clinical effects of androgen insufficiency 
often affect it to a greater or lesser extent.24 While many 47,XXY individuals remain undi-
agnosed, it is estimated that approximately 10% of the diagnoses are made prenatally, 
approximately 10% in the pediatric population, and approximately 20% in the adult 
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population. Metabolic and auto-immune disease25-27 and low bone mineral density28 
may be diagnosed in some men with 47,XXY. Thus, two-thirds remains undiagnosed.7,8,29 
The syndrome may seriously affect social interactions, due to mild cognitive and social-
ization impairment, learning disorders, delayed language development, and/or certain 
behavioral disorders.7,30-33 Most 47,XXY individuals are infertile due to degeneration of 
the seminiferous tubules and sclerosis.34 For some 47,XXY men, the diagnosis of the 
syndrome occurs when their infertility is ascertained. In some cases, ART may enable 
procreation with testis sperm extraction and intracytoplasmic sperm injection (ICSI) 
techniques.4,24,35 
47,XXX, Triple X syndrome
Triple X syndrome was first described in 1959 in a 35-year-old woman with normal 
intellectual abilities who presented with secondary amenorrhea at 19 years of age.36 Ap-
proximately 10% of the cases are ascertained clinically. There is considerable variation in 
the phenotype, with some individuals being very mildly affected and others displaying 
more significant physical and psychological features. They may be taller and have longer 
legs than average. There are reports of increased prevalence of thoracic kyphosis, a short 
neck and scoliosis, developmental delay, hypotonia, learning disabilities, and emotional 
or behavioral difficulties. Delayed language development, low self-esteem, motor coor-
dination problems, and certain behavioral difficulties may occur. Psychotic disorders are 
rarely described. There is a certain elevated risk of premature ovarian insufficiency.5,37,38 
Preventive management for developmental and educational delay is recommended. 
Other X–Y aneuploidies (“47,XXY variants” or “X polysomy women”)
The negative effects on physical and mental development increase with the number of 
extra Xs, and each X reduces the overall IQ by 15 to 16 points. Men with extra Ys have 
a higher overall adaptive scale in daily living skills, socialization, and communication.5 
Women with supernumerary Xs have an increased risk of mortality because of cardio-
vascular and respiratory disease and cancer.39
The incidences of specific features such as decreased height, hypertelorism, clinod-
actily, pes planus, dental problems, and medical conditions such as asthma, deep vein 
thrombosis, and type 2 diabetes appear to be greater than the corresponding incidences 
in the general population.40 Certain neurodevelopmental and behavioral disturbances 
may exist, along with mood or tic disorders.40  Boys with extra Xs may be at risk of mal-
adaptive behavior and may have little tolerance of rejection or teasing. Specific recom-
mendations and interventional strategies may benefit their psychosocial functioning.5,30 
Males may have a small penis and small testicles. Infertility and gynacomastia as a result 
of hypogonadism have been reported.41,42
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In conclusion: the most serious problems are encountered in individuals with 45,X 
and 47,XXY. They entail growth disturbance, cardiovascular and metabolic disease, au-
toimmune diseases, increased cancer incidence, endocrinological insufficiency, puberty 
failure, and infertility. An early diagnosis of SCA can enhance the general quality of life 
of SCA individuals because it makes early treatment and preventive programs possible.
incidence
The incidence of all SCAs in humans is 1 in 400 newborns.41,43 The incidence of SCA mo-
saicisms is not exactly known, as mosaic individuals are not always diagnosed because 
of very mild or no evident clinical features. In mosaicism, the co-existence of a normal 
cell line modifies the effect of the aneuploid cells.44 
The incidence of SCA diagnosis after prenatal invasive testing is 1 in 250 to 1 in 300 
individuals.41,45 There is no direct causality to maternal age, but it is important to realize 
that in prenatal testing procedures for advanced maternal age, the incidence of the find-
ing of a fetal SCA is comparable to the incidence of Down syndrome.41,46  
Postnatal versus prenatal incidences 
Due to a high rate of fetal demise, the postnatal incidence of 45,X is 1 in 2000 to 2500 
newborn girls,2,3 resulting in a worldwide occurrence of 1.5 million 45,X women.47,48 
The incidence of diagnosis of 45,X in prenatal testing depends on the presence of fetal 
ultrasound abnormalities and the indication for the testing procedure. 
The 47,XXY abnormality occurs with an incidence of 1 in 500 to 1000 newborn 
boys;4,6,49,50 many 47,XXY individuals remain undiagnosed. Prenatally, the incidence of 
47,XXY diagnosis  is 1 in 650 fetuses;50  it includes 25% of all chromosomal abnormalities 
after invasive prenatal testing. 
The postnatal incidence of 47,XXX is 1 in 1000 newborn girls, the same incidence as 
in prenatal testing.37,38,51 Prenatally, the syndrome is diagnosed in 0.1% of all cases with 
chromosomal abnormalities, generally as an incidental finding.6,38,52 The addition of 
more than one extra sex chromosome is rare; the prevalence of other X–Y aneuploidies 
is estimated at 1 in 18,0005 or less.41 
diagnosis of sCas
Except for 45,X, prenatal ultrasound abnormalities are not encountered in most SCAs 
and no prenatal indication is given of the fetal genetic abnormality. Postnatally, these 
children may have a different phenotype than children with the same SCA for whom 
a prenatal ultrasound abnormality has been found.11 Certain fetal ultrasonographic 
abnormalities are associated with a poor prognosis for the child after birth because 
they reflect early disturbances in organ functioning. Some full-blown SCAs show fetal 
abnormalities that may be discovered with prenatal ultrasound investigation, such as 
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an enlarged nuchal translucency or cardiac abnormalities in 45,X. These ultrasound ab-
normalities may indicate somatic problems, such as heart, lymph, or kidney defects.11,53 
Some case reports of 47,XXY or variant forms of 47,XXY (polysomy X or Y), have de-
scribed ultrasound abnormalities.54-56 The detection of these ultrasound abnormalities 
may be considered as additional karyotype-independent features.49 Generally, no fetal 
ultrasound anomalies are found for most cases with 47,XXX.38 One case report described 
prenatal ultrasound dilated fetal stomach and upper part of the duodenum in duodenal 
atresia (double bubble phenomenon).57
The diagnosis of a fetal SCA may be unforeseen in invasive prenatal testing procedures 
for determining whether the risk of a fetal genetic disorder is increased. Girardin7 and 
Bondy2 described the postnatal phenotypes of fetuses with incidentally diagnosed SCAs 
as less problematic, whereas Zeger58 found no clinical differences between individuals 
with prenatally and postnatally ascertained SCAs. As these syndromes are generally 
unfamiliar to the parents, professionals who are involved in post-test counseling require 
specific knowledge and counseling skills so that they can provide adequate guidance 
and care for these parents.8,59,60  
Table 1 shows relevant prenatal and postnatal characteristics associated with SCAs.  
table 1. Pre- and postnatal phenotypical aspects of SCAs
sex chromosomal aneuploidy Prenatal aspects Phenotypical postnatal aspects
45,x 
turner syndrome
·   Nuchal translucency enlargement 
·  Septated hygroma colli
·  Fetal edema
·  Cardiac abnormality
·  Growth restriction
·  Webbed neck
·  Puffy hands and feet
·  Small stature
·   Health problems: heart, kidney, autoimmune, and 
metabolic diseases
·  Estrogen deficiency
·  No or late puberty
·  No mammary growth
·  Infertility
·  Risk of gonadal dysplasia 
·  Behavioral disturbances
47,xxY 
Klinefelter syndrome
 
 
·  None ·  Large stature
·   Health problems: autoimmune and metabolic 
diseases
·  Testosterone deficiency
·  Risk of bone fragility
·  No or late puberty
·   mammary growth, risk of mammary carcinoma
·  Infertility
·  Risk of gonadal dysplasia
·  Behavioral disturbances
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1.2 sex ChroMosoMe aneuPloidY: eMerGenCe, x inaCtivation, 
GenetiCs, and CounselinG asPeCts
emergence of fetal sCa
Most genetic abnormalities are the result of a random event that occurs during the 
formation of the haploid reproductive cells followed by a fusion to generate the diploid 
embryo. Partly because of this, all pregnant women have an approximately 3% risk of 
carrying a child with a genetic abnormality; 0.5% of this risk is of chromosomal autoso-
mal or sex chromosomal aneuploidies.61 
In the normal human genotype, each cell contains 46 chromosomes, including two 
sex chromosomes: either XX or XY. The normal female genotype is 46,XX, while the 
normal male is 46,XY. The fusion of two haploid cells creates the fetus – a woman’s egg 
and a man’s sperm. Each fetal cell is then diploid – it contains 46 chromosomes. During 
meiosis, the formation of four haploid cells from one precursor cell is of fundamental 
importance. However, this process does not always work perfectly and may sometimes 
lead to aneuploidy due to misdivision of a chromosome pair. A more complex situation 
occurs after a mitotic misdivision of a chromosome pair. This event creates an embryotic 
cell-line with an extra copy of a chromosome and another cell-line lacking this chromo-
some next to the normal cells. Such co-existence of genetically different cells within the 
same individual is called mosaicism.
x inactivation
In normal 46,XX women, one of the X chromosomes is inactivated during the early blas-
tocyst stage of embryonic development and does hardly contribute to transcription. 
The inactivated X chromosome may be of maternal or paternal origin. This inactivation 
occurs randomly, and it leaves only one X chromosome fully functioning in each cell of 
the body.62-65 The remaining condensed and inactivated X takes only very little part in 
the transcription of genetic information. Its genes, therefore, contribute much less to 
the function of the cell. 
table 1. Pre- and postnatal phenotypical aspects of SCAs (continued)
sex chromosomal aneuploidy Prenatal aspects Phenotypical postnatal aspects
47,xxx 
triple x syndrome
·  None ·  Large stature
·   Risk of premature ovarian insufficiency
·  Behavioral disturbances
other x or Y polyploidies ·  None ·  Variable
·  Behavioral disturbances
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In normal 46,XY men, the X chromosome is of maternal origin and is normally active. 
The number of genes on the Y-chromosome is limited, while the SRY gene, which is 
located on the short arm of the Y chromosome acts as the primary factor for developing 
the testes. The long arm contains several genes, necessary for spermatogenesis. These 
genes are typically situated in three regions of Yq11 (AZFa, AZFb and AZFc). Deletions in 
AZFc are the most common ones, and they are associated with oligozoospermia or the 
complete absence of germ cells.66-68 
In men and women who have SCAs with supernumerary X chromosomes the rela-
tive small number of transcribed genes from the inactivated X chromosomes probably 
contribute to the phenotypical abnormalities of individuals with an SCA.63,69,70
sex chromosome aneuploidies and genetics
45,X, Turner syndrome
Monosomy 45,X, or having only one X-chromosome in all cells, is the most frequently 
occurring karyotype in Turner syndrome anomalies (50%) and is the only chromosomal 
monosomy compatible with life. A significant number of the X chromosome genes 
escape inactivation, and the loss of these non-inactivated X genes cause the phenotypic 
manifestations characteristic of the Turner syndrome.69,71  The incidence of this genetic 
anomaly is 3% of all female conceptions, 99% of which are lost during early pregnancy.48 
Thirty to forty percent of these individuals have a mosaicism, with two or more chromo-
somally different cell lines, for example 45,X/46,XX; 45,X/47,XXX; or 45,X/46,XY. The level 
of mosaicism depends on the time of the occurrence in the embryo after fertilization. A 
mitotic error that occurs at a later stage after fertilization may lead to an abnormal line of 
cells confined to the placenta or a certain area or tissue in the developing individual.72-75 
Other patients have structural sex chromosome anomalies such as deletions or ring 
chromosomes or a karyotype with a duplication of the long arm of the X chromosome 
together with a deletion of the short arm (isochromosome, 46,X,i(Xq)), showing the 
complete Turner phenotype.1,47,76,77 Prenatally, 45,X is diagnosed after prenatal invasive 
testing often because of fetal ultrasound anomalies; fetal hydrops and septated nuchal 
hygroma are typically associated with 45,X.77-79 Other anomalies may come forward as 
incidental findings in prenatal testing procedures aimed at the exclusion of another ge-
netic anomaly.80,81  Due to the complexity of the post-zygotic mechanism of emergence 
of this SCA, 45,X mosaicism may be present in cell lines that are not easily detectable in 
prenatal diagnostic testing. 
The exact nature of the abnormality on the X chromosome will determine the effect 
on the phenotype. For instance, deletions in the long arm of one of the X chromosomes 
(Xq) may lead to gonadal dysgenesis, whereas deletions in the short arm (Xp), includ-
ing the SHOX gene, may be compatible with normal gonadal function, but lead to a 
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small stature and other skeletal anomalies in the affected women.80 The presence of 
Y chromosome material in certain cell lines increases the risk of androgen-producing 
gonadal tumors, such as gonadoblastoma and dysgerminoma,82,83,84 and may result in 
in genital abnormalities ranging from hypospadias to genitalia ambiguity. The use of 
sensitive polymerase chain reaction (PCR) techniques enables the detection of such 
Y-chromosome-specific material in 12% of the initially pure 45,X females.84 Women who 
present with the complete Turner phenotype often have a mosaicism of 45,X cell lines in 
combination with an isochromosome Xq.3,80 
47,XXY, Klinefelter syndrome
The karyotype of males with supernumerary X chromosomes will be full-blown 47,XXY 
in 90% of the diagnosed cases,85 but mosaicism with normal male or female cell lines, 
mosaicisms with trisomy cell lines of chromosome 18 and 21, and polyploidy of the 
X or Y chromosomes have been described: 47,XXY/46,XY; 47,XXY/46,XX; 48,XXY+18; 
47,XXY+21; 48,XXXY; and 48,XXYY. The occurrence of a double aneuploidy often leads 
to a miscarriage.49 The additional sex chromosome is almost as likely to come from the 
father as from the mother.86 
It has been firmly established that a higher polyploidy of X chromosomes is nega-
tively correlated with the phenotype of the patient, while the role of X chromosome 
inactivation leading to the variability in 47,XXY phenotypes has not yet been completely 
unraveled.70,87 Most importantly, the postnatal phenotype mainly affects behavior and 
mental capacity.7 
47,XXX, Triple X and other supernumerary X syndromes
Women with supernumerary X chromosomes usually have the 47,XXX karyotype, but 
48,XXXX and 49,XXXXX also occur. Ninety percent of the extra X chromosomes are of 
maternal origin as a result of nondisjunction in meiosis I.37,52 The extra X chromosomes 
are always inactivated (n-1 rule), although, as mentioned before, not completely,88 and 
unbalanced expression of X chromosomal genes may therefore contribute to subopti-
mal brain development. 
Most 47,XXX women have normal phenotypes, but there are risks of premature 
ovarian insufficiency and behavior disturbances. Like in males, a higher polyploidy of X 
chromosomes increasingly affects the phenotype, which in turn affects behavior.5 
A certain association of a 47,XXY or 47,XXX outcome with advanced maternal age has 
been reported,6,45 but not for 45,X. Of all 45,X cases, 55%89 to 83%90 appeared to be 
diagnosed by routine karyotyping after the detection of ultrasound abnormalities. The 
detection of most other SCAs were incidental findings during prenatal testing aimed at 
the exclusion of another genetic anomaly.11,49,91 
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sex chromosome aneuploidies and counseling 
In general, counseling parents after a prenatal diagnosis of SCA is a complex issue be-
cause of the large variability in the postnatal phenotypic consequences of the diagnosed 
genetic abnormality. Differences in attitude and approach of the genetic specialists and 
the obstetrical or neonatal counselors may influence the communication of the infor-
mation about the fetal abnormality.59,92-95 It has been shown that a highly structured 
home environment has an important positive influence in reducing the emergence of 
psychological disorders in SCA.44
45,X
The prenatal diagnosis of 45,X after invasive diagnostic testing provides difficulties for 
the counselor because phenotypic consequences may be hard to predict. In the case of 
fetal ultrasound anomalies, the prognosis of phenotypic outcome depends on the exact 
nature of the fetal anomaly. If no ultrasound anomalies are detected in the fetus, the 
prenatal diagnosis of 45,X is often an incidental finding in testing aimed at the exclusion 
of another genetic anomaly.2 
Due to the possibility of mosaicisms, two or more cell lines may co-exist in the fetus, 
some of which may not be detectable in amniotic fluid or chorion villus tissue. After the 
prenatal finding of a 45,X without the presence of any fetal abnormality, this cytoge-
netic diagnosis has limited predictive value because low grade mosaicism is difficult to 
exclude. These circumstances result in a wide range of possible associated phenotypes. 
The more aberrant cell lines co-exist within a SCA individual, the more they affect the 
phenotype, but the complete genetic scale of co-existing cell lines is not necessarily 
visible prenatally. The presence of a cell line with a normal female genotype is favorable 
to the prognosis of the postnatal phenotype.44,80 
Parents are often counseled about the typical small stature, the webbed neck, the 
cardiovascular diseases, the behavioral difficulties and the infertility, but there is no 
guarantee that the postnatal phenotype will indeed lead to all of these problems in 
incidentally diagnosed cases.2,59,80,94,95 
47,XXY
Prenatal diagnosis of 47,XXY is generally an incidental finding in a testing procedure 
aimed at excluding another genetic anomaly. Fetal ultrasound anomalies are not often 
encountered, whereas the presence of more X chromosomes (such as 49,XXXXY) often 
corresponds to abnormal fetal growth.5,96 
The co-existence of two or more cell lines in 47,XXY mosaicism may have a major im-
pact on postnatal phenotype. The presence of a mosaicism and another chromosomal 
anomaly (such as a trisomy 21) negatively influences the phenotype. This is also the case 
for 47,XXY syndromes with more X chromosomes: these genotypes correspond with 
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more postnatal phenotype abnormalities in health, behavior, and fertility associated 
with specific brain anomalies.5,40,96,97 Co-existence with a normal male cell line is prog-
nostically beneficial. The individual shows very few phenotypic aspects, so that fertility 
may not be completely disturbed and adolescent sperm recovery may be possible to 
enable procreation in a later stage of life.4
The counseling after an incidental prenatal finding of 47,XXY entails providing the 
parents with information about the very broad scale of the postnatal phenotype of 
these males. On one side, this scale shows a normal, self-supporting male individual 
without any health or behavior problems,95 but ultimately he will discover his genetic 
anomaly in his medical search for the reason for his infertility. On the other side of the 
scale, a male individual may have many health and behavior problems, and even very 
serious metabolic, auto-immune or psychiatric disorders.7  
47,XXX
In most cases, the prenatal diagnosis of 47,XXX is an incidental finding in a testing pro-
cedure aimed at excluding another genetic anomaly. Fetal ultrasound anomalies that 
typically correspond with this genotype are uncommon. There are some case reports in 
which 47,XXX was diagnosed after the detection of fetal ultrasound abnormalities,98,99 
but a typical association of specific fetal anomalies that point to 47,XXX have not been 
described.
Mosaicism with normal cell lines may occur, and it influences the postnatal phenotype 
positively. The opposite is true of mosaicisms with genetically abnormal cell lines. More 
X chromosomes correspond with a more abnormal phenotype in health and behavior.5 
Counseling after the incidental prenatal finding of a 47,XXX entails the description of a 
relatively normal physical appearance, the risk of premature ovarian insufficiency, and 
the possibility of slight behavior disturbances, which may benefit from early support 
treatment.37,38
1.3 fetal investiGation: sCreeninG and diaGnostiC tests, 
non-invasive and invasive tests, tarGeted or GenoMe-wide 
testinG, and inCidental findinGs assoCiated with sCas
screening tests
Non-invasive: first-trimester screening
All pregnant women are now offered a non-invasive, first trimester, screening test via 
nuchal translucency measurement (Figure 1A-C) combined with serum measurement of 
pregnancy-associated plasma protein A (PAPP-A) and free beta human chorionic gonad-
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otropin (hCG).100-102 The purpose of the screening test is to identify a well-defined target 
population, i.e., pregnant women at risk of having a child with Down syndrome.103-106 
If the screening result is positive, subsequent invasive diagnostic testing in conjunc-
tion with karyotyping is offered. Since karyotyping is a full-scale test, all chromosomal 
aneuploidies with potential diagnostic and prognostic significance are detected. First-
trimester ultrasound may also reveal important structural defects in the fetus, such as 
anencephaly. These findings may have important implications for the parents’ decision-
making about continuing the pregnancy.107 
The first-trimester screening test reveals no major abnormalities for most SCAs, but for 
45,X, early fetal hydrops or a septated nuchal translucency is associated with a negative 
prognostic outcome: survival to term is reported to be less than 10%.2
Non-invasive: ultrasound findings in the second-trimester screening 
Most parents consider fetal assessment by ultrasound to be a social ritual of meeting 
the baby,108 but from the professionals’ point of view, it is an important tool for prena-
figure 1a-C First-trimester screening test, ultrasound:
(source: Department of Obstetrics and Gynecology, Division of prenatal diagnosis and therapy. Radboud 
University Nijmegen Medical Centre  Nijmegen, the Netherlands)
  
 
A. Normal nuchal translucency measurement
B. Enlarged nuchal translucency 
C.  Anatomic view: left fetus with normal nuchal translucency, the right fetus with an enlarged nuchal translucency
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tally detecting many fetal congenital abnormalities.109,110 Second-trimester ultrasound 
screening may reveal structural fetal defects that may be associated with certain chro-
mosomal aberrations. Soft markers for chromosomal abnormalities may be detected, 
such as choroid plexus cysts (Figure 2A), renal pelvic dilatation (Figure 2B)111-114  in which 
case, karyotyping of the fetus is advised. An incidental discovery of a skeletal dysplasia 
on routine ultrasound screening or fetal biometry that does not fit exactly within the 
standard fetal growth cards is a reason for additional diagnostic karyotyping. 
No important ultrasound abnormalities are found for most SCAs except 45,X. Nuchal 
septated hygroma, cardiac abnormalities, fetal hydrops (Figure 2CD) and growth restric-
tion are often encountered, and subsequent karyotyping may reveal the syndrome.2 No 
specific second-trimester ultrasound findings for other SCAs point to a fetal syndrome, 
apart from some cases with supernumerary X chromosomes. Intra-uterine growth re-
striction and sporadically major structural defects can be found in these cases.5 
diagnostic tests: non-invasive and invasive
Non-invasive test: ultrasound as diagnostic tool
Major congenital defects, such as neural tube defects (Figure 3AB), kidney malforma-
tions as well as lymphatic system (Figure 4) or cardiovascular anomalies (Figure 5ABC) 
possibly associated with a fetal aneuploidy may be diagnosed.1,103,115 The accuracy 
of ultrasound imaging of fetal abnormalities has improved in recent years due to the 
introduction of 3D and 4D ultrasound.116,117
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figure 2 A-D. Second-trimester screening test, ultrasound : (source: Department of Obstetrics and 
Gynecology, Division of prenatal diagnosis and therapy. Radboud University Nijmegen Medical Centre  
Nijmegen, the Netherlands) 
 a. isolated plexus chorioideus cyst  in fetal brain. Choroid plexus cysts are believed to be caused by abnormal folding of 
the epithelium lining of the choroid plexus which traps fluid and debris. More than 90% of choroid plexus cysts resolve 
spontaneously by 28th weeks’ gestation. 
B. fetal hydronephrosis, dilation of the renal collecting system. The collecting system is the structure that collects urine 
directly from the kidney tissue and routes it by way of the ureter to the bladder. Blockage of urine flow can possibly lead 
to infections, scarring, and long term damage of the kidney.
C. d. fetal hydrops, an accumulation of fluid, or edema, in at least two fetal compartments. Here, pleural effusion results 
in skin edema (C) and hydrothorax (D). 
A-D are soft markers for fetal aneuploidy
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figure 3B.
 
Associated “lemon sign” of the fetal head, a characteristic scalloping of the frontal bones. This is a result of the tethering 
of the spinal cord with subsequent downward displacement of the brain as the fetus grows (Sebire 1997).
figure 3a.  Non-invasive diagnostic test, ultrasound:
(source: Department of Obstetrics and Gynecology, section prenatal diagnosis and ultrasound. Radboud University 
Nijmegen Medical Centre  Nijmegen, the Netherlands)
 
Neural tube defect, one of the most common birth defects. It is an opening in the spinal cord or brain that occurs very 
early in human development. In the 3rd week of pregnancy called gastrulation, specialized cells on the dorsal side of 
the fetus begin to fuse and form the neural tube. When the neural tube does not close completely, an NTD develops. 
Examples of open NTDs are anencephaly, encephaloceles, hydranencephaly, iniencephaly, schizencephaly,and spina 
bifida. Rarer types of NTDs are called closed NTDs. Closed NTDs occur when the spinal defect is covered by skin.
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figure 4. Ultrasound malformation associated with fetal SCA:
 
Large hygroma colli, an anomaly of the lymphatic system characterized by single or multiple cysts within the soft tissue, 
usually involving the neck. It contains a clear or cloudy fluid-like lymph. Here a septated hygroma is shown, typically 
associated with bad prognosis in 45,X.
figure 5 A-C.
 
 
 
a
B
C
figure 5a. Normal 4-chamber view of the fetal heart, normal dimensions of atria and ventricles, normal foramen ovale, 
normal and continuous ventricle septum.
figure 5B. Ventricular septal defect. Abnormal 4-chamber view of the fetal heart, with abnormal dimensions of the atria 
and ventricles with a defect seen in the ventricle septum. 
figure 5C. Color doppler technique will reveal the blood flow from left to right ventricle through the defect. This 
abnormality may be associated with 45,X
26 Chapter 1
Invasive test: karyotyping
Traditional karyotyping of the fetuses of pregnant women with an elevated risk of fetal 
aneuploidy can be performed using an invasive procedure, namely, chorion villus biopsy 
or amniocentesis, between 10-11 and 15 weeks of gestation (Figure 6A-D). In human 
embryology, the chorion is defined as the layer consisting of the trophoblast plus the 
underlying extraembryonic mesoderm. Amniotic fluid contains amniocytes in addi-
tion to fetal cells from the skin, genitourinary system, and gut, along with biochemical 
products that may be removed for analysis. Mosaicisms found in the chorion may only 
be related to placental tissue;72 (mosaic) aneuploidies found in amniocentesis directly 
relate to the fetus.
If fetal ultrasound abnormalities are detected in the second-trimester, amniocentesis 
may be performed, with a slightly smaller risk of miscarriage. Overall, invasive prenatal 
testing carries a certain risk of pregnancy loss (0.2-0.5%).118 
figure 6a-d. Invasive diagnostic test, karyotyping:
(source: Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands)
a. 46,XX, karyotype of normal female    
B. 46,XY, karyotype of normal male
C. 45,X, karyotype of female, missing one X-chromosome, a condition associated with Turner syndrome
d. 47,XXY, karyotype of male with an extra X-chromosome, a condition associated with Klinefelter syndrome
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Rapid aneuploidy detection 
Interphase fluorescent in situ hybridization (FISH) (Figure 7A-D), multiplex ligation-
dependent probe amplification (MLPA) and quantitative fluorescence polymerase chain 
reaction (QF-PCR) (Figure 8AB) are available for rapid aneuploidy detection (RAD) of the 
most common chromosome anomalies, specific for chromosomes 13, 18, 21, X and Y. 
These techniques may be useful in cases with fetal ultrasound abnormalities, and enable 
rapid diagnosis in 2 or 3 days.119  The accuracy of these rapid testing techniques in de-
tecting non-mosaic common aneuploidies is similar to that of traditional karyotyping,120 
but low grade mosaicisms and uncommon aneuploidies are not detected.121,122
figure 7a-d. Rapid aneuploidy detection, FISH:
(source: Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands)
 
a. normal male: 1 green signal for X chromosome, 1 red signal for  Y chromosome 
B. Klinefelter male: 2 green signals for X chromosome, 1 red signal for  Y chromosome
C. normal female: 2 green signals for X chromosome
d. Turner female: 1 green signal for X chromosome
(2 blue signals for chrom. 18: control for disomy)
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figure 8aB. Rapid Aneuploidy Detection, QF-PCR:
(Source: Aneufast User’s Manual Revised 2007)
a. Normal XX female sex chromosome constitution
Only the X- specific product of the AMXY is present and SRY is not amplified.
Both pseudoautosomal markers (X22 and DXYS218) and the X-linked HPRT are normal heterozygous, reflecting a normal 
XX sex chromosome complement. Four markers on chromosome 21 (D21S1414, D21S1411, D21S1446, D21S1435), 18 
(D18S535, D18S391, D18S386, D18S390) and 13 (D13S631, D13S634, D13S258, D13S305) are normal heterozygous, 
confirming the presence of normal chromosome copy number for these autosomes. 
B. Detection of monosomy X 
X chromosome monosomy is indicated by the single fluorescent products for the two pseudoautosomal markers (X22 
and DXYS218 ) and the X-linked HPRT, in the absence of Y-specific products of AMXY and SRY.
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new technological advances and future:
Micro-array testing
Recent implementation of array genomic hybridization technology in prenatal diag-
nostics may give rise to the diagnosis of genetic aberrations that may or may not be 
associated with the observed fetal ultrasound abnormalities. In these cases, certain 
postnatal prognoses cannot always be given.123-125 Micro-array testing is used usually 
after the exclusion of a fetal aneuploidy, to represent genome-wide screens for detect-
ing sub-microscopic chromosomal deletions or duplications that are associated with 
serious fetal ultrasound abnormalities. The array test provides the possibility to reveal 
the deletion of a gene that is known to prevent cancer. Such a deletion significantly 
increases the lifetime risk of developing cancer. Genetic aberrations may come forward 
of which the clinical significance is as yet unclear, or family members may be diagnosed 
with a genetic abnormality that may have a negative effect on their (future) health.
Next-generation sequencing of cell-free fetal DNA in maternal plasma 
Application of fetal cells and fetal cell-free genetic material in the maternal blood are 
two approaches currently being investigated. They are promising with regard to the 
rapid and reliable detection of fetal genetic abnormalities.126-130 
1.4 the right to inform and to be informed about incidental findings and 
ethical and policy dilemmas
While the novel molecularly targeted approaches focus on the diagnosis of specific 
genetic diseases, current discussions tend to focus on the possibility of full-scale 
testing using microarray-based techniques with a maximum of genetic information at 
an unequaled detection level. The use of these novel molecular genetic technologies 
for prenatal diagnoses gives rise to many ethical, social, and medico-legal problems 
and dilemmas.131,132 From the ethical point of view, the parents’ autonomous “right 
to know” versus “the right not to know” is of topical interest.133  In view of these new 
technological developments, it is relevant to examine the parents’ preference, i.e., 
whether women considered to be at high risk of having a child with Down syndrome 
who undergo invasive testing would opt for full-scale genetic testing  for other 
disorders for which they do not have an a priori increased risk.
The right to be informed has been the basis of current laws and regulations “Everyone 
has the right to seek, receive and impart information”.134 The debate about patients’ right 
to be informed of their health status and treatment began in the mid-twentieth century 
in the United States, where these rights have now been consolidated and can still be 
considered an example for many countries in the world.135 In its Charter of Fundamental 
30 Chapter 1
Rights of the European Union of 2000, the European Union states that free and informed 
consent of the patient must be respected according to the procedures laid down by the 
law of each country. These codes refer to the Hippocratic Oath, which obliges physicians 
never to harm their patients.136,137 The right to information can be understood as an 
update of the Hippocratic obligation that refers to the relationship between physicians 
and patients. The patients’ right to information can be considered a result of mutual 
trust. In the case of an incidental finding in pregnancy with an uncertain prognosis, two 
patients are involved: the pregnant woman and the fetus. The benefits for each of them 
are unclear. 
New communication technologies are both a risk and an opportunity. There is an 
increasingly important role for the Internet to provide additional medical information, 
aside from professional information. The access to and acquisition of large amounts of 
information has become an obvious right. The relevance of the acquired information 
varies for each person, and this applies to all kinds of genetic information. The Internet 
service can be critical in providing extended medical information, which should always 
be discussed with a professional.138 
In view of the new technological developments in prenatal testing, the parental 
preference is an important factor.119,139,140 The question is whether women considered 
at high risk of having a child with Down syndrome and who undergo invasive testing 
would opt for full-scale genetic testing, even for disorders for which they do not have 
an a priori increased risk. It is not always easy to choose between full-scale testing using 
microarray-based techniques with a maximum of genetic information and molecularly 
targeted approaches that focus on the diagnoses of specific genetic diseases. Chromo-
some abnormalities are associated with severe, moderate, or mild disease, although 
sometimes the clinical relevance is uncertain. Many women who undergo invasive 
prenatal tests are unaware of the possible adverse effects of an uncertain prognosis.141 
Herein lies an important task for the professionals who are responsible for the pre-test 
counseling.
1.5 aim and outline of the thesis
Aim
The aim of the thesis was to examine the value - in a positive or negative sense - of the 
incidental finding of a fetal sex chromosomal aneuploidy in invasive prenatal diagnostic 
procedures. The main study question was whether the incidental finding of a fetal sex 
chromosomal abnormality is a diagnostic gain or whether it should be omitted because 
of diagnostic damage.
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Outline of the thesis
In order to answer the main study question, we have formulated some questions that 
are closer to the heart of the matter: 
1. What are the attitudes of women in low-risk pregnancies towards full-scale genetic 
testing? Chapter 2 reports the answers.
2. What is known about the problems most often encountered by SCA-afflicted indi-
viduals? What has recently been published in the medical literature about incidental 
prenatal findings of sex chromosomal aneuploidies and the postnatal phenotypes 
of these individuals? Chapter 3 reports a review of this selected literature and its 
conclusions.
3. What are the perspectives of parents who have been confronted with an unforeseen 
prenatal finding of a sex chromosome aneuploidy (full blown or mosaic) when 
they think about the events in retrospect? What were their reasons for continuing 
or terminating the pregnancy? Two qualitative interview studies were set up – one 
with parents who decided to continue the pregnancy and one with parents who 
decided to terminate the pregnancy. Chapters 4 and 5 present their responses. 
4. What are the views of medical professionals who counsel the parents and treat SCA 
individuals? These experts may decisively affect the parents’ considerations and 
decision-making, and they are involved in future medical policy changes. Chapter 
6 reports the results of our qualitative interview study with several experts in this 
field. 
During the study period, we had a scientific discussion with authors of a recently pub-
lished review of factors that may influence the decision-making of parents confronted 
with a prenatal diagnosis of an SCA. Chapter 7 presents a letter to the editor of the 
journal Genetics in Medicine and the response of the authors to this letter.
The most important items that emerged for the literature study, as well as the results 
and conclusions of the three qualitative studies, have been assembled in a such way 
that they provide a practical answer to our main study question. Chapter 8 presents this 
material in relation to recent literature (General Discussion).
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objectives
Innovations in the field of prenatal diagnostic testing have led to the development of 
molecular tests that allow the rapid detection of specific genetic defects, such as Down 
syndrome. In addition, full-scale tests have been developed allowing the detection of 
many genetic disorders in a single test. Here we examined the attitudes of pregnant 
women in low risk pregnancies towards full-scale genetic testing and explored relation-
ships between demographic characteristics and the level of interest.
Methods
A prospective study was performed on 115 consecutive pregnant women. They com-
pleted the same structured questionnaire at two different time points, before counsel-
ling (T1) and after 4 weeks (T2), to assess a possible change of attitude.
results 
At T1, 33% of the respondents were in favour of full-scale testing of their unborn child, 
whereas at T2, this percentage had dropped to 18%. Except for educational level, no 
significant relationships were noted between the demographic variables and the wish 
to opt for full-scale testing. A low educational level was significantly related to the inter-
est in full-scale testing.
Conclusions 
Low risk pregnant women expressed little interest in full-scale genetic testing. Educa-
tional level appeared to affect their views.
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introduCtion
Since January 2006, the guidelines on prenatal tests have changed in the Nether-
lands.1 All pregnant women are now offered the opportunity to undergo a non-invasive 
first trimester Down syndrome screening test via nuchal translucency measurement 
combined with serum measurement of PAPP-A and free beta hCG.2-4 The objective of 
the screening test is to identify a well-defined target population, i.e., pregnant women 
at risk for having a child with Down syndrome. If the screening result is positive, subse-
quent invasive testing in conjunction with karyotyping is offered. Since karyotyping is 
a full-scale test, next to trisomy 21 (Down syndrome) other chromosomal aberrations 
with potential diagnostic and prognostic significance may be detected. In addition to 
traditional karyotyping, recent molecular genetic innovations have led to the develop-
ment of microarray-based genomic profiling technologies that allow full-scale screen-
ing for chromosomal anomalies at an until recently unprecedented resolution.5-7 This 
technique might be particularly useful for those cases in which fetal malformations are 
manifested by ultrasound investigation. In contrast, the recent introduction of quantita-
tive PCR-based techniques have led to the development of tests that allow the detection 
of specific genetic defects such as trisomy 21.8-11
Recently, we implemented targeted testing for Down syndrome by multiplex ligation-
dependent probe amplification (MLPA) in our diagnostic clinical service. Within this 
service, the parents have the autonomy to choose between targeted testing and full-
scale testing. This new possibility is of topical ethical interest in terms of the parent’s 
autonomy to make their own decisions. In a Dutch national study, M.A.K.E. (MLPA and 
karyotyping, an evaluation) the parent’s preference for MLPA and traditional karyotyp-
ing is examined.12 
While the novel molecularly-targeted approaches focus on the diagnoses of specific 
genetic diseases, current discussions tend to focus on the possibility of full-scale test-
ing using microarray-based techniques, with a maximum of genetic information at an 
unequalled detection level. The use of these novel molecular genetic technologies for 
prenatal diagnoses gives rise to many ethical, social and medico-legal problems and 
dilemmas.13,14 From the ethical point of view, the parent’s autonomous ‘right to know 
versus not to know’ is of topical interest.15 In view of these new technological develop-
ments, we examined the parent’s preference, i.e., whether women considered at high 
risk of having a child with Down syndrome and undergoing invasive testing, would opt 
for full-scale genetic testing also for disorders for which they do not have an a priori 
increased risk. In this prospective pilot study, being part of a larger study on general 
knowledge on prenatal testing, we examined whether specific demographic variables 
affected the women’s preferences towards full-scale testing.
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Methods
From October 2004 to March 2005, pregnant women who visited the prenatal outpa-
tient clinic at the St. Elisabeth Hospital Tilburg, the Netherlands were approached before 
their intake consultation and invited to take part in this prospective pilot study. During 
this intake consultation all possibilities of prenatal screening and diagnostic tests were 
explained by the genetic counsellor. After this consultation, the women were asked to 
make an appointment for performing of one of the tests. The test population comprised 
a non-selected group of pregnant women, whether or not referred by a midwife or gen-
eral practitioner, mostly accompanied by their partner. Women who were not proficient 
in the Dutch language were excluded. 
All participants completed the same questionnaire at two different time points (T1 
and T2), with an interval of at least 4 weeks. The reason for using the same questionnaire 
was to examine the basic knowledge at T1 and the possible increase in knowledge (and 
change of views) at T2, thus after prenatal intake consultation. This same interval period 
is also used in studies examining the effect of an intervention.16,17 Completion of the 
questionnaire at T1 took place before the prenatal intake consultation, whereas comple-
tion at T2 took place by telephone 4 weeks later at a pre-arranged time. 
The two questions that are relevant for this study were:
1. Imagine that you undergo amniocentesis or chorionic villus sampling and 
the technique is so advanced that a whole range of abnormalities or diseases can be 
detected, even abnormalities that will not affect your child until later in life. Would you 
want to know all possible genetic information of your future child? When the answer 
was yes, the second question was asked.
2. Would you be willing to wait a little longer for the results, or would you rather 
hear them quickly and in brief?
The questionnaire contained also a few multiple choice questions, which could give 
some insight in their general knowledge and comprehension of the prenatal test that 
they had asked for and were about to undergo. This information, however, will not be 
evaluated here and lies beyond the scope of this article.
Demographic data were obtained on age, parity, a priori risk, educational level 
(low versus middle/high), previous experience with fertility treatment and previous 
experience with prenatal testing. To analyse possible relationships between these de-
mographic data and the dependent variables, responses were analysed using Phi and 
Cramer’s V tests. Logistic regression analysis was performed to identify demographic 
characteristics that could predict a respondent’s attitude towards full-scale testing of 
her unborn child. The study was approved by the medical ethics committee of the St. 
Elisabeth Hospital.
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results
The response rate before prenatal counselling (T1) was 100%, i.e., all couples who were 
eligible for the study and were asked to participate indeed answered our questionnaire. 
At the second time point, 4 weeks later (T2), 20 respondents dropped out with no clear 
reasons given, which turns the response rate at T2 into 83%. 
low educational level influenced the number of couples dropping-out
Table I shows an overview of the obtained demographic variables of the respondents 
at T1 and T2. The majority of patients had a middle/high educational level (87.8% at T1; 
92.6% at T2). As stated above, a total of 20 respondents dropped out between T1 and T2. 
Low educational level of the respondents (Table II) was significantly related to this drop-
ping out (p=0.002). The other demographic variables were not found to be associated 
with the decision to drop out of the study.
table i. Demographic characteristics of the participants at T1 and T2.
Study variables N (%) at T1 N(%) at T2 Study variables N(%) at T1 (115) N(%) at T2 (95)
Age<36
Primigravida
No earlier PND
No earlier fertility treatment
Educational level
A: low
No risk a priori
66 (57.4)
40 (34.8)
96 (83.5)
95 (82.6)
14 (12.2)
113 (99.1)
56 (58.9)
31 (32.6)
79 (83.2)
79 (83.2)
7 (7.4)
94 (98.9)
Age>36
Primigravida
No earlier PND
No earlier fertility 
treatment
Educational level
B/C: middle/high
49 (42.6)
75 (65.2)
19 (16.5)
20 (17.4)
101 (87.8)
2 (1.7)
39 (41.1)
64 (67.4)
16 (16.8)
16 (16.8)
88 (92.6)
1 (1.1)
table ii. Educational level of the participants, drop-out.
Educational level Type of schooling Education no. of years N (%) at T1 (115) N(%) at T2 (95)
A: low
B: middle
C: high 
Primary school, lower secondary 
vocational education, junior secondary 
education
Senior secondary vocational education
First degree level vocational education, 
university or equivalent
Max. 12
12 or more
12 or more
14 (12.2)
45 (39.1)
56 (48.7)
7 (7.4) p=0.002
40 (42.1)
48 (50.5)
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limited interest in full-scale testing and association with educational 
level
At T1, 33% of the respondents (38/115) were interested in full-scale testing. This number 
decreased to 18% (17/95) at T2, 4 weeks after the intake consultation. The respondents 
with a low educational level had higher preference for full-scale testing (T1: p=0.026; T2: 
p=0.049). None of the other demographic variables showed a significant relationship 
(Table III).
negative attitude towards invasive diagnostics and association with low 
educational level
This pilot study enquired specifically about the respondent’s attitudes towards invasive 
diagnostics (amniocentesis and chorionic villus sampling). The results showed that 
educational level was  significantly related (p=0.031) to the respondent’s attitudes. 
More respondents with a low educational level had a negative attitude towards invasive 
techniques than those with a higher educational level.
decrease in interest in full-scale testing
In our study population, 15% of the respondents retracted their original decision to opt 
for full-scale testing after 4 weeks. The vast majority of these respondents had a middle/
high educational level (92.3%), as respondents with low educational level mostly ad-
hered to their prior wish to opt for full-scale testing. In contrast, one respondent who 
did not opt for full-scale testing at T1 opted for this possibility at T2. At T1, 71% (27/38) 
of the respondents who opted for full-scale testing indicated that they would be willing 
to wait longer for the results, whereas at T2 this percentage had dropped to 47% (8/17). 
None of the demographic variables appeared to be related to this change in opinion.
Taken together, we conclude that the respondent’s interest in full-scale testing was 
generally limited and that this applied particularly to women with a middle/ high edu-
cational level. Women with a low educational level did not exhibit a positive attitude 
towards invasive testing but, in  contrast, appeared to be more interested in full-scale 
table iii. Influence of demographic variables on interest in full-scale testing at T1, T2.
Independent variables T1: interested in full-scale testing T2: interested in full-scale testing
Age (yrs)
Parity
Educational level*
Earlier PND
Fertility treatment
Risk a priori
p=0.472
p=0.262
P=0.026
P=0.569
P=0.504
P=0.693
p=0.418
P=0.256
P=0.049
P=0.484
P=0.624
P=0.842
*Low versus middle/high.
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testing. This latter result may be explained by limited understanding and knowledge 
about the procedure and the implications of full-scale testing within this group. There 
appears to be a positive relationship18 between the level of education and correctly an-
swering general questions about prenatal diagnostic tests before counselling (Table IV). 
The higher the level of education, the more correct answers were given at T1. Therefore, 
the level of  education appears to be a significant predictor of giving the correct answers 
at T1 (Table V).
disCussion
The results of this prospective pilot study indicate that if full-scale testing was made 
available for low risk pregnant women as part of invasive diagnostics, they would not 
accept this unquestioningly. An additional aim of the questionnaire survey used was 
to determine whether certain demographic variables may affect the respondent’s 
attitudes towards full-scale testing. Special attention was given to the relationship 
between educational level and the answers given to our two questions. The majority 
of the respondents (67%) stated that they would not opt for full-scale testing and this 
percentage increased to 82% 4 weeks after the intake consultation.
No demographic characteristics could be found that were significantly associated with 
the decision to refuse full-scale testing. A low educational level, however, appeared to 
table iv. Significant relationship between high level of education and correctly answering the individual 
knowledge items at T1.
Prenatal tests: question asked Level of education p
NTM: when performed
Ultrasound: what is examined
What entails CVS 
CVS: what is examined
Amniocentesis: what is examined
Cramer’s  V = 0.353 
Cramer’s  V = 0.239
Cramer’s  V = 0.268
Cramer’s  V = 0.246
Cramer’s  V = 0.269
0.000
0.016
0.006
0.0125
0.006
From Ref. 18.
table v. Level of education as a significant predictor of answering the individual knowledge items correct 
at T1.
Prenatal tests: question asked   Level of education; p-value
Purpose of NTM
NTM: when performed
Ultrasound: what is examined
0.0025
0.006
0.0125 
What entails CVS 
CVS: what is examined
0.0035
0.0295
From Ref. 18.
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be significantly linked with an interest in full-scale testing. As yet, it remains to be estab-
lished which motives may underlie this latter finding, but it is possible that the impact 
of full-scale testing was not fully understood by this group of respondents. Interestingly, 
we found respondents with a low educational level having a negative attitude towards 
invasive techniques, which is inconsistent with the overall positive attitude within this 
group towards full-scale testing. Earlier studies reported lower rates of informed choice 
for women from socio-economic disadvantaged groups.19 Also the necessity of provid-
ing extra information to women with a low educational level has been investigated.20 
Our data confirm that the general basic knowledge on prenatal testing appears to be 
positively linked with the educational level. In addition, we found that, relative to T1, at 
T2 the overall interest in full-scale testing was decreased in all groups of respondents 
(33% at T1 versus 18% at T2). Actively informing pregnant women about the risk of 
genetic defects in their unborn child may decrease their demand for full-scale testing 
and, therefore, more knowledge does not inevitably lead to higher demand. It is not 
yet clear whether anxiety acts as a causal factor for this notion.21 In addition, it cannot 
be excluded that a majority of the parents that we questioned chose not to opt for a 
full-scale test because of a limited understanding of the procedure and a limited insight 
into the implications of full-scale testing.
The fact that informing patients about serious diseases does not always lead to an 
increase in testing is in agreement with the results obtained by earlier studies on late-
onset diseases, with a specific familiar risk such as Huntington’s disease.22 Even within 
this population in the Netherlands only 2% of the persons at risk make use of the test of-
fered to them. he choice for parents to achieve comprehensive knowledge or to restrict 
to one or more certain conditions has now become a reality in prenatal diagnostic test-
ing. This novel development will certainly have important implications on the counsel-
ling process and the specific knowledge and skills of the counsellor concerned. Indeed 
the parent’s autonomy to provide a valid consent to be tested for genetic conditions is 
highly dependent on the adequacy of the counselling they receive. 
Offering only full-scale testing to pregnant women who have a referral reason for inva-
sive diagnostics is a matter of debate because this may introduce treatment inequality, 
i.e., women who do not have an a priori increased risk for a specific genetic defect and, 
therefore, do not have a referral reason for invasive diagnostics would thus be excluded 
from full-scale testing. This is in conflict with the principle of equality of care for patients.
At present, parents can choose between molecular targeted testing and traditional 
karyotyping. This choice is of topical ethical interest in terms of the parent’s autono-
mous ‘right to know versus not to know’ genetic information on the unborn child. As 
noted in the report of the human genetics commission: specific ethical considerations 
relevant to genetic issues in healthcare, a competent patient must give valid consent to 
be tested for genetic conditions. Some people, however, prefer not to know, particularly 
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if it contains a disease of late onset and when the likelihood of manifestation of the 
disease is uncertain.15  
The technologies to prenatally diagnose genetic defects are undergoing a rapid evolu-
tion.  Application of molecular targeted testing for the detection of common aneuploidies 
is already a fact and it is technically possible to increase the number of targets by adding 
probes for the detection of specific severe diseases such as cystic fibrosis. However, full-
scale testing by microarray-based technologies provides an almost unlimited scope to 
detect genetic anomalies. The decision to apply this technique for prenatal diagnostic 
purposes, however, still remains to be made. This is because of recent observations that 
normal copy number variation within the human genome is unexpectedly high,23 thus 
hampering the interpretation of the test results and putatively leading to uncertainty 
and anxiety in the prospective parents. Besides this notion, the ethical-moral question 
has been raised whether full-scale testing should be offered to pregnant women at all.
In conclusion, our results show that the opportunity to undergo full-scale testing was 
not accepted casually by pregnant women. Educational level and limited knowledge of 
genetic defects may have played a role in their decisions. Further research is indicated 
to gain better insight into the factors that may be of influence to prospective parents 
in their decisions. The choice to make use of new techniques in the field of prenatal 
diagnostics is a precious one to be counselled carefully, taking into account the different 
levels of resolution.
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Current KnowledGe on this suBJeCt
The use of modern molecular genetic technologies for prenatal diagnoses gives rise to 
many ethical, social and medico-legal problems and dilemmas, because of the possibil-
ity of full-scale testing at an unequalled detection level.
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• Undergoing prenatal diagnostic tests has been shown to give rise to a scale of 
psychological, relational and emot
• A competent patient must give valid consent to be tested for genetic conditions. 
However, some people prefer not to know; particularly if it contains a disease of late 
onset and when the likelihood of manifestation of the disease is uncertain.
• Low educational level is a factor of concern when providing information to patients 
to help them making an informed choice in medical decisions. Counselors should 
take this factor into account in daily practice when offering information.
• Earlier studies described lower rates of informed choice for women from socio-
economic disadvantaged groups. Earlier studies described the low uptake of tests 
available for patients with an a priori risk of late-onset diseases.
• Anxiety possibly plays an important role when making decisions whether undergo-
ing prenatal screening and diagnostic tests.
what this studY adds
• New technologies will soon replace the classic procedure of karyotyping, offering 
the opportunity to detect thousands of genetic variations in one test, which means 
full-scale testing at an unequalled detection level. Before these new techniques are 
implemented in routine clinical care, it is important to explore the sentiments of 
future parents and the possible problems it will cause when counseling them.
• In view of these new technological developments, the interesting question arises 
whether pregnant women want to undergo genetic testing for disorders that a 
priori do not have an increased risk of being present.
• This study showed that the opportunity to undergo full-scale testing was not 
accepted casually by pregnant women. The majority of our respondents stated that 
they would not opt for full-scale testing.
• Educational level and limited knowledge of genetic defects may have played a role 
in their decisions. A low educational level appeared to be significantly linked with 
interest in full-scale testing.
• This prospective pilot provides insight into the apparent need of a different ap-
proach when counseling and explaining difficult choices to parents with a lower 
educational level.
• Further research is indicated to gain better insight into the choices that prospective 
parents will make concerning the different levels of targeted testing.
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aBstraCt
objective
To assess the diagnostic relevance of incidental prenatal findings of sex chromosome 
aneuploidies.
Methods 
We searched with medical subject headings (MeSH) and keywords in Medline and the 
Cochrane Library and systematically screened publications on postnatally diagnosed 
SCAs from 2006 to 2011 as well as publications on incidentally prenatally diagnosed 
SCAs from 1980 to 2011. 
results
Postnatally diagnosed SCA’s demonstrated three clinical relevant domains of abnormal-
ity: physical (22-100%), behavior (0-56%) and reproductive health (47-100%), while 
incidentally prenatally diagnosed SCAs demonstrated, respectively:  0-33%, 0-40% and 
0-36%. 
Conclusion
In literature incidental prenatal diagnosis of SCAs is associated with normal to mildly af-
fected phenotypes. This contrasts sharply with those of postnatally diagnosed SCAs and 
highlights the importance of this ascertainment bias towards the prognostic value of 
diagnosis of fetal SCAs. This observation should be taken into account, especially when 
considering excluding the sex chromosomes in invasive prenatal testing using Rapid 
Aneuploidy Detection.
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introduCtion
Sex chromosomal aneuploidies (SCAs) are usually diagnosed postnatally in association 
with specific physical, developmental, and psychological health problems, diminished 
fertility, or infertility (incidence 1 in 400).1 Prenatally, the overall incidence of SCAs is 1 
in 435,2 depending on the reason for referral for invasive prenatal testing. For pregnant 
women whose unborn children are at risk for Down syndrome (e.g., maternal age > 35 
years or a positive first trimester screening result without ultrasound abnormalities); the 
incidence of SCAs is comparable to that of Down syndrome (1 in 300),3 which represents 
25% of all abnormal karyotypes identified.4 Diagnoses of SCAs in routine prenatal inva-
sive testing are often incidental and present unforeseen findings to the parents, whereas 
their diagnostic significance is uncertain.5 As such, these SCAs may be considered as 
nondiscretionary test information. They are indicative for an abnormality that in the end 
may not cause any relevant symptoms, or only mild symptoms such as a slightly reduced 
intelligence and/or a diminished fertility. Taking into account that parents are primarily 
tested to exclude Down syndrome the diagnosis of an SCA may elicit unforeseen dilem-
mas about whether or not to terminate the pregnancy.6 A recent study revealed that in 
36% of prenatally detected sex chromosome trisomies these findings have resulted in 
pregnancy termination.7 Early and pre-symptomatic diagnoses may, however, provide 
opportunities for early treatment of certain health and developmental problems and, as 
such, may represent an advantageous step towards future healthcare for the child. This 
latter issue has amply been discussed in the literature.8-12
Since molecular diagnostic technologies based on Multiplex Ligation-dependent 
Probe Amplification (MLPA) or Quantitative Fluorescent Polymerase Chain Reaction 
(QF-PCR) are designed for rapid aneuploidy detection (RAD) of the most common aneu-
ploidies (i.e., of chromosomes 13, 18, 21, X, and Y),13 the question of whether or not to 
continue the inclusion of probes for the sex chromosomes arises, since sex chromosome 
detection does not always provide useful information to parents referred for advanced 
maternal age.14 Replacement of full karyotyping with stand-alone RAD for chromosomes 
13, 18, and 21 only, would avoid incidental SCA findings. An advantage of early SCA 
detection may provide opportunities for preventive programs aimed at ameliorating 
the quality of life. This study consists of a systematic literature review assessing the 
syndrome-specific, health-related, quality of life (QOL) aspects of patients with postna-
tally diagnosed SCAs and comparing these results with those of prenatally incidentally 
diagnosed SCAs.
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Methods: sourCes, searCh strateGY, and studY seleCtion
sources and search strategy
We performed systematic electronic searches during the period of August 2010 until 
March 2011 in Medline (PubMed) and the Cochrane Library (Database of Systematic Re-
views and the Cochrane Pregnancy and Childbirth Group’s Trials Register) using medical 
subject headings (MeSH), filters and keywords. We employed a two-stage process for 
our searches: first, we assessed the literature over the last 5 years (2006–2011) aimed 
at gathering information about specific phenotypes associated with postnatally diag-
nosed SCAs. Second, we assessed the literature from 1980 onward aimed at gathering 
information about the difference in phenotype after an incidental prenatal detection of 
SCAs and the associated phenotypes that were ascertained postnatally.
study selection:
We used the following terms in our PubMed literature search: sex chromosome aberra-
tions “or” sex chromosome disorders “or” X chromosome “or” chromosome human X “or” 
Y chromosome “or” Turner syndrome “or” 45,X syndrome “or” Klinefelter syndrome “or” 
47,XXY syndrome “or” Triple X syndrome “or” Trisomy X syndrome “or” 47,XXX syndrome, 
and “not” Fragile X syndrome. We used filters for publications in English dealing with 
human subjects.
We prepared a PICO research query in order to focus our search for the period 
1980–2011 (Table 1). The accountability for this research period is the fact that the first 
studies on ultrasonographically abnormal fetuses were published around 1980. We 
double-checked all retrieved publications for the following MeSH inclusion criteria and 
keywords: prenatal diagnosis; disease; prognosis; quality of life; postnatal; phenotypic; 
prospect; prognosis; unforeseen; unintended; accidental. We combined all search terms 
and keywords with [MeSH, tiab].
table 1. PICO research query used to focus literature search and data abstraction
How does a prenatal diagnosis of SCA affect quality of life for individuals, whether intended or not?
PiCo-research query: 
P: fetus/child with SCA
I: invasive prenatal diagnostic test with incidental finding of fetal SCA
C: prenatal ultrasound abnormality or postnatal diagnosis SCA
O: postnatal prognosis in syndrome-specific health related quality of life
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Inclusion criteria (stage 1)
All publications used were published in peer-reviewed journals listed in the Science 
Citation Index. We included original articles, reviews, randomized trials, cohort studies, 
case-control studies, case reports, letters, expert opinions, and consensus meeting 
reports dealing with either full-blown or mosaic SCA.
Inclusion criteria for publications according to the research query (stage 2)
We used the criteria of stage 1, publications concerning the incidental prenatal SCA find-
ings in relation to the postnatal, syndrome-specific, QOL prognosis and a comparison 
with this prognosis for postnatally ascertained SCAs.
Exclusion criteria
We excluded all publications dealing with ultrasonographic fetal abnormalities, epide-
miology, registration or counseling issues in relation to SCAs, cytogenetic or molecular 
technical prenatal diagnostic research and animal studies.
Publication selection for stages 1 and 2
In both stages, the authors (JP and AK) screened the titles of all potentially relevant 
publications and marked them as “included” (title clearly related to SCA and meeting 
the inclusion criteria set for both stages) or “excluded” (not related, other syndrome, or 
not meeting the inclusion criteria). Next, the authors (JP and AS) screened the abstracts 
of the remaining titles, again marking them as “included” or “excluded”. All authors dis-
cussed the items that were unclear until they reached agreement. Finally, we grouped 
all included publications by syndrome.
results
stage 1: sCa and syndrome-specific quality of life, 2006-2011
Using the criteria set (see Methods) we retrieved 1093 potentially relevant publications 
from the period 2006-2011. Specifically, we screened for issues concerning syndrome-
specific, health-related, QOL prognoses for persons exhibiting SCA. This resulted in 
607 selected publications dealing with either Turner syndrome (TS, n=400), Klinefelter 
syndrome (KS, n=193), Triple X syndrome (Tr X, n=7), or other SCAs (n=7), see Table 2.
Syndrome-specific, health-related, quality of life domains
Based on the results, we were able to determine three domains that could be considered 
the core outcome domains in assessing the syndrome-specific QOL of patients with SCA, 
i.e., physical health, behavior, and reproductive health (Table 2, Table 3).
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Domain 1: physical health
Physical health was characterized by abnormal growth, diminished bone mineral 
density, cardiovascular, metabolic, and other disease, autoimmune disease, increased 
cancer risk, dental problems, otologic problems, and overall disease susceptibility and 
mortality. Also, early screening and preventive programs for health were mentioned. All 
SCA-related health hazards and overall QOL were said to benefit from early recognition, 
prompt diagnosis, and pharmacologic or psychosocial treatment in an early stage. Other 
SCAs were associated with the exacerbation of certain medical conditions relative to the 
burden of these conditions among the general population. Examples of such conditions 
are asthma, congenital heart defects, and increased morbidity or mortality rate caused 
by epileptic insults, cardiovascular disease, or respiratory disease. Most health hazards 
table 2. Number of publications on SCA in the period 2006-2011. Syndrome-specific quality of life 
domains
Publications per 
domain
45,x
(n,%)
45,x
mosaic
(n,%)
47,xxY
(n,%)
47,xxY
mosaic
(n,%)
47,xxx
(n,%)
47,xxx
mosaic
 (n,%)
other 
sCa
(n,%)
other sCa
mosaic 
(n,%)
i: physical health 
(n=446) 
295 (78.5%) 21 (87.5%) 117 (61.6%) 2 (66.7%) 4 (66.7%) - 5 (100%) 2 (100%)
ii: behavior 
(n=73)
41 (10.9%) - 31 (16.3%) - 1 (16.7%) - - -
iii: reproductive 
health (n=88)
40 (10.6%) 3 (12.5%) 42 (22.1%) 1 (33.3%) 1 (16.7%) 1 (100%) - -
n= 607 376 (100%) 24 190 (100%) 3 6 (100%) 1 5 (100%)     2
N= number of publications found 2006-2011
(%)= percentage of total number of publications on that type of SCA
table 3. Categorization of disease-specific QOL domains related to SCA
domain I - physical health growth and bone mineral density
cardiovascular, metabolic and other disease
auto-immune disease
other SCA-associated health problems
overall disease susceptibility and mortality
domain II - behavior psychosocial functioning
quality of life
sexuality
domain III -  reproductive health puberty
fertility
assisted reproduction techniques
disease
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were described in association with TS and KS, while Tr X syndrome and other SCA-related 
disorders were only rarely discussed in relation to domain 1. A relevant finding was the 
importance of early recognition and preventive treatment of certain health problems.
Domain 2: behavior
Problematic psychosocial functioning and learning capacities, diminished QOL, and 
problems with relationships and sexuality were discussed in association with SCA. 
Certain behavioral weaknesses (DSM IV: Adjustment Disorder with Mixed Disturbance 
of Emotions and Conduct)  and limited skills associated with specific brain asymmetries, 
especially in TS and KS, have been found, and a high body mass index has been related 
to a negative body attitude. Early psycho-educational support and medical therapy 
were found to positively affect the patients concerned. Health aspects, infertility, aber-
rant stature, and psychosocial disabilities negatively influenced the QOL. Positive effects 
of early growth hormone and estrogen treatment on the psychosocial functioning and 
self-esteem of girls with TS and of testosterone treatment on the pubertal changes, 
behavior, and sexuality of boys with KS have been reported. Domain 2 was a focal point 
of attention both for individuals with Tr X syndrome and those with other SCAs. Atten-
tion deficit disorders, autism spectrum disorders, mood disorders, and tic disorders were 
found.
Domain 3: reproductive health
A variety of aspects of fertility and endocrinology were denoted as problematic in TS 
and KS, including problematic puberty or abnormal gonadal development (TS: n=25 
and KS: n=33 reports, respectively), but there were very little reports of infertility associ-
ated with other SCAs. Although assisted reproduction techniques (ART) created new 
possibilities of procreation, associated risks were mentioned.
Most patients with a non-mosaic SCA karyotype (TS and KS) were infertile, whereas 
those with mosaicisms were usually fertile. Also here, early gamete cryopreservation 
and ART have made procreation possible, but medical hazards and the risk of transmis-
sion of aneuploidy to the next generation have been discussed.
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Domain 1 (physical health) was mostly discussed in the SCA literature in general and, 
specifically, in conjunction with all types of SCA. Behavior was not a prominent issue, 
and reproductive health was mostly discussed in relation to KS. For further details about 
the incidence of the domains discussed per syndrome in the period 2006-2011, see 
Table 3 and Figure 1; the study selection process is shown in Figure 2.
figure 1. Publications on SCA 2006-2011, syndrome-specific quality of life domains
Incidental prenatal detection vs postnatal diagnosis
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figure 2. Prisma Flowchart of systematic study selection (stage 1: 2006-2011)
Publications identified through database searches (n=1093) 
 
Turner syndrome (n=729) 
{Search terms: Turner syndrome[Mesh, tiab] OR 45,X [Mesh, tiab]} 
Klinefelter syndrome (n=329) 
{Search terms: Klinefelter syndrome[Mesh, tiab] OR 47,XXY [Mesh, tiab]} 
Triple X syndrome (n=14) 
{Search terms: Triple X syndrome[Mesh, tiab] OR Trisomy X OR 47,XXX [Mesh, tiab]} 
 
 
Publications excluded after title 
screening 
 
(n=486) 
(Reasons: duplicates, not English, not SCA, 
animal studies, not listed in Scince Citation 
Index, technical PND studies, not related to 
research query) 
Publications included for judging domains (n=607) 
Domains 
I (%)  II (%)  III (%) 
 
 Turner syndrome (n=376) 78.5  10.9  10.6 
 mosaic 45,X (n=24)  87.5  -  12.5 
 
 Klinefelter syndrome (n=190) 61.6  16.3  22.1 
 mosaic 47,XXY (n=3)  66.7  -  33.3 
 
 Triple X syndrome (n=6) 66.7  16.7  16.7 
 mosaic 47,XXX (n=1)  -  -  100 
 
 Other SCA (n=5)  100  -  - 
 mosaic (n=2)   100  -  - 
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stage 2: incidental prenatally diagnosed sCa and postnatally 
ascertained sCa, 1980–2011
We searched PubMed and the Cochrane Library for eligible publications about the inci-
dental prenatal diagnosis of SCA with special attention to our PICO research query. We 
identified 6345 potentially relevant SCA publications using the MeSH terms, search con-
ditions, and filters described in the Methods section. We excluded publications that did 
not meet all our inclusion criteria. We included 1278 publications that were subjected 
to peer review with regard to the relevance of an incidental intrauterine SCA finding 
for the long-term developmental prognosis. Finally, we included 32 publications for ab-
stract screening and categorization by domain. After abstract screening, 21 potentially 
relevant publications remained, seven of which were selected after full text screening 
(Table 4 and Figure 3) relating to the PICO query: an incidental prenatal diagnosis of 
SCAs, description of the associated phenotype and the syndrome-specific quality-of-life 
aspects for postnatal life, and a comparison with postnatally ascertained SCAs.
1. Wheeler et al.15 compared the postnatal phenotypes of six incidental prenatally diag-
nosed 45,X/46,XY fetuses of couples with an increased risk for a chromosome abnormal-
ity. The postnatally diagnosed children were all phenotypically abnormal in domain 3, 
whereas the incidentally prenatally diagnosed fetuses all developed into phenotypically 
normal boys.
2. Pettenati et al.16 reported a comparison of three incidental prenatally diagnosed 
cases with 45,X/47,XYY mosaicisms with four cases diagnosed postnatally with similar 
mosaicisms. The three incidental prenatally diagnosed cases were all physically normal 
at birth, whereas the postnatally diagnosed cases all exhibited phenotypic anomalies 
(which had been the reason for karyotyping). 
3. Hsu17 reviewed many studies on Y chromosome aneuploidies (except non-mosaic 
47,XYY), going back to publications of as early as 1961; and reported in this elaborate 
review on 600 cases with mosaicisms for genotype-phenotype correlations. Of these, 
93 were incidentally prenatally diagnosed while all the other cases were postnatally 
diagnosed because of phenotypic anomalies. All postnatally diagnosed cases were phe-
notypically abnormal (which had been the reason for karyotyping), while 67-97% of the 
prenatally diagnosed cases exhibited a normal male phenotype at birth.
4. Koeberl et al.18 reported on 12 incidental prenatally diagnosed 45,X/46,XX patients 
and compared the outcome with 41 postnatally diagnosed girls. They concluded 
that, although a certain ascertainment bias did exist, the prevalence of a 45,X/46,XX 
mosaicism was 10 times higher among the group diagnosed prenatally as compared 
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to postnatally diagnosed TS patients. Absence of hydrops fetalis may account for the 
milder phenotype of the prenatally diagnosed group.
5. Gunther et al.19 compared 16 incidental prenatally diagnosed patients with TS with 
72 traditionally diagnosed children (typical fetal anomalies on ultrasound or postnatal 
clinical features). The incidental group exhibited significantly fewer phenotypic TS fea-
tures than the traditional group. The authors concluded that a significant ascertainment 
bias does exist in our understanding of TS, with important implications for prenatal 
counseling in case no fetal abnormalities are found.
6. Zeger et al.20 compared phenotype data from 55 postnatally diagnosed 47,XXY boys 
with those from 35 prenatally diagnosed 47,XXY boys and found no significant differ-
ences between the two groups. Invariably, all features occurred comparable in both 
groups.
7. Girardin et al.21 reported a comparison of clinical symptoms of adolescents with KS 
after incidental prenatal diagnosis (n=11) with those of adolescents diagnosed because 
of an abnormal phenotype (n=17). They conclude that there were some differences be-
tween the two groups with respect to the presence of gynaecomastia, school delay, and 
testosterone substitution. Although these differences were not significant, the incidence 
of phenotypic problems in the postnatally diagnosed group was somewhat higher than 
in the incidental prenatally diagnosed group. The incidences differed significantly in 
comparison with the general population. 
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table 4. Publications on the incidental prenatal diagnosis vs postnatal diagnosis of SCA in period 1980-
2011: Case-control studies, clinical comparison, outcome data
author, year prenatal incidental diagnosis SCA  
outcome of domains:
postnatal diagnosis SCA 
outcome of domains:
Type SCA
1.
Wheeler, 1988 6 pregnancies, 3 term, 1 premature delivered 
infants, 1 termination, 1 intra-uterine death:
4 healthy children, 2 fetuses normal on autopsy
Domain I:
100% normal 
Domain II:
100% no mental retardation
Domain III:
100% normal reproductive fertility and normal 
genitalia
9 children with abnormal intern / extern genitalia, 7 
children with ambiguous genitalia at birth, 2 children 
with primary amenorrhea at age 17
Domain I:
22% short stature, webbed neck
Domain II:
100% no mental retardation
Domain III:
88%: ambiguous genitalia, changed sexual 
assignment, rudimentary phallus, urogenital sinus, 
hypospadias, undescended testes; 22%: primary 
amenorrhea
45,X/46,XY 
mosaicism
2.
Pettenati, 1991 3 prenatally detected cases; clinical comparison 
with the postnatally detected cases
Domain I:
two phenotypically normal term born infants, 1 
postermination normal male fetus on autopsy
Domain II:
normal 
Domain III:
normal external male genitalia in both children; 
fetus with normal position of testes, normal penis 
and scrotal development 
4 postnatally detected cases, clinical comparison with 
the prenatally detected cases
Domain I:
all had phenotypic abnormalities: short statue, 
short limbs, cubitus valgus, nevi, epicathical folds, 
depressed nasal bridge, micrognathia, low hair 
implantation, webbed neck, shield chest, posteriorly 
rotated ears
Domain II:
one child developmental delay
Domain III:
all children had genital abnormalities: ambiguous 
genitalia, mixed gonadal dysgenesis, streak gonads, 
hypospadias, small penile length
45,X/47,XYY 
mosaicism
3.
Hsu, 1994 phenotype of 93 prenatally diagnosed cases, 
liveborn and abortuses
Domain I:
not discussed
Domain II:
not discussed
Domain III:
67-97% normal gonads or genitalia
phenotype of 503 postnatally diagnosed cases
Domain I:
0-25% phenotypically abnormal stature
Domain II: 
not discussed
Domain III:
66-100% abnormal gonads or genitalia
Y chromosome 
aneuploidy (except 
non-mosaic 47,XYY)
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table 4. Publications on the incidental prenatal diagnosis vs postnatal diagnosis of SCA in period 1980-
2011: Case-control studies, clinical comparison, outcome data (continued)
author, year prenatal incidental diagnosis SCA  
outcome of domains:
postnatal diagnosis SCA 
outcome of domains:
Type SCA
4.
Koeberl, 1995 12 prenatally diagnosed cases
Domain I:
all (100%): normal growth, 3 (25%) health 
problems: ASD, ptosis, dysplastic kidneys
Domain II:
8% mental retardation
Domain III:
10 (83%) : normal ; 2 (17%): labial fusion, 
urogenital sinus
 
41 postnatally diagnosed patients
Domain I:
22-53% malformations or phenotypic problems 
(edema, cardiac, renal otologic, gastrointestinal)
Domain II:
8% developmental delay
Domain III:
72% no spontaneous menarche
45,X/46,XX 
mosaicism
5.
Gunther, 2004 16 incidentally diagnosed cases
Domain I:
31% heart defects, 25% renal anomalies, length/
height deficit (-1.1 SDS), weight deficit (-1.0 SDS)
Domain II and III:
not discussed
72 traditionally postnatal diagnosed cases
Domain I:
64% heart defects,19% renal anomalies,  length/
height deficit (-1.7 SDS), weight deficit (-1.7 SDS)
Domain II and III:
not discussed
45,X
6.
Zeger, 2008 35 prenatally diagnosed boys
Domain I:
tall stature, hypotonia, increased BMI
Domain II:
Speech and reading therapy 
Domain III:
below average size penis and testes, low 
testosterone level, low inhibin B and AMH levels, 
elevated FSH and LH levels
20 postnatally diagnosed boys
Domain I:
tall stature, hypotonia, increased BMI
Domain II:
Speech and reading therapy 
Domain III:
below average size penis and testes, low testosterone 
level, low inhibin B and AMH levels, elevated FSH 
and LH levels
no significant differences with prenatal group
47,XXY
7.
Girardin, 2009 11 prenatally diagnosed patients
Domain I:
gynaecomastia 33%, BMI, height: normal
Domain II:
school delay 40%
Domain III:
all had spontaneous puberty, testosterone 
substitution 36%
17 postnatally diagnosed patients
Domain I:
gynaecomastia 77%, BMI, height: normal
Domain II:
school delay 56%
Domain III:
all had spontaneous puberty, testosterone 
substitution 47% 
47,XXY
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Conclusions of stage 2
Physical health (domain 1) was abnormal for 0-33% of those who were diagnosed inci-
dentally prenatally, whereas it was abnormal for 22-100% of those who were diagnosed 
postnatally. The behavior (domain 2) was abnormal for 0-40% of the incidental prena-
tally diagnosed patients, while the behavior was abnormal for 0-56% of the postnatally 
diagnosed patients. The reproductive health (domain 3) was problematic for 0-36% of 
the incidental prenatally diagnosed patients, whereas it was problematic for 47-100% of 
the postnatally diagnosed patients (Table 4, Figure 3).
figure 3.  Flow diagram of systematic literature search of SCA 1980-2011: phenotype and health of 
incidental prenatal diagnosis vs postnatal diagnosis 
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Four of seven publications regarding the incidental prenatal diagnosis of SCAs dealt 
with mosaic SCAs, which resulted in normality in the domains of physical health (100%), 
behavior (100%), and reproductive health (67-100%). For non-mosaic cases, the normal-
ity results were: physical health, 67-75%; behavior, 60-100%; and reproductive health, 
64-83%. For postnatally ascertained SCAs, the mosaicism-related normality results were: 
physical health, 0-47%; behavior, 75-100%; and reproductive health, 0-34%, while for 
non-mosaic cases, the normality results were: physical health, 0-36%; behavior, 0-44%; 
and reproductive health, 0-53%.
disCussion
A putative change in prenatal diagnosis policy from full karyotyping to stand-alone, rapid 
aneuploidy detection (RAD) with the standard inclusion of probes for the sex chromo-
somes needs to be assessed carefully. The purpose of this review was to reveal the clini-
cal relevance of a diagnosis of SCA for the postnatal quality of life (QOL) of symptomatic 
individuals and for those in whom the prenatal diagnosis was an incidental finding. First, 
we assessed the SCA literature of the last 5 years, in order to gather information about 
the specific, phenotypic and clinical problems associated with postnatal SCA detection. 
By doing so, we found that these publications all addressed one or more domains of 
syndrome-specific health. Next, we assessed whether the phenotypes of patients with 
SCA were comparable, irrespective whether the diagnoses were made postnatally or 
prenatally without any ultrasonographic abnormalities, due to an incidental finding. To 
this end, we screened all SCA literature between 1980 and 2011. We used 1980 as a start-
ing point since the first studies of fetal ultrasound abnormalities that were associated 
with a genetic syndrome were published around that time.22
We found in our first literature search that physical health (domain 1) is by far most 
often discussed (74%), followed by reproductive health problems (domain 3, 14%) 
and behavior (domain 2, 12%), see Table 2 and 3. Problematic physical health is an 
important issue for patients with an SCA. It manifests itself as disturbances in growth 
or bone mineral density and cardiac, autoimmune, and other diseases, and it certainly 
influences the QOL. Many publications dealing with domain 1 mentioned possible 
early preventive measures. Timely screening and treatment may significantly improve 
the QOL of patients with certain very health-menacing conditions such as abnormal 
growth, diminished bone mineral density, and cardiovascular problems. Early detection 
of SCA-related problems varied between domains. Some authors have elaborated on 
the minimal negative side-effects of lifelong hormonal treatment, but it is clear that the 
positive effects of this treatment far exceed the potentially negative effects.23,24 Appar-
ently, reproductive health problems and behavioral abnormalities trouble these patients 
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to a much lesser extent than physical health problems. Early preventive management 
has been described; e.g., induction of puberty and breast development in TS and techni-
cal advances in ART increasingly permit parenthood. We are aware of the fact that the 
number of selected publications is not automatically a measure of its importance, but 
its frequency is of note. 
In the second stage of our literature study, we focused on the impact of the incidental 
finding of a prenatal SCA on the postnatal outcome. The selected publications report 
on comparisons of patients who were incidentally prenatally diagnosed with patients 
who were diagnosed through traditional postnatal karyotyping (either non-mosaic 
or mosaic). In six out of seven publications, the overall phenotypic outcomes affected 
incidentally prenatally diagnosed SCA patients significantly less than those who were 
postnatally diagnosed and karyotyped because of phenotypic abnormalities. In one 
publication,20 no significant differences in certain phenotypic characteristics were noted 
after prenatal or postnatal diagnosis.
  It is well known that certain fetal ultrasonographic abnormalities are associated 
with a poor prognosis for the child after birth, because they reflect early disturbances 
in organ functioning.18 Genetic mosaicisms are known to be related to mild, or even 
complete lack of phenotypic features, and those affected may go through life without 
ever knowing they carry a genetic abnormality.21,25 Saenger’s review26 showed that most 
prenatal diagnoses of TS occur by chance after routine invasive procedures for advanced 
maternal age, and the phenotypes of these women are usually less pronounced.19 
Those with TS detected by ultrasound (increased nuchal translucency or fetal hydrops) 
exhibit a high rate of spontaneous fetal loss or associated cardiac or renal disease.18,27 
Bondy10 discusses the fact that incidentally diagnosed TS in prenatal diagnostic tests 
for advanced maternal age lead to termination of most of these pregnancies, and that 
the ability to assess clinical outcome is limited. High termination rates for incidentally 
diagnosed TS reflect overrated pessimistic views, as the phenotype of someone with an 
incidentally ascertained TS is compared with the phenotypic problems of those who 
are postnatally diagnosed, or prenatally diagnosed because of fetal abnormalities. Only 
10% of those with KS are diagnosed prenatally, another 25% are diagnosed during child-
hood or adolescence, and 65% remain undiagnosed.28 KS is the most frequent genetic 
cause of infertility29,30 (11% of azoospermic men), and parents often report frustration 
with the consequences of a delay in diagnosis.31
Publications on the diagnosis of Tr X syndrome did not address its incidental prenatal 
finding and the subsequent clinical consequences. A recent literature review of Tr X32 
(Otter) reports mainly personality and behavioral problems and finds that many of the 
studies reviewed were “biased because of referral bias”. Furthermore, the incidental 
prenatal finding of Tr X is discussed only in terms of termination rates and intercultural 
differences. The author concludes that Tr X syndrome is not rare, but often remains un-
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diagnosed. Approximately 20% of other SCAs have higher grade chromosome aneuploi-
dies (e.g. 48,XXXY) or mosaicisms and the associated clinical health issues are usually 
very mild.
To the best of our knowledge, this study for the first time categorizes the abundant 
SCA literature into three syndrome-specific, QOL-related domains of health. This catego-
rization provides a way to judge the importance of phenotypic problems of an incidental 
prenatal ascertainment of SCA relative to a postnatal ascertainment of SCA. However, 
we acknowledge that even if there is an abundance of publications about the clinical 
implications of SCA for the affected individual, there is little literature that compares 
the difference in QOL prognoses for incidental prenatally diagnosed patients to those 
diagnosed postnatally. Despite this limitation, however, we have endeavored to review 
the literature in a way that is helpful to professionals who wish to use this information in 
counseling and decision-making processes.
Routine prenatal testing procedures with the standard diagnostic outcome of fetal 
gender offer a unique opportunity for early prevention and management of SCA-related 
disease, psychological issues, and fertility issues. This benefit is evident from the profes-
sional point of view, but it should be balanced against the possible negative impact of 
this unexpected diagnosis for the future child. Incidental prenatal diagnosis of a SCA 
may cause stigmatization and possible damage to the child’s self-esteem or distortion 
of the family’s perception of the child. Indeed, parents may consider termination of the 
pregnancy while being uncertain about the prognosis for the child.33,34 Molecularly tar-
geted testing through RAD enables the exclusion of the sex chromosomal markers, thus 
avoiding unexpected sex chromosome-related SCAs. A discussion about this policy has 
been published.35 (Hills) It is considered a more or less acquired right in routine prenatal 
practice that pregnant women can be informed about the sex of their unborn children if 
they wish to know. However, ultrasonography can also determine fetal gender with high 
accuracy (98.3%) at 13 weeks of gestation,36 and an almost 100% accuracy is achieved 
around 20 weeks of gestation.37 
ConClusion
Early knowledge of a SCA could help the parents and their child to adapt to the con-
sequences of the corresponding syndrome in a timely fashion rather than having the 
information presented at puberty or even a later stage in life. This fact must be balanced 
against the ethical concerns about the diagnosis of a genetic condition with an uncer-
tain prognosis. This review shows that, in the medical literature, the syndrome-specific 
QOL of patients with a SCA contrasts sharply between postnatal and incidental prenatal 
diagnoses for the three major domains of health. Phenotypic abnormalities in prenatal 
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or postnatal life were found to be associated with significantly more severe clinical 
consequences. In contrast, the absence of fetal abnormalities in incidental prenatal di-
agnoses was found to be associated with a normal to mildly affected phenotype and as 
such, a significant ascertainment bias may exist in our understanding of SCA. Although 
it seems rather obvious that the outcome of a child with an incidental discovery of a sex 
chromosome abnormality is better than one who is diagnosed postnatally, this review of 
the literature since 1980 shows that counselors may reassure the parents in the knowl-
edge that indeed all studies until now support  this conclusion.
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aBstraCt
objective 
To investigate the parental perspectives of being confronted with an unforeseen fetal 
sex chromosomal aneuploidy (SCA), in light of the fact that this accidental finding is 
avoidable by rapid aneuploidy detection (RAD).
Methods 
Exploratory qualitative interview study. We conducted 16 semi-structured interviews 
with parents who decided to continue pregnancy after the unforeseen finding of a fetal 
SCA.
results 
The communication of the unforeseen finding of SCA; the informed decision-making 
process concerning the pregnancy follow-up and the child and its future were the 
extracted themes. Parents were not prepared to accidental findings in routine prenatal 
diagnostics. All started an unguided search on the Internet. It is not at all clear whether 
parents have preference for an RAD test with X and Y probes. Parents were satisfied with 
the post-test professional information they received to make an informed decision, 
whereas after birth questions still remained to be answered.
Conclusion 
Parents’ perspectives may serve as major contributors to research on the  question 
whether or not the X and Y probes should be standard included for purposes of RAD. 
The fact that RAD has the possibility to avoid accidental findings of SCAs, brings up the 
question whether any benefits outweigh the potential harms.
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introduCtion
Chromosome abnormalities investigated by invasive prenatal testing are associated 
with severe, moderate or mild diseases, although sometimes there is uncertainty about 
the clinical relevance. Many women who undergo invasive prenatal tests are unaware 
of the possible adverse consequences of uncertain prognosis.1 The birth prevalence of 
sex chromosomal aneuploidies (SCAs) is 1/426,2 depending on the reason of referral. In 
pregnant women ‘at risk’ for Down syndrome (maternal age >35 years), the risk of SCAs 
is 1/300.3 
SCAs are associated with specific physical, developmental and mental health prob-
lems, diminished fertility or infertility and are often diagnosed postnatally with an inci-
dence of 1/400.4 The diagnosis of an SCA in women referred for advanced maternal age 
(AMA) and ‘at risk’ for Down syndrome is experienced as unforeseen. To be confronted 
with an unforeseen finding is a confusing experience and as such a difficult dilemma 
arises regarding decision-making on continuation of pregnancy. A recent Eurocat study 
showed that prenatally detected sex chromosome trisomies resulted in termination of 
pregnancy in 36%.5 Consequently, there is a need for an exploratory study to determine 
from parents’ perspective the diagnostic relevance of accidental findings, especially 
SCAs. 
As new diagnostic tests, such as MLPA (Multiplex Ligation-dependent Probe Amplifi-
cation) and QF-PCR (Quantitative Fluorescence Polymerase Chain Reaction), have been 
implemented in prenatal diagnostics for rapid aneuploidy detection (RAD) of the most 
common fetal aneuploidies (13, 18, 21, X and Y), the possibility arises to exclude X and 
Y probes and herewith avoid findings of a fetal SCA. The discussion whether or not to 
continue the standard inclusion of the X and Y probes in RAD has been ongoing.6 
The aim of this study was to explore in depth the parental experiences of being con-
fronted with an unforeseen prenatal finding related to the decision of completing or 
terminating pregnancy.
Method and analYsis
Ethics approval for the study was granted by the institutional Research Ethics Commit-
tee (CMO, Arnhem- Nijmegen) and the National Ethics Board for Research on Humans 
(CCMO, The Hague). General practitioners were contacted to examine the actual status 
of the parents. The head of the Ob/Gyn Department initiated postal contact with the 
parents, inviting them to participate in an interview with the principal investigator (JP), 
along with a response form. Upon receipt of a positive response form, participants were 
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telephoned to arrange an interview date, time and location. They were asked for verbal 
consent to record the interview. 
Parents referred for AMA and confronted with a fetal SCA who choose to continue 
their pregnancy were included. The tests were performed in the Department of Human 
Genetics of the Radboud University Nijmegen Medical Centre in the period between 
1994 and 2006. Twelve couples were included: eight couples responded positively, two 
replied that they wished not to participate, both stated that they had received excellent 
care but had no wish to talk about the events again; one couple did not reply; one family 
was not contactable. 
All interviews were held by the same investigator after having been trained in 
theoretical and practical aspects of qualitative research including the grounded theory 
approach, the scientific status of the interview and the concepts of methodical and 
systematic analysis of the data to objective and reproducible results. Pilot interviews 
have been performed as practical training on different stages from thematizing, tran-
scribing, analyzing, verifying and reporting. The interviews took place between October 
2008 and December 2009 and lasted between 40 and 80 min (mean: 60 min). Separate 
semi-structured interviews were held with both parents after the prenatal diagnosis 
of a full-blown as well as mosaic SCA. In a semi-structured way, parental experiences 
were investigated in depth, using an interview guide with relevant topics, composed 
after literature search and consultation with experts. Participants were specifically asked 
their opinion on the routine inclusion of the X and Y probes in the test kit for prenatal 
diagnosis. Sixteen separate interviews were completely taped, transcribed verbatim, 
coded and analyzed. The transcripts of each participant’s interview were coded using 
the Atlas t.i. program for qualitative research. Interview transcripts were read line by line, 
sentences and phrases were assigned specific codes, using quotes to highlight them. 
Further conversion resulted in an organized hierarchical list of themes and subthemes. 
The analysis process was both inductive and iterative, performed by the principal in-
vestigator and discussed with three other investigators until agreement was reached. 
Hereafter, coding was renewed and re-discussed. Theoretical saturation was reached (no 
more new themes identifiable in additional interview data) according to the definition 
described by Guest et al.7 
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results
sample characteristics
At the time of the invasive prenatal test, mean maternal and paternal age was respec-
tively 38.4 years (range 36–40) and 39.7 years (range 36–44). Mean maternal and pater-
nal age at the time of the interview was 47 years (range 42–52) and 48.5 years (range 
43–54), respectively. The cytogenetic findings (full-blown or mosaic) were 45,X, 47,XXY 
and 47,XXX (Turner, Klinefelter and Triple X syndromes, respectively). Demographic 
details regarding the parents (eligible and non-eligible) are shown in Table 1. During 
the studied period, 13 171 invasive tests were performed for AMA, 51 (0.3%) SCAs were 
diagnosed of which 7 (14%) were aborted.
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interview findings
Parents’ perspectives of fetal SCAs were surveyed and subsequently categorized into 
themes and subthemes. Saturation of information was reached after eight interviews 
(Figure 1).
All couples stated that their reason for having the test was to detect Down syndrome. 
In one couple there was previous experience with invasive prenatal testing, with a nor-
mal test result. None of the couples had considered unforeseen findings like a SCA. Six 
couples intended to terminate the pregnancy if Down syndrome was present, whereas 
two couples had doubts about termination. The relatively mild clinical features associ-
ated with SCAs in comparison with that of Down syndrome prompted all the couples 
to continue the pregnancy. All the parents communicated with family or friends, and 
seven parents (three mothers and four fathers out of six couples) said that they were 
religious, but they said this would not influence their decision-making process. The risk 
of the invasive test was acknowledged and in two pregnancies a second test was done 
because of uncertainty about the diagnosis SCA (mosaicism, not enough material); 
these couples were particularly distressed. Four of the 16 parents (three mothers and 
one father out of four couples) wanted to know the fetal gender. Almost all the mothers 
(n = 7) expressed negative effects on emotions during pregnancy and childbirth; only 
two fathers mentioned this problem. Normal results in the additional tests  (amniocen-
tesis, ultrasound) reassured parents; in one case, ultrasound scans repeatedly showed 
hydronephrosis, which was experienced as very burdensome. All but one of the parents 
mentioned that they trusted the test result; in two cases, karyotyping was repeated after 
birth at their request, because the child showed no apparent problems. Most of the 
parents appreciated knowing about the syndrome, because it enabled them to provide 
figure 1. Saturation of information in interviews with parents
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their child with adequate support, whereas one couple would have preferred not to be 
told at all. Parents were asked to formulate advice for professionals, to help improve 
future care. Not all the parents were able to give advice (n = 3), some of them gave 
advice during the interview (n = 5) and others did so when asked (n = 8). All but two of 
the parents would make the same choice for invasive testing again in a next pregnancy 
(two couples had already done so).
Analysis of the transcripts revealed three main themes. Subthemes could be defined 
(Table 2) and relevant quotes were selected to highlight the subthemes. Examples of the 
advice given by the parents are shown in Table 3.
table 3. Advises to professionals
numerical code
communication of the unexpected result
prior to test more information on possibility of an unexpected or 
uncertain finding
1A
3A/B
preferably no resident for invasive procedure 5B
telephone call rather in evening instead of afternoon (quiet 
hours, husband at home)
8A
decision-making process
guidance by professional when searching for extra information 
on the Internet
2B
need for written information or leaflet immediately after the 
post-test counselling
4A
child & future
need for guidance and support of the child, unclear how to 
arrange this
8A/B
need for information leaflets on syndrome after birth  4A
table 2. Main themes and sub-themes
1. communication of the unexpected result 1.1 telephone call
1.2 first emotions
1.3 comprehension of facts
2. decision-making process 2.1 Internet-search
2.2 information and support
2.3 role general practitioner
3. child & future 3.1 quality of life
3.2 medical concerns
3.3 knowledge of psychosocial problems
3.4 need for guidance and support
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theme 1: Communication of the unforeseen findings after rad
Receiving an unexpected telephone call, while waiting for a letter of reassurance
All the parents expected that the test result would be reassuring and had been waiting 
for a letter with ‘good news’. At an unexpected moment, they had been confronted with 
unforeseen findings. 
•  I received this phone call, I was at work. He started to tell me about Turner syndrome, over 
the telephone. I think the first thing he said was: don’t start looking it up on the Internet. 
(5B)
Feelings of shock and distress, or even anger, directly after the telephone call about 
the unforeseen results 
All the parents reported feelings of anguish and fear, even anger or panic.
•  About a week later or so, a lady phoned and said that we had to go to the hospital, because 
something was wrong and that really frightened us. (1A)
Poor comprehension of the information given in this telephone call, due to emotional 
turmoil
Generally, the parents showed poor understanding of the information they received 
during the telephone call about the unforeseen findings, mostly due to strong emotions 
and grief. In all the cases, an appointment was made for a visit to the hospital within 1 
or 2 days.
•  The anger, over the telephone how it was told. I found it very overwhelming and very 
frightening as well. (1B)
•  They rang my partner, so he came to pick me up from work in a panic and we were going to 
have a very large baby, he hadn’t understood that very well. (2A)
theme 2: the decision-making process of whether or not to continue 
the pregnancy
After the telephone call, unguided searches were made on the Internet for extra 
information
All but three of the parents started searching the Internet for information about the 
findings; one couple only discussed the findings with their general practitioner (1AB). 
All the parents reported feeling more negative after reading the Internet information. 
The father who decided not to search for extra information (3B) had confidence in the 
explanations given by the health care professionals and had no wish for supplementary 
information. One of the parents (2B) stated that a great deal of the medical information 
was difficult to understand and should be explained by professionals.
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•  I started searching the Internet. And then it became a very emotional evening, you read 
those chat sites for girls with Turner. I remember crying rivers of tears. It had really fright-
ened me. (4A)
Post-test counseling was generally perceived to be adequate and the offer of 
psychosocial support was greatly appreciated
All the parents reported that they had received adequate counseling after being 
informed of the findings. Their understanding of the prognosis of children with SCAs 
varied widely and they considered that the syndrome was not as bad as Down syn-
drome, which resulted in continuation of pregnancy. Decision making was autonomous 
and all the parents reached mutual agreement. Most of the parents had been offered 
psychosocial support and they valued this gesture. They all stated that they were able to 
manage their emotions themselves and provide enough support for each other.
•  He gave us a really good explanation. Well, I didn’t feel completely reassured. But he was 
really calm. (5A)
•  If you look on the Internet. . . then you don’t know what is true. Hearing it from a genetic 
expert was nice actually. (5B)
General practitioners made only a marginal contribution to the parents’ decision-
making process 
Only one couple (1AB) discussed the unforeseen findings with their general practitioner; 
none of the other couples had been in touch with their general practitioner at all.
•  The GP didn’t, as far as I can remember, have any role at all in it. (2AB, 3AB, 4AB, 5AB, 6AB, 
7AB, 8AB)
theme 3: the child and its future
Parents had general faith in a good quality of life for the child
All the parents reported that they had faith in a good quality of life for their child. Most 
of them appreciated knowing about the syndrome, in order to be able to provide extra 
care. One couple stated that they would rather not have been told at all.
•  But if you could see the little guy, he is just an easy-going kid, he is really doing his best. It is 
going extremely well. (2B)
•  My daughter is 5 years old now I no longer think about it. She is a lovely little girl and she is 
my daughter. (4B)
Parents were most concerned about infertility, stature and health
Generally, there was incomplete recall of the information provided about health, fertility 
and psychosocial issues. Parents confessed that they did not remember all the facts that 
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had been discussed. Their worries mainly concerned future infertility and stature. One 
couple expressed faith in new medical advances to treat the fertility problems in their 
son with Klinefelter syndrome (3AB); one mother hoped that vitrification of oocytes 
would solve the infertility in her daughter with Turner syndrome (8A). Knowledge about 
specific health problems was somewhat sparse, except in one couple who were well 
aware of specific cardiac risks in their daughter with Turner syndrome (8AB).
•  The only thing I found a pity was that he can’t have children, I don’t know what the future 
will bring or do. If those legs really get so big, can something be done about it. (2B)
•  And yes, you are small, well. . . for a woman that’s not quite so bad as for a man. The girls 
probably can’t have children. It also makes you think with being able to freeze egg cells, 
that in 10 or 15 years it might be possible. (8A)
Very little focus on psychosocial problems
Overall, there were only minor concerns about psychosocial issues. Learning problems 
were mentioned by several couples. No other psychological and social disturbances 
were put forward during the interviews, even after specific questioning.
•  If he’s having problems learning then we do remedial teaching, the child is really very 
bright. (2A)
Much need was expressed regarding extra support and guidance for the child in the 
future
All the parents reported that they pay special attention to the general health and 
well-being of their child. Most of the parents explicitly mentioned the need for extra 
support and guidance for the child in the future. Remarkably, none of the couples had 
any knowledge of the existence and availability of special care.
•  The growth is something you can see, but the heart valve whether that needs to be tested 
again, or when. I don’t know if it happens automatically from the hospital or whether we 
have to take the initiative ourselves. (8A)
•  I would have liked to have a information leaflet ‘Turner syndrome’. Not that letter, was pretty 
full of medical jargon, what I remember. What I should normally be able to cope with, but in 
emotional circumstances, I couldn’t absorb much. (4A)
Parents’ opinions about routine inclusion of the x and Y markers in 
prenatal diagnosis
Two mothers and three fathers would not want to include the X and Y probes if they 
chose to have diagnostic testing again; two couples did not express an opinion, whereas 
all the others (four mothers and three fathers) gave preference to standard inclusion of 
the X and Y probes.
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disCussion
Parents are generally not prepared to accidental findings in routine invasive prenatal 
testing procedures. Besides providing proper pre-test information, the initial contact 
with parents in post-test counseling deserves attention. We extracted three themes: 
the communication of the unforeseen finding of SCA, the informed decision-making 
process concerning the continuation of pregnancy and the child and its future. We will 
discuss these themes separately hereafter.
Concerning the communication of SCA, parents referred for AMA and ‘at risk’ for Down 
syndrome did not consider the possibility of accidental findings. It is proposed by Ferm 
et al.8 that pre-test counseling should include the possibility of unintended findings and 
the lack of complete information has been shown to be experienced as rather prob-
lematic.9 Parents were all hoping for a letter of reassurance concerning the exclusion 
of Down syndrome, but received a telephone call at an inopportune time to handle the 
finding of an unfamiliar syndrome. They reported to be overwhelmed by emotions and 
did not understand the explanation given. This prompted them to make immediate use 
of the Internet to gather information about SCAs; however, this was generally perceived 
as very disturbing. The Internet service can play a critical role in providing extended 
medical information and should therefore always be discussed with a professional.10 
Post-diagnostic counseling in cases of mosaic or full-blown SCAs is widely regarded as a 
difficult issue,11 as one argued at the International Society of Prenatal Diagnosis (Amster-
dam, 2010) a letter of invitation for personal counselling may be more appropriate than 
providing clinical details by telephone.
Concerning the informed decision-making process of whether or not to continue the 
pregnancy, the early diagnosis of SCA provides an opportunity for early guidance and 
support of the child, but some parents may prefer not to know about syndromes with 
mild phenotypes. In fact, as RAD is available, parents are becoming increasingly involved 
in personal and individual choices of targeted testing and its ethical considerations.
The possibility to choose between traditional karyotyping and RAD in women referred 
for increased risk of Down syndrome has been implemented in Sweden and The Nether-
lands. Respectively, about 70% and 60% of the women in Sweden and The Netherlands 
preferred RAD.12,13 
Offering individualized options for prenatal testing of women following a positive 
diagnosis of SCA is twofold: preparing for a life with a disabled child or terminating the 
pregnancy.
The prognosis and phenotype of individuals with SCAs are usually mild as compared 
to Down syndrome. The high overall termination rates for Down syndrome may reflect 
a more negative attitude toward giving birth to a child with serious cognitive impair-
ments; the considerable lower overall rate of termination when SCA is detected may 
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reflect a greater tolerance to children with relatively minor physical and cognitive 
impairments.14 The different situations of the pregnant couples should also be taken 
into consideration; for a couple with previous experience of a child with chromosomal 
abnormality, even syndromes with mild phenotype may be too much. In a study on 
attitudes toward termination of pregnancy, 90% of the participants would choose TOP 
for Down syndrome, whereas 50% would do so for Klinefelter or Turner syndrome.6 A 
recent publication showed a termination rate of 36% for sex chromosomal trisomies.5 
As the phenotype of SCAs is usually less predictable, the counseling skills of the medical 
caregiver is of critical importance and may influence parental decision-making.9,15 All 
parents were relieved after post-test counseling; they mentioned to have been provided 
with useful and reliable facts on the syndrome. Participants reported to have been 
counseled adequately in order to be able to make a well-informed decision concerning 
the continuation of pregnancy. Consultation with their general practitioner was in most 
cases not appreciated. 
Concerning the child and its future, parents reported to have faith in a good quality of 
life for their child. Phenotypic appearance, medical, psychological and fertility problems 
and also improvement of quality of life for individuals affected with SCAs by early support 
of the child have been published on Turner syndrome,16-18 Klinefelter syndrome18-20 and 
other XY aneuploidies.21,22 Preventive medical and psychological screening programs 
offer these individuals better  prospects in terms of health and social adjustment. In this 
study, parents were most concerned on subfertility and aberrant stature, while psycho-
logical problems seemed to be less important for them. Most participants reported that 
they appreciated knowing about the syndrome and would choose the same procedure 
again if a next pregnancy would occur. This aspect is an important finding when discuss-
ing the option of excluding the X and Y probes using RAD. Although specialized clinics 
for fetal and pediatric medicine provide specific care, counseling and treatment in cases 
of SCA, the way to this care is not always easy to find for parents.
The results of this study should be interpreted as indicative rather than conclusive. 
The choice for qualitative research through in-depth interviews was useful for exploring 
parental personal feelings, opinions and experiences about unforeseen findings of SCA 
and may serve as major contributors to research on the question whether or not the X 
and Y probes should be standard included for purposes of RAD.
ConClusion
Parents’ perspectives may serve as major contributors to research on the question 
whether or not the X and Y probes should be standard included for purposes of RAD. The 
fact that RAD has the possibility to avoid accidental findings of SCAs, brings up the ques-
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tion whether any benefits outweigh the potential harms. Research on the experiences of 
parents who decided termination of pregnancy may shed a more complete light on the 
desirability of preventing accidental findings, such as fetal SCA.   
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aBstraCt
objectives 
To investigate the parental perspectives of being confronted with an unforeseen fetal 
sex chromosomal aneuploidy (SCA) and to explore their considerations regarding ter-
mination of the pregnancy.
Methods
Exploratory qualitative interview study. We conducted semi-structured interviews with 
couples who were confronted with the diagnosis of a fetal SCA and decided to terminate 
the pregnancy. Factors of decisive importance were evaluated. 
results 
The percentage of respondents was 31.2. We extracted three major themes: (i) parents’ 
perspectives before performing the prenatal test; they aimed at the exclusion of a se-
vere condition such as Down syndrome, (ii) parents’ perspectives after the unforeseen 
diagnosis of fetal SCA; the impact of the counseling and the perceived burden on the 
family and (iii) reasons for the decision to terminate; parents had many concerns about 
the child’s future health and socio-psychological wellness. Parents expressed advices for 
professionals and would include the probes for the sex chromosomes again in a future 
test.
Conclusion 
All couples were satisfied with their decision. The high percentage of selective non-
responders might reflect parents’ inner feelings and thoughts on the terminated 
pregnancy. Our study showed that the main reason to terminate was the negative 
perspective from which the parents judged the child’s future. 
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introduCtion
Sex chromosomal aneuploidies (SCAs) are usually diagnosed after birth; the incidence 
is 1 in 400.1 However, SCAs can also be detected with various prenatal tests, such as 
amniocentesis and chorionvillus biopsy. For pregnant women whose unborn children 
are at increased risk of Down syndrome (because of advanced maternal age (AMA) or 
an increased risk found in first trimester screening tests),  the incidence of prenatal SCAs 
is comparable to that of Down syndrome: 1 in 300.2 The SCAs encompass syndromes 
caused by the abnormal presence of absence of X or Y chromosomes; they include 
Turner syndrome (45,X), Klinefelter syndrome (47,XXY), Triple X syndrome (47,XXX) or 
other aberrant karyotypes (47,XYY, 48,XXXY, 49,XXXXY, etc). The postnatal phenotype of 
SCA individuals is very variable3-5 and clinical symptoms may include more or less prob-
lematic growth, several health problems such as cardiac, renal and autoimmune disease, 
neurocognitive or psychosocial impairment as well as infertility and endocrinological 
problems. In general, when no ultrasound abnormalities are detected in fetuses with an 
SCA, the postnatal clinical prognosis is likely to be good with no phenotypic symptoms 
or only mild ones.6-8
The SCAs found prenatally are associated with high termination rates (68-100%), 
despite their non-life-threatening impact.9-11 Termination rates for the most often en-
countered types of fetal SCA are quite divergent: the highest rate is for Turner syndrome: 
66-100%, for Klinefelter syndrome: 12-70% and the lowest is for Triple X syndrome: 36-
50%.9,11-13 These termination rates vary according to the country where the study took 
place. A recent review reported that factors that were unique to termination decisions 
included the parents’ anxiety and the directive counseling that they received from 
medical professionals.14 The authors conclude that often no statistical association could 
be found for possible associated factors and that some findings in the literature were 
inconsistent. They stated that there is a need for qualitative studies examining parents’ 
experiences with decision-making when they are informed of a fetal diagnosis of SCA. 
This qualitative study deals with parents’ perspectives on the unforeseen finding of a 
fetal SCA to gain insight into the motives and experiences of couples who had decided 
to terminate their pregnancy. The clinical impact of the SCA for the future child and for 
their family life, as well as the other factors that might influence their decision were 
the main objects of interest to us. This study may help professionals better understand 
the parental dilemmas and attempts to determine whether an unforeseen prenatal 
diagnosis of a fetal SCA is useful to the parents and the future child or whether it can 
harm them.
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Patients and Methods
We retrospectively interviewed parents who were referred because of AMA and who 
chose to terminate their pregnancy after being confronted with the accidental finding of 
a fetal SCA. The institutional Research Ethics Committee (Arnhem-Nijmegen) approved 
this study. The head of the Department of Obstetrics and Gynecology or the treating gy-
necologist initiated contact with the parents, inviting them to participate in an interview 
with the principal investigator (JP). When couples agreed to participate, we telephoned 
them to arrange an interview date, time and location. We requested their verbal consent 
to record the interview. The cytogenetic diagnostic tests took place in the Department 
of Human Genetics at the Radboud University Nijmegen Medical Centre, the Erasmus 
Medical Centre of Rotterdam and the Utrecht Medical Centre in the period 1994 - 2006. 
The same investigator conducted the interviews after successful training in theoreti-
cal and practical aspects of qualitative research. The interviews took place between June 
2010 and January 2012 and each one lasted between 40 min and 80 min (mean: 60 min). 
Semi-structured interviews were held with both parents separately after the prenatal 
diagnosis of a full-blown SCA or a mosaic SCA. One father could not participate, because 
he often lived and worked in a distant area of the country or abroad (1B). In a semi-
structured way, we investigated parental experiences in depth. For this purpose, we 
used an interview guide with the relevant topics, which we composed after searching 
the literature and consulting experts. The most relevant topics were: their perspec-
tives before the prenatal testing procedure, their attitudes toward termination of the 
pregnancy, their conception of risks, the perception of support by close relatives and 
professionals, their post-test decision-making process and the reasons for their deci-
sion to terminate the pregnancy. We specifically asked the participants their opinion 
of the routine inclusion of the sex chromosomes with X and Y probes besides probes 
for the common aneuploidies of the chromosomes 21, 13 and 18. We asked parents if 
they preferred learning about the sex of their child by ultrasonography. We also asked 
about their main motives to continue or terminate the pregnancy and we finally asked 
them to formulate advices for the professionals. Nine interviews were completely taped, 
transcribed verbatim, coded and analyzed. We used Atlas t.i. for qualitative research to 
code the transcripts of each participant’s interview. We read interview transcripts line by 
line, assigned specific codes to sentences and phrases, using quotes to highlight them. 
Further conversion resulted in an organized hierarchical list of themes and subthemes. 
The principal investigator analysis was both inductive and iterative. The points of differ-
ence were discussed with the other investigators (EvL, CV and AS) until agreement was 
reached. Then the coding was renewed and discussed again. Theoretical saturation was 
reached (no more new themes identifiable in additional interview data) according Guest 
and colleagues’ definition.15
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results
sample characteristics
We contacted 16 couples who decided to terminate pregnancy after the unforeseen 
finding of a fetal SCA. Five couples were willing to be interviewed (31.2%), four couples 
replied that they definitely did not want to participate in the study (25%) and the remain-
ing seven couples did not reply at all (43.8%). We did not approach the non-responders 
again because the protocol did not allow a repeat contact so as not to disturb the 
couples’ rights to privacy. 
At the time of the invasive prenatal test, the median maternal and paternal ages 
were,  respectively, 38.5 years (range 36–43 years) and 39 years (range 30–48 years). All 
the couples had the Dutch nationality. Table 1 shows the socio-demographic personal 
profiles.
interview findings
We surveyed the parents’ perspectives of fetal SCAs and their decision to terminate and 
then we categorized the data into themes and subthemes. Saturation of information 
was reached after six interviews. The couples’ reason for having the test was to check 
the baby’s health status and to rule out Down syndrome. One couple had a child with 
Down syndrome, but no prenatal test had been performed (4AB). All the parents talked 
to family or friends, from whom they said they received much support. One couple 
stated that they were religious (5AB), but they argued that religion had not influenced 
their decision. All the parents would make the same choice for invasive testing again for 
another pregnancy.
table 1.  Socio-demographic personal profiles
Diagnosis Age of mother 
(A) in years
at prenatal test
Pregnancy 
number
Level of 
education
Age of  father 
(B) in years  at 
prenatal test
Level of 
education
Time lapse 
between 
interview and 
prenatal test in 
years
(1A*) 47,XXY 37 2 high 38 high 7 
(2AB) 47,XXY 43 2 medium 30 medium 10 
(3AB) 47,XXX 39 4 high 40 high 1 
(4AB) 47,XYY 36 3 high 38 high 5 /12
(5AB) 47,XXY 40 2 high 48 high 9 
Median:
39
Median:
39
Median: 
7 
Educational level: low, primary school; medium, secondary school; high,  university or other tertiary education
* 1B was not available
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Qualitative analysis of the interviews: themes and subthemes
Analysis of the transcripts revealed three main themes. We defined the subthemes and 
selected relevant quotes to highlight these themes and subthemes (Table 2).
Theme 1: Parents’ perspectives before the prenatal test 
All women underwent the invasive prenatal test with the intention of ruling out Down 
syndrome and to check the child’s health status. The SCAs were unfamiliar syndromes 
table 2. Themes, subthemes, and quotes 
Main themes Subthemes Quotes 
1.  Parents’ perspectives before 
the prenatal test
1a. Deciding  beforehand  to terminate if 
there is an abnormality
At the time we did say that there is a result that made us 
think: if we and our family can’t live with that the way we 
want to, then we would have to terminate the pregnancy. 
3A (47,XXX)
1b. The reason for the test was to rule out 
Down syndrome
The only thing we were concerned about  was Down. Or spina 
bifida. As for all the other abnormalities, I simply didn’t know 
they existed. 1A (47,XXY)
1c. Trusting that the  result of the test would 
be reassuring
No, and there was absolutely no reason to think that anything 
might be wrong, because that only happens to someone else. 
So it was a very carefree pregnancy.1A (47,XXY)
2.  Parents’ perspectives after 
the unforeseen diagnosis of 
fetal SCA
2a. Unguided Internet searches for extra 
information
We googled everything. A 40% chance of all kinds of 
problems, such as underdeveloped language, learning 
disabilities, and concentration problems. Not to mention 
height, acne, and possible bone problems. 4A (47,XYY): 
Domain I–II
2b. Syndrome was unfamiliar but perceived 
as very burdensome
The child has no kind of life. We’ve received enough 
information. And in the second place, we wouldn’t have a life 
either. So our decision is for both parties, but in the first place 
it’s for the child. 2B (47XXY) 
3.  Reasons for decision to 
terminate the pregnancy
3a. No faith in good quality of life for child We know a boy who has Klinefelter. He is depressive and 
suicidal. And that was confirmation for me. 5A (47,XXY): 
Domain II
3b. Much focus on psychosocial problems We really wanted to know a lot more about hyperactivity.  
Behavior problems and being too slow learning to talk. 4A 
(47,XYY):Domain II
3c. Would take the same decision if this ever  
happened again
I would do the same again. It was a good decision; I have 
never regretted it. 5A (47,XXY)
3d. Reason for termination primarily 
considering the child’s perspective: 2/9
I put it all together: if he had only 2 or 3 of the 50 possible 
problems; then I’d think, my God, what have I done to him? 
Just because we wanted a child so badly. 2A (47,XXY): 
Domain I–III
3e. The reason for termination primarily 
considering the parents’ own perspective: 
7/9
What I was most afraid of was the child’s behavior problems 
and infertility; and for a lot of going to the doctor, which I 
would have manage on my own. (1A, 47,XXY):  Domain I–III
What would your own quality be like? That sounds very 
egotistical, but it is definitely a factor.  (5B, 47,XXY)
Parents’ experiences with termination of pregnancy 99
to all of them. None of the couples had considered fetal SCA as an unforeseen finding of 
the test and all the parents said they had agreed beforehand to terminate the pregnancy 
in case Down syndrome or a relevant clinical abnormality was found. All the parents 
acknowledged the risk of the invasive test. All the parents wanted to know the gender 
of the fetus and had asked to be informed before the test.
Theme 2: Parents’ perspectives after the unforeseen diagnosis of fetal SCA
One couple (3AB) had a family member (a niece) with perhaps a similar syndrome 
(47,XXX). This syndrome was in their opinion very burdensome for herself and the 
rest of the family. Another couple (4AB) already had a child with Down syndrome and 
thought the burden of extra care would be detrimental to the other two children and 
the stability of their household (47,XYY). All parents immediately searched the Internet 
for extra information about the syndrome. They generally found such information useful 
in their decision-making as a supplement to the professional post-test counseling they 
received. Three couples (3AB, 4AB, 5AB) stated that they did not appreciate the positive 
tone of the Internet information.
Theme 3: Reasons for the decision to terminate the pregnancy
All the parents who decided to terminate the pregnancy doubted that the child would 
have a good life. They expressed concerns about the limited possibilities for providing 
adequate support for the child, with regard to both health and infertility problems, but 
most of all they were very concerned about possible behavior problems. They said all 
these factors would probably be very burdensome to the other children and to the fam-
ily as a whole, and it would affect their own happiness as parents. They were unanimous 
in these reasons for deciding to terminate the pregnancy. There was an important role 
for the midwife in the decision-making for one couple (4AB), neither the family doctor 
nor the midwife participated in the post-test decision-making for the other couples.
three domains of health
Recently, we studied the medical literature for SCA and categorized the SCA phenotypi-
cal problems in three domains: I health, II behavior and III fertility, endocrinology.6 We 
also used these three categories in this study for factors that the parents mentioned as 
decisive for termination.
The effect of the three domains on termination of pregnancy
The reasons the parents decided to terminate the pregnancy were the uncertain prog-
nosis for the child after birth, the future infertility, no faith in a happy life for the child, 
the foreseeable burden of the necessary support programs and the negative impact all 
this would have on the whole family.  
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The decisive factors were mainly found in domains I and II: parents had many worries 
about their ability to cope and the poor health of the child. Therefore they doubted that 
the child would have a happy life. They all felt that the child would be too great a burden 
on the family because of the necessary support programs. 
Table 3 shows the decisive factors in the three domains.
advice to professionals
We asked the parents to formulate advice for professionals to help improve future care. 
Some parents (1A, 4AB, 5AB) mentioned the timing and manner of communicating the 
diagnosis, they thought the professional information and the Internet information were 
perceived by them as overly optimistic, one parent (3B) said the actual medical initiation 
of the termination was much too easy and one couple (5AB) stressed the importance of 
adequately informing parents about the cremation of the fetus by a letter afterwards as 
promised. Table 4 shows the advice to the professionals. 
All couples were satisfied with their decision. The high percentage of selective 
non-responders might reflect parents’ inner feelings and thoughts on the terminated 
pregnancy. The main reason to terminate was the negative perspective from which the 
parents judged the child’s future.
table 3. Decisive factors and domains
Diagnosis Domain I:
health
Domain II:
behavior
Domain III:
Fertility and 
endocrinology
Decisive factors for termination
47,XXY
n = 3
X X Worries about happiness and health 
Unlikelihood of a happy life for the child
The child would be too great a burden on the family 
47,XXX
n = 1 X
Experience of a family member with many behavior problems
Unlikelihood of a happy life for the child
The child would be too great a burden on the family 
47,XYY
n = 1 X X
Already have a child with Down syndrome
Worries about behavior and health
Unlikelihood of a happy life for the child
The child would be too great  a burden on the family 
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disCussion
Parents’ perspectives on the clinical impact of the SCA syndrome for the future child and 
for their family life, as well as the exploration of their considerations regarding termina-
tion of the pregnancy were our main interest.
A striking result of the study was the low participation rate of the couples who were 
invited to an interview. Only 31.2% of the parents whom we contacted agreed to an 
interview. The demographic variables of the total non-responders in this study were 
comparable to those of the participating couples. Most mothers were also multiparous 
and the median age (39 years) was not as in the analyzed population. In our previous 
study of the perspectives of parents who continued the pregnancy after an unforeseen 
prenatal diagnosis of fetal SCA, 72.7% of the couples were willing to participate.16 The 
reason for the large proportion of total non-responders among couples who terminated 
pregnancy is unknown, we can only speculate. The decision to terminate a wanted or 
planned pregnancy following prenatal diagnosis of fetal anomaly should be considered 
a major life event.17-20 Feelings of grief, guilt and failure after the termination procedure 
with no apparent decrease in symptomatology of post-traumatic stress symptoms have 
been reported even up to 7 years after the termination procedure.21,22
All the participating mothers who decided to terminate were multiparous (Table 1) 
and this appeared to be the only difference with the socio-demographic profiles be-
tween these parents and those who continued the pregnancy. Most of the participating 
mothers (87.5%) who continued were nulliparous. Maternal age has been shown to 
influence termination decisions. The European Surveillance of Congenital Anomalies re-
cently reviewed sex chromosomal trisomy (SCT) cases in the period 2000-2005 from 11 
European countries.11 The review found that the difference in the proportion of termina-
tions for SCTs for the group of mothers 35 years old or less and the group more than 35 
table 4. Parents’ advice to professionals
Theme Advice to professionals
1. Parents’ perspectives before  the prenatal test Invasive tests should also be available for young women with no a priori risk (2B)
2.  Parents’ perspectives after the unforeseen 
diagnosis of fetal aneuploidy
Post-test counseling should be given only by specialists in the field who are very 
knowledgeable about these syndromes (4B)
Post-test counseling is much too positive, as is the Internet (4A/B, 5B)
3. Decision to terminate the pregnancy Information about cremation and farewell rituals should be made available before the 
actual termination (3 A/B)
The initiation of the termination should not be so easy; preferably a contract should 
be signed (3B)
Women should always be given the advice to stay home from work to be able to think 
things over (4A)
The promised information letter about the hospital cremation of the baby has never 
arrived. That’s a very bad thing and it’s very unprofessional of the hospital (5A/B)
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years old was statistically significant, with more terminations for the younger mothers. 
In a study considering termination for Down syndrome, maternal age appeared to be a 
significant influencing factor, younger mothers more often terminated than older moth-
ers.23,24 However, another study found no such association.25 As the indication for referral 
in our study was advanced maternal age (AMA), we could not compare the interview 
findings with data from younger mothers.
The median time lapse between the prenatal finding of SCA and the invitation to the 
interview was 7 years. In the study that described the parental views of continuation, the 
median time lapse was a comparable 8 years. The time lapse between the events and the 
invitation for the interview in the population of the total non-responders in this study 
was median 8 years, which indicates that even after such a long period, many parents are 
still not willing to talk about their personal perspectives on the decision to terminate. 
In an earlier study, possible factors of persisting post-traumatic stress symptoms proved 
to be an important issue,22 but we cannot draw any conclusions because we have not 
analyzed for these specific symptoms. Other studies have found non-response to be a 
problem in qualitative research on traumatic events.26
We extracted three main themes and 10 subthemes in the analysis of the interviews 
(Table 2). The first theme was: “parents’ perspectives before the prenatal test”. Parents 
all intended to rule out Down syndrome with the invasive prenatal test, but SCAs were 
unfamiliar syndromes to all of them. All the couples said they agreed beforehand to 
terminate the pregnancy if a relevant clinical abnormality was found. In the population 
that decided to continue,16 the prenatal test was intended by them to rule out Down 
syndrome; only 75% of the parents stated that they would terminate, although some 
hesitated on this point. Garcia and colleagues27 studied parents’ perspectives before the 
prenatal test and reported that women decide about prenatal testing by balancing the 
test information against the emotional burden of a disabled child on their well-being 
and life perspective and on that of their family members. 
The second theme was: “Parents’ perspectives after the unforeseen diagnosis of 
fetal SCA”. Couples appreciated the post-test counseling information from the medical 
professionals and they all searched the Internet for additional information about the 
syndrome. They interpreted the Internet information as much too positive and hopeful; 
they expected the syndrome would affect the child much more. This was contrary to the 
findings in the population that continued,16 where the parents experienced the Internet 
information as very frightening and worrisome, but decided that it could not be that bad 
and their child deserved a chance. Not many studies about the interpretation of Internet 
information by worried and emotional patients are available. One study addresses the 
Internet service and states that the Internet can play a critical role in providing extended 
medical information which should always be discussed with a professional because of 
possible insufficient comprehension of the medical details.28 
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The third theme was: “reasons for decision to terminate the pregnancy”. These parents 
doubted that the child would have a good life. They were concerned about the limited 
possibilities in providing adequate support and about health and infertility problems, 
but most of all they were concerned about behavior disturbances. These factors were 
likely to be very burdensome for the other children and for the family as a whole, as 
well as being detrimental to their own happiness as parents. The parents in our previous 
study16 had faith in the support programs and hoped for medical advances that would 
cure the infertility problem. They all believed a happy and fulfilling life for the child 
would be possible. They found no justification for terminating the pregnancy. 
A trend towards fewer terminations in the last decade suggests an improved under-
standing of the pathology associated with SCA.29-31 In the medical literature, pregnan-
cies with 47,XXY, 47,XXX or 47,XYY karyotype were reported to be continued more 
often (66%)31 than pregnancies diagnosed with 45,X genotype (0-30%).30,32,33 Parental 
concern about having a child both with infertility and very short stature may account 
for this finding. The termination rates are comparable to the incidence of termination of 
pregnancy after a prenatal diagnosis of Down syndrome, which appears to be around 
75-92%.29 
When comparing the parents of both our studies, we found that the parents who 
decided to terminate were more autonomous, while parents who continued were more 
dependent on the caregivers.
Phenotypical problems for SCA individuals were categorized into three domains: I 
health, II behavior and III fertility and reproductive endocrinology.6 The analysis of these 
interviews showed that a major factor in the decision to terminate was the expected 
behavioral problems (domain II).  This was mentioned most in the interviews, as worried 
parents had no faith in a happy life for the child despite the supporting programs. The 
parents said that fear of health problems (domain I) was burdensome for them and their 
family, because of the predicted frequent doctors’ visits, preventive tests and treatment 
programs in case of disease (Table 3). This is contrary to our findings in the interviews 
with the parents who decided to continue pregnancy. The couples in that study said 
they appreciated the knowledge of SCA in their pregnancy which gave them the op-
portunity to provide extra medical care and psychosocial support to their child, who 
they believed had a good chance of a happy life. Parents who continued mentioned 
problems in domain III (infertility) many times, always as an important and sad fact, 
whereas the future infertility appeared to be of no great importance to the parents who 
decided to terminate. Earlier reports of decision-making about a prenatal finding of 
SCA, conclude that future infertility, sexual development and behavioral problems were 
the most worrisome for parents and professional support for these aspects was most 
needed.33-35
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Parents spontaneously advised better counseling and medical support; a few parents 
sharply criticized some of the procedures (Table 4). Parents also advised more neutral 
information and less intervention by a psychologist. One parent would have liked a 
more formal contract at the start of the termination procedure. The advice of the parents 
in this study is completely different from the advice the parents in the previous study. 
Parents in the continuation study mainly emphasized the necessity of extra guidance 
for them in the process of decision-making and support for the child after birth. Both 
groups mentioned that test results should always be given in the promised time. Some 
couples were informed of the unforeseen finding after this period had elapsed, which 
made them very sad and they thought it very unprofessional. 
To highlight the importance of the role of the counselor in this difficult decision-
making process, we include this relevant quote: “Nobody gave us any bad news, then 
we talked to a female specialist and she was the only one that expressed a clear opinion. 
This was a very important opinion to me, I really held on to it“ (5B).
Considering the practical and moral considerations in prenatal diagnostic testing, it 
should be noted that testing may sometimes lead to processes beneficial to the fetus and 
the future child in terms of preventive programs or early treatment options,36 but more 
often it may be especially beneficial to the parents because it enhances their autonomy 
and enables them to decide to terminate in certain cases.37 New technologies in the 
field of prenatal diagnostic testing, such as MLPA (Multiplex Ligation-dependent Probe 
Amplification) and QF-PCR (Quantitative Fluorescence Polymerase Chain Reaction), 
have been implemented for rapid aneuploidy detection (RAD) of the most common fetal 
aneuploidies (13, 18, 21, X and Y), the possibility arises to exclude X and Y probes and 
herewith avoid accidental findings of a fetal SCA.38,39,40 In both populations, the parents 
stated they had taken the right decision then and would do exactly the same again, they 
had no regrets. They would all want to include the X and Y probes in a future RAD test 
because they would want to know about SCA in the fetus.
ConClusion
Parents who were willing to talk about their experiences after a diagnosis of an unfore-
seen finding of SCA followed by termination of the pregnancy on the one hand suffered 
grief with many emotional feelings, but were nonetheless content with the procedure 
and their decision. On the other hand, termination of a planned pregnancy might cause 
the parents significant clinical distress, which may account for the large proportion of 
total non-responders. Parents who terminated confirmed that they appreciated neutral 
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medical information about the syndrome and appeared to be rather autonomous in 
their termination decision, whereas parents who continued the pregnancy asked for 
more guidance from medical advisers. 
PraCtiCe iMPliCations
The unforeseen finding of a fetal SCA and the subsequent decision of parents to ter-
minate the pregnancy may be considered a traumatic life event. Even after some years 
it is possibly still painful for parents to talk about the events again, which we believe 
to account for the large percentage non-responders in this study. The interpretation of 
Internet information is variable among couples and may be interpreted as too positive 
on the one hand, or as very frightening on the other hand. Professional counselors play 
an important role in guiding and supporting parents to make the right decision.
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aBstraCt
objective
Incidental findings in prenatal diagnostic testing may or may not have clear prognostic 
significance for the phenotype. We studied experts’ opinions of the benefit and disad-
vantage of an incidental prenatal diagnosis of a sex chromosomal aneuploidy (SCA). 
Methods
We interviewed 16 experts in the field of counseling and treatment of people with SCA 
and asked 13 clinical geneticists and genetic associates about the clinical relevance of 
an incidental prenatal diagnosis of SCA.
results
Most of the experts and clinical geneticists (87.5% and 76.9%, respectively) stated that 
an incidental prenatal diagnosis of SCA was a benefit for the child and the parents. They 
acknowledged the possibility of parental decisions to terminate pregnancy. Expert op-
tions in screening, training, and treatment of health, behavior, and fertility problems 
increase with an early diagnosis of SCA. 
Conclusion
Most experts favored an incidental prenatal diagnosis of SCA, despite the complex 
counseling issues and their acknowledgment of possible parental decisions to terminate 
pregnancy. They believed the benefits greatly outweigh the disadvantages. 
Experts’ opinions on the benefit of an incidental prenatal diagnosis of SCA 113
introduCtion
In prenatal diagnostic testing procedures, medical experts may be confronted with 
incidental findings regarding the fetus. Such findings may or may not be important for 
health and reproduction. Technological advances are causing rapid changes in prenatal 
diagnosis. For example, the use of genome-wide molecular tests leads to more diag-
noses of genetic aberrations, for which the phenotypic significance is relevant, trivial, 
or uncertain. In good clinical practice, medical experts who are involved in counseling 
before and after testing inform the parents about the purpose of the test, the potential 
risks of the procedure, and the odds of a positive or unforeseen finding.1 Whether it 
would be an appropriate standard of care to avoid incidental findings with uncertain 
clinical relevance is a subject of debate. Especially in the case of a fetal sex chromosomal 
aneuploidy (SCA), the potential gain or damage is unclear and is considered a difficult 
counseling issue.2 
The incidental finding of an SCA is considered a challenge to professional counseling 
skills because its clinical significance is variable.3 Sex chromosome aneuploidies encom-
pass syndromes caused by the abnormal presence or absence of X or Y chromosomes; 
they include Turner syndrome (45,X), Klinefelter syndrome (47,XXY), Triple X syndrome 
(47,XXX), or other aberrant karyotypes (47,XYY, 48,XXXY, 49,XXXXY, etc.). The phenotype 
of a person with SCA is very variable after birth4-6, and the clinical symptoms may include 
problematic growth; health problems such as cardiac, renal, and autoimmune disease; 
neurocognitive or psychosocial impairment; infertility; and endocrinological problems.7
Especially when no ultrasound abnormalities are found, the diagnosis of a fetal SCA 
(mosaic or full blown) creates a complex counseling issue for medical counselors, as 
the phenotype is still uncertain after birth, and there may be only mild symptoms or 
none at all. Some people with SCA may have visible stigma (webbed neck in 45,X or 
breast enlargement in 47,XXY), some may be karyotyped because of health problems 
or infertility, and others may go through life without ever knowing they have a genetic 
anomaly.8-10 Earlier studies have described the postnatal SCA phenotype after an inci-
dental prenatal diagnosis as very mild compared to the individual phenotypes that are 
ascertained because of clinical symptoms.6,9,11,12
Following the diagnosis of a fetal SCA, the genetic counselor provides unbiased and 
objective information about the syndrome, the disability of the fetus, its postnatal 
prognosis, and the necessary extra care. Due to the unpredictability of the postnatal 
phenotype, future infertility, health, and behavior, parents sometimes decide to termi-
nate the pregnancy.2,3
In this study, we asked medical experts who counsel and treat individuals with an 
SCA to give us their opinion of the benefit or possible disadvantage of a prenatal diag-
nosis of an SCA. We analyzed expert opinions to determine whether continuing testing 
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procedures that include the possible incidental diagnosis of a fetal SCA is indeed good 
medical care.
Material and Methods
interviews with expert professionals in the field of sCas
We invited experts involved in the medical and psychosocial treatment of  children and 
adults with SCA in the Netherlands to participate in a structured telephone interview 
with the principal investigator (JP). 
The institutional Research Ethics Committee (CMO, Arnhem-Nijmegen) approved the 
study. The same investigator (JP) conducted all the interviews after successful training in 
the theoretical and practical aspects of qualitative research. The participants were asked 
their opinion of the value of a prenatal diagnosis of an SCA, primarily for the child and 
secondarily for the parents. 
First, we e-mailed the selected experts to explain the purpose of the study, to invite 
them to participate, and to name a time for the investigator to call them. Second, we 
assured them of confidentiality: all information from the interviews was to be anony-
mously reported as part of a larger qualitative survey.
A study of the literature about the phenotypical problems of both children and adults 
with SCA showed that the experts we needed for this study were working in areas that 
cover the three domains in which most of the SCA characteristics of clinical health, be-
havior, and fertility appear.7 We interviewed 16 nationally known medical experts who 
are the authors of various articles about care for children or adults with an SCA. Two 
experts in each domain (health, behavior, and fertility) for each of the three most com-
mon SCAs (45,X; 47,XXY; 47,XXX) participated in the study. In the case of 45,X, children 
are treated by pediatrician-endocrinologists. Then they are treated by gynecologists 
and endocrinologists from the age of 18 years. 
Regarding 45,X, we interviewed two pediatrician-endocrinologists, two endocri-
nologists, two psychologists, and two gynecologists specializing in fertility. Regarding 
47,XXY, we interviewed two endocrinologists, two psychologists, and two urologists 
specializing in fertility. Regarding 47,XXX, we interviewed two psychologists.
The interviews took place between September 2011 and April 2012, and each lasted 
between 15 and 40 min (mean: 25 min). The interviewer used an interview guide with 
the relevant topics, composed after a literature search. We used the same topic list in the 
same sequence in each interview (Table 1). The first author (JP) encouraged the experts 
to give their opinions of all the topics in the interview guide. The answers were noted 
during the interview and categorized afterwards. The interviews were transcribed, cod-
ed, and analyzed to retrieve the most important expert counseling aspects. Theoretical 
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saturation of information was reached (no more new information in additional interview 
data) according to Guest et al.’s definition.13 
Questionnaire for clinical geneticists and genetic associates
We presented a short and unannounced questionnaire to seven clinical geneticists and 
six genetic associates (health professionals with training in  genetic  counseling who 
work with clinical geneticists), all of whom were associated with the Radboud University 
Medical Centre, Nijmegen. We used the same topic list for the questionnaire that we 
used for the interviews (Table 1). At one of the monthly conference rounds in the Genetic 
Department of the Radboud University Medical Centre, before the scientific meeting 
started, we asked the professionals to fill in a questionnaire with three questions about 
whether a prenatal diagnosis of an SCA is a diagnostic gain or a disadvantage to the 
parents and/or the child. They were unprepared for the questionnaire, and we asked 
them to give their intuitive opinion as medical experts in genetics. We assured them 
that all information would be treated with confidentiality and that only anonymized 
information would be analyzed. The first author (JP) analyzed the answers and discussed 
their relevance with the other authors (CV, DB, EL, and AS) until agreement was reached.
table 1. Interview guide: topics and sequence
Medical professionals who are experts in the treatment and care for SCA individuals
Burden of disease To your opinion, what is the burden of disease for the SCA individual, 
which domain of health is most burdensome?
Advantage of prenatal diagnosis Is there an advantage in prenatal diagnosis of SCA? 
a. for the child
b. for the parents 
Disadvantage of prenatal diagnosis Is there a disadvantage? 
a. for the child
b. for the parents
Quality of life
prenatal diagnosis vs postnatal diagnosis
Do you see differences in quality of life between: 
a.  the individuals that know of the SCA diagnosis prenatally or soon after birth
or
b: the SCA individuals that learn about their syndrome later in life
Please explain
Standard inclusion X and Y probe Would you advise for or against routinely including the X and Y probe in prenatal diagnostic testing?
Why?
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results
Saturation of information was reached after eight interviews. Additional interviews 
brought the number of experts to two for each domain and for each type of SCA, but no 
new aspects were mentioned in these additional interviews (Figure 1). 
expert interviews
Thirteen interviews took place by telephone, while three interviews took place in a face-
to-face meeting with the expert. 
Aspects of professional post-test counseling 
After we qualitatively analyzed the interviews, we extracted five central aspects con-
cerning the professional counseling that is given after an incidental finding of a fetal 
SCA. All the participating experts mentioned these aspects.
Positive views
1. Early (childhood) knowledge of SCA is favorable in terms of early treatment pos-
sibilities.
2. Late diagnosis of SCA deprives experts of the chance to adequately treat growth, 
behavior, and/or endocrinological insufficiencies.
figure 1. Saturation of information in interviews with experts
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Critical views
1. The large variability in phenotype creates complexity in the counseling. 
2. The incidental diagnosis of fetal abnormalities with uncertain postnatal prognosis 
poses ethical dilemmas for the parents in deciding to continue or to terminate the 
pregnancy. However, the experts respect the parental autonomy to decide what 
they think best. 
3. Stigmatization and over-medicalization may occur as result of an incidental prenatal 
diagnosis of SCA, experts have an important task in guiding the parents in their 
attitude towards the child.
Early knowledge of SCA is favorable in terms of early treatment possibilities 
All experts said that the most important advantage of a prenatal diagnosis of SCA is the 
early treatment, training, and prevention possibilities for all three domains of health. 
The participating experts had not treated many prenatally diagnosed SCA cases, as 
prenatally incidentally diagnosed SCA individuals tend to cause a few or no postnatal 
phenotypical problems. They all said that the earlier the diagnosis took place, the bet-
ter for the individual because of early prevention, training, and treatment options. All 
the experts mentioned the social problems connected with all types of SCA; they had 
specific problems in mind that were related to their field of expertise. 
Late diagnosis of SCA deprives experts of providing adequate treatment 
The experts we interviewed about health and behavior were all convinced that a late 
diagnosis frustrates good quality of life for anyone with SCA because many treatment 
options are no longer possible. The fertility experts stated that future infertility could 
neither be prevented nor treated. They also noticed that infertility in SCA might be more 
of a problem for the parents than for the children with SCA themselves, as they may 
learn to adapt to this condition. An early diagnosis gives the expert the opportunity to 
counsel the child and the family regarding the future possibility of artificial reproduc-
tion techniques. 
Experts have an important task in guiding the parents regarding their attitude towards the 
child 
The risks of stigmatization and over-medicalization of the child were two more problems 
that the experts named. The experts reported the important role they have in guiding 
the parents to deal with the weaknesses in health and behavior that are associated with 
each type of SCA. Professional support is equally important as parental acceptance of 
the child’s opportunities, if properly trained and guided.
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The large variability in phenotype creates complexity in counseling 
Postnatal phenotype is very difficult to predict in the prenatal finding of SCA, certainly 
when no ultrasound abnormalities are present in the fetus. All the experts acknowledged 
the complexity in counseling parents, who are anxiously searching for information 
about their child’s prognosis. The experts said that parents might decide to terminate 
the pregnancy because of uncertainty about postnatal phenotype and worries about 
the child’s quality of life. 
The incidental diagnosis of fetal abnormalities with uncertain postnatal prognosis poses 
ethical dilemmas for the parents in terms of continuation or termination decisions
Postnatal phenotype is not easy to predict. The experts said that, on the one hand they 
informed the parents that the child might very well lead a normal and happy life, but 
on the other hand, they were obliged to provide full information about possible prob-
lems in the domains of health, behavior, and fertility. Once they have received all the 
extensive information from professional counseling, the parents can make an informed 
decision to continue or terminate the pregnancy. Table 2 gives a summary of the experts’ 
answers to the five questions in the interview guide.
table 2. Results interviews experts SCA (n=16)
Q-1, advantage prenatal diagnosis SCA
1.  early knowledge of SCA is favorable in terms of early treatment possibilities 
2.  the large variability in phenotype poses difficulties in the counseling 
3.  late diagnosis of SCA deprives professionals of the possibility to give adequate treatment of growth, behavior  or endocrinological insufficiencies
4.  professionals have an important task in guiding the parents on their attitude towards the child to prevent stigmatization and over-medicalization
Q-2, disadvantage prenatal diagnosis SCA
Decision to terminate the pregnancy
Stigmatization and overprotection of child
Q-3, Burden of disease for SCA individuals
45,X: infertility and behavior most burdensome, health problems less; quality of life can be improved by early training and acceptance of weaknesses; 
health problems may benefit by early treatment (growth, puberty induction)
47,XXY: infertility; apart from this, some of these men have perfectly normal lives
47,XXX: behavior may be vulnerable; most girls and women have normal lives
Q-4, Differences in quality of life between prenatally or postnatally diagnosed SCA individuals
The earlier the diagnosis, the better for the individual because of early prevention, training and treatment options.
Q-5, would you advise for or against routinely including the X and Y probe in prenatal diagnostic testing why?
 For: 14; reason: prenatal diagnosis offers good possibilities for counseling of parents to enhance their understanding and acceptance of the child;  it 
offers early screening, training and treatment programs for the child which enhances the quality of life 
Against: 2; reason: prenatal diagnosis poses difficult dilemma for the parents, risk of parental decisions to terminate the pregnancy because of 
uncertainties in the postnatal phenotype. Early postnatal diagnosis is early enough.
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Experts’ opinions on the standard inclusion of the X and Y probes in routine prenatal 
diagnostic testing
All 16 experts stated that early knowledge of SCA is important for adequate treatment, 
prevention, and acceptance of postnatal phenotypic problems. The earlier the condi-
tion is diagnosed, the better the prospects. Fourteen of the 16 experts were in favor 
of including the X and Y probe in prenatal diagnostic testing procedures, although all 
of them were well aware of a possible disadvantage of a prenatal SCA diagnosis: the 
decision of parents to terminate the pregnancy. Two professionals thought that early 
childhood diagnosis was early enough and prenatal diagnosis unnecessarily burdened 
the parents with the dilemma of whether or not to continue the pregnancy. 
Questionnaire for clinical geneticists and genetic associates 
Thirteen clinical geneticists and genetic associates were asked to spontaneously answer 
questions about the benefits, disadvantages, and burden of a prenatally diagnosed SCA 
(45,X; 47,XXY; 47,XXX) for the child and for the parents.
Question 1. Is there an advantage in prenatal diagnosis of SCA (45,X; 47,XXY; 47,XXX)? 
a. For the child
b. For the parents 
For 45,X, 10 of the 13 agreed with this statement. 
For 47,XXY, a minority  of 3 agreed with this statement: 6 answered “no” and 4 had “no 
opinion”. 
For 47,XXX, only one participant agreed, while 7 said “no” and 5 had  “no opinion”.
Question 2. Is there a disadvantage?
The complexity of the counseling because of variability in the phenotype and the pos-
sibility of a termination decision was mentioned by all the participating staff members.
Question 3. In your opinion, what is the burden of disease for the person with SCA, and 
which domain of health is the most burdensome?
For 45,X, 6 participants said health was the most problematic domain, 2 said behavior, 
and 5 said fertility.
For 47,XXY, all the participants said fertility was the most problematic domain.
For 47,XXX, 11 participants said behavior was the most problematic domain, one said 
health, and one said fertility.
Table 3 shows the clinical geneticists’ and genetic associates’ answers to the three ques-
tions 
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table 3. Questionnaire answers clinical geneticists and associates Radboud University Medical Centre
SCA Question N=13
Q-1, advantage prenatal diagnosis SCA
45,X yes
no
no opinion
10
3
0
47,XXY yes
no
no opinion
3
6
4
47,XXX yes
no
no opinion
1
7
5
Q-2, disadvantage prenatal diagnosis SCA
Complexity of  counseling procedure: all experts
Decision to terminate the pregnancy: all experts
Q-3, Burden of disease for SCA individuals
45,X Health
Behavior
Fertility
6
2
5
47,XXY Health
Behavior
Fertility
-
-
13
47,XXX Health
Behavior
Fertility
1
11
1
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disCussion
Medical experts in the field of counseling and treatment of individuals with an SCA were 
generally in favor of continuing testing procedures that include the possibility of an inci-
dental diagnosis of a fetal SCA. In their opinion, early treatment of health, behavior, and 
fertility problems is an important factor in enhancing the child´s quality of life; however, 
they all acknowledged the possibility of parental decisions to terminate pregnancy. 
Whether an unforeseen prenatal diagnosis of SCA may be a disadvantage or a benefit to 
the child or the parents is still a subject of debate.2
experts’ opinions on early and pre-symptomatic diagnosis of sCa
Critical views
The experts unanimously acknowledged the complexity of the counseling after a pre-
natal diagnosis of SCA. This was mainly attributed to the unpredictability and variability 
of the postnatal phenotype of the person with SCA, especially when no ultrasound 
abnormalities appeared during the mother’s pregnancy. An incidental prenatal diag-
nosis of SCA may be associated with a phenotype that is even milder than phenotypes 
diagnosed on traditional clinical grounds.8,9,11,12 Counseling of the parents is even more 
challenging after an incidental prenatal finding of a sex chromosomal mosaicism.3,5,14,15
Stigmatization of the child was mentioned as a serious risk. The experts stated they had 
an important task in guiding the parents in their attitude towards the child to prevent 
stigmatization and over-medicalization. Early professional explanation helps parents 
accept the child’s condition, as has been published for prenatal diagnosis of children 
with cleft lip and palate.16-18 Prenatal counseling may add to better understanding and 
acceptance of the child. The diagnosis of a genetic abnormality may harm the child’s 
self-esteem, distort the family’s perception of the child, damage future autonomy, and 
possibly lead to discrimination of the child.19
What are the public, parental, ethical, and medical perspectives of these technologic 
advances? Pre-symptomatic fetal diagnostics may give rise to moral and ethical dilem-
mas for parents about whether to continue the pregnancy. In two earlier studies, we 
have surveyed parents’ perspectives of the dilemmas they face after the incidental 
prenatal finding of a SCA and the reasons they might have for deciding to continue or 
terminate the pregnancy. Parents in both groups stated clear views of their decisions, 
and all expressed satisfaction with their decisions (published article and manuscript 
in progress).20 Most parents preferred knowing about the fetal SCA and would want 
to include the X and Y probes again in a prenatal test for a future pregnancy. The ex-
perts we interviewed in the current study had concerns about the risk of the parents 
terminating the pregnancy after an incidental prenatal diagnosis of SCA. The different 
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view of the geneticists when compared to the clinical experts is an important fact to 
consider, as most parents-to-be will be provided with post-test counseling information 
by the geneticist first and thereafter will make the decision to continue or terminate the 
pregnancy. Our earlier studies have shown that, with professional guidance of medical 
experts, parents are very capable of handling these dilemmas, and will ultimately reach 
a satisfactory decision.
The medical experts are involved in counseling parents after an unforeseen diagnosis 
of a fetal anomaly that is unfamiliar to them. Therefore, these experts require specific 
knowledge and counseling skills so that they can provide adequate guidance and care 
for these parents.21 Termination decisions after a prenatal diagnosis of SCA have been 
associated with the amount of training and the professional or cultural background 
of the counselor.10,22-26 Improved professional knowledge of the conditions associated 
with SCA have positively influenced a decreasing trend to terminate pregnancy.27,28 
The expert’s neutrality in his or her attitude towards pregnancy termination and non-
directiveness is a prerequisite for adequate counseling both before and after testing. 
It has been shown that personal attitude may play a variable influencing role,29,30 this 
attitude may be colored by the gravity of the phenotypic aspects of SCA that the expert 
will have encountered.
Positive views
A prenatal diagnosis of SCA opens options for early screening and treatment of cardio-
vascular, metabolic, and endocrine disease. Experts can start preventive training for the 
child’s and the parents’ acceptance of the behavioral weaknesses. They can also provide 
coping strategies in an early stage before real problems, such as growth retardation, 
failed puberty or psychosocial problems come forward. Fertility problems such as the 
risk of premature ovarian failure or infertility can be disclosed in a very early stage and 
discussed with the child and the parents, along with the options for assisted reproductive 
techniques. A late diagnosis of SCA, however, deprives the experts of the opportunity to 
give adequate early treatment of growth, behavior, and/or endocrinological insufficien-
cies. Medical or psychological screening options may no longer be possible, and health 
or behavior problems may have advanced to a stage where treatment options may have 
become scarce. The recent literature describes the current advice for screening and early 
treatment programs for children with an SCA.6,8,31-33 Table 4 lists the experts’ opinions of 
counseling issues and treatment policy after the incidental prenatal finding of a SCA, 
categorized into critical and positive views. 
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Standard inclusion of the X and Y probe in routine prenatal tests
Notwithstanding the difficulties that medical experts encounter in counseling parents 
after an incidental prenatal finding of SCA, 87.5% were convinced of the benefit of a 
prenatal diagnosis of SCA. When specifically asked, they were in favor of continuing 
the inclusion of the X and Y probe in routine prenatal testing procedures because the 
benefits of early knowledge greatly outweigh the disadvantages.
The questionnaire for clinical geneticists and genetic associates about the benefits, 
disadvantages, and burden of a prenatally diagnosed SCA revealed that 76.9% agreed 
that an incidental prenatal finding of 45,X is a diagnostic gain. For 47,XXY, 23.1% agreed 
it was a diagnostic gain, and for 47,XXX, only one participant saw benefits in prenatal 
table 4. Expert´s  remarks on complexity and positive issues for counseling and medical policy after 
prenatal diagnosis SCA
SCA
complexity
Domain I: health Domain II: behavior Domain III: fertility
45,X Phenotype very variable and 
unpredictable
Phenotype very variable, large 
scale from normal coping to serious 
psychiatric disease
No doubts: always infertile
47,XXY Phenotype very variable and 
unpredictable
Phenotype very variable, large 
scale from normal coping to serious 
psychiatric disease
Sometimes artificial reproductive 
techniques possible 
Problem of over-medicalization of 
normal SCA individual 
47,XXX Sometimes long stature when compared 
to classmates
Phenotype very variable, most girls have 
normal behavior and coping
 
Fertility may be problematic because 
of premature ovarian failure in some 
women
Positive issues
45,X
Early screening program to detect and 
treat cardiovascular, metabolic and 
endocrine disease
Preventive training for acceptance of 
weaknesses and coping strategy
Early disclosure of infertility
Early start Growth Hormone therapy Counseling mothers about oocyte 
donation
Alertness for dysplastic gonads and 
timely extirpation
Timely start puberty induction
47,XXY
Early screening program to detect and 
treat cardiovascular, metabolic and 
endocrine disease
Preventive training for acceptance of 
weaknesses and coping strategy
Early disclosure of infertility
Alertness for mamma carcinoma
 
Counseling about possibilities of early 
sperm preservation in young puberty
Alertness for dysplastic gonads and 
timely extirpation
47,XXX
Preventive training for acceptance of 
weaknesses and coping strategy
Counseling about the risk of premature 
ovarian failure
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detection (7.7%). Despite the professional knowledge of these clinical geneticists and 
genetic associates about SCA, medical experts in the field of care for children or adults 
with SCA stated that parents might benefit from their additional counseling after an 
incidental prenatal diagnosis of SCA. Earlier reports have shown that there may be a 
gap in clinical geneticists’ and medical experts’ counseling of people with a SCA.3,22,34 
A combination of both counselors might provide a comprehensive view of the child’s 
quality of life for the parents.
ConClusion
Most experts were in favor of an incidental prenatal diagnosis of a SCA, notwithstanding 
the complexity of the counseling issues and the moral dilemma for parents faced with 
deciding to terminate or continue the pregnancy. Medical experts who are involved in 
the counseling and treatment of people with SCA had a clear opinion of the incidental 
fetal diagnosis of SCA: the benefits greatly outweigh the disadvantages. They proposed 
that the X and Y probes should remain available for rapid and definitive prenatal diag-
nosis. 
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what’s alreadY Known aBout this toPiC?
• Incidental prenatal findings create complex counseling issues for the professionals 
involved. The variability of the SCA postnatal phenotype puts an extra strain on 
professional guidance of parents after an incidental prenatal finding of an SCA.
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what does this studY add?
•	 Despite the complexity of the counseling and the possibility of parental decisions to 
terminate the pregnancy, most experts believe that the benefits of a prenatal SCA 
diagnosis far outweigh the disadvantages.
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aBort after a Prenatal diaGnosis of a sex ChroMosoMe 
aBnorMalitY
to the editor:
In their interesting study,1 Jeon and colleagues evaluated demographic factors to study 
associations with decisions to terminate or continue pregnancy. While their review is 
a valuable contribution to the existing literature about the complex issue of decision-
making after a prenatal diagnosis of a sex chromosomal aneuploidy (SCA), it does not 
address some relevant factors that might affect this decision-making. We would like to 
bring these factors to the readers’ attention. Each of a multitude of factors, separately or 
in combination, may influence parental decisions about terminating pregnancy.
I: Reason for referral
 Various studies report that a fetal ultrasound abnormality strongly affects the decision 
to abort.2 The review reports indications for invasive prenatal testing in 12 of the 19 
articles studied, but does not address the reasons for referral. In our opinion, addressing 
these reasons is necessary. The authors report that young mothers (<36 years old) are 
more likely to abort after being informed of a fetal SCA. However, as long as the reason 
for referral is unknown, the maternal age factor must be interpreted with great care. 
One must take into consideration that these young mothers may have been eligible for 
invasive prenatal testing on the indication of a fetal ultrasound abnormality. The prog-
nosis is substantially poorer for a fetal ultrasound abnormality than for an incidental 
finding of SCA. The latter makes the decision-making even more burdensome because 
the phenotype may be quite normal but uncertainty remains concerning psychosocial 
development and late-onset diseases.
II: Role of the Internet
The important role of the Internet in providing anxious parents with extensive medical 
information is not mentioned in the review. We checked whether the informative role 
of the Internet was considered in the articles reviewed and discovered that it was not, 
even though the Internet has played an ever greater role in public information since the 
1990s. Medical professionals must be aware of the fact that patients check the Internet 
for extensive information about their disease and/or possible treatments. Parents search 
the Internet looking for additional information about the syndromes for which their 
unborn children are diagnosed. In a qualitative interview study (as opposed to a quan-
titative one), which we published in 2011,3 all the participating couples independently 
searched the Internet and stated that the information they found was a shock to them. 
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After professional counseling they decided that the Internet information was too nega-
tive, and ultimately they decided to continue pregnancy. We found two articles regard-
ing the impact of medical information that patients can find on the Internet,4,5 and we 
believe that more research on this important issue will follow in the near future. In the 
complex of emotions after the unforeseen diagnosis of a fetal SCA, parents have a need 
for additional information; they start searching the Internet even before the post-test 
counseling appointment. The impact of searching the Internet for their decision-making 
is an important factor that we believe deserves more attention in future research.
III: The counseling
Directive counseling is an important factor in Jeon colleagues’ review. It is associated 
with the decision to terminate pregnancy, but the authors do not report the profes-
sional qualifications of the counselors or consider whether one type of counselor is 
more tempted to direct parents to abort than another. The profession of the counselor 
has been reported in 11 of the 19 studies, and the influence of the counselor’s profession 
on the decision to terminate is elaborately discussed in 6 of these studies. Other publica-
tions report that counseling by non-geneticists may be associated with more decisions 
to terminate.6,7
The authors used a methodological quality score for the articles they reviewed. It 
would increase the usability of their review if each of the 19 articles in the table was 
accompanied with its individual score.
We conclude that: (i) the reason for referral plays a major role in the process of deci-
sion- making when a fetal SCA is diagnosed, as fetal ultrasound abnormalities may 
influence the prognosis. The presence or absence of a fetal ultrasound abnormality was 
not addressed, this fact importantly affects the results of the review; (ii) the Internet 
has an increasingly important role in providing additional, but sometimes confusing, 
medical information to anxious parents who are searching unguided for help in their 
difficult decision-making; (iii) geneticists can make a significant contribution to the field 
of decision-making of parents to continue or to abort their pregnancy.
Jacqueline JPM Pieters1, Angelique JA Kooper2, Ton B Feuth3, Arie PT Smits2 
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Response to Pieters et al.
To the Editor: We wish to thank Pieters, Kooper, Smits, and 
Feuth for their interest in our review. We appreciate their 
thoughtful comments and the important factors raised in their 
letter “Considering Factors Affecting the Parental Decision to 
Abort After a Prenatal Diagnosis of a Sex Chromosome Abnor-
mality”1. Nonetheless, for the sake of clarity, we would like to 
point out that our review2 extends beyond an analysis of demo-
graphic factors to include nondemographic variables such as 
type of sex chromosome abnormality and parents’ fears.
No doubt the confounding factors raised by Pieters and col-
leagues (reason for referral, the role of the Internet, and quali-
fications of counseling providers) are extremely important for 
more fully understanding decisions to continue or terminate 
a sex chromosome abnormality–affected pregnancy. Unfortu-
nately, these factors did not emerge as findings in the studies 
we reviewed, as they were not sufficiently explored in this body 
of work. Therefore, we thank Pieters and colleagues for helping 
to highlight and reinforce both this gap and our call for better-
quality studies. To date, assessments of decisions surrounding 
a sex chromosome abnormality–affected pregnancy have been 
limited in their ability to identify the multiple factors shaping 
these decisions, the nuanced variability within those factors, 
and the complex interactions among them. Studies that (i) tap 
into the context of decision-making, (ii) examine how parents 
obtain information on their own through the Internet, and (iii) 
explore the role played by various types of service providers, 
in-depth—are urgently needed!
Moreover, as we argue in our review, studies of better meth-
odological quality are also missing from this body of literature. 
Given the multifactor nature of the topic, it makes little sense 
to capture complex associations among factors and decisions 
using descriptive or bivariate statistical analyses without con-
trolling for confounders or covariates. Also missing from this 
literature are qualitative studies that portray parents’  points  of 
view and voices, directly.
Finally, given the below-average methodological quality 
scores of most studies in the review, we chose not to report each 
study’s score individually. These are available, however, upon 
request to the authors.
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General disCussion and future ProsPeCts
1.1 Prenatal findings of sex chromosomal aneuploidies 
1.2 Ethical considerations 
1.3 Future prospects 
8.1 Prenatal findinGs of sex ChroMosoMal aneuPloidies
Incidental findings are an inevitable part of medical examinations and may appear in 
any physical or laboratory test. They usually come as unforeseen to the person involved, 
even though most medical professionals are aware of the phenomenon. Interpreting 
the significance of incidental findings may not always be easy for a trained researcher, 
but it is certainly difficult for the patient.
Prenatal screening and diagnostic testing are widely implemented to gain informa-
tion about the health of the unborn child. The incidental finding of a sex chromosomal 
aneuploidy (SCA) in prenatal testing intended to exclude another abnormality is not 
uncommon. The finding of a fetal SCA in a seemingly normal pregnancy may cause 
parental anxiety, as SCAs are unfamiliar syndromes to most parents. They cause dilem-
mas in deciding whether to continue the pregnancy because the postnatal phenotype 
and quality-of-life prognosis of those with an SCA are so variable. Medical professionals 
generally consider the post-test counseling very challenging. Counseling is complicated 
by the fact that many parents use the Internet to collect additional – sometimes incor-
rect or incomplete – information. 
Whether an incidental finding of a fetal SCA provides a diagnostic benefit or creates 
diagnostic damage is the central study question of this thesis. Some incidental findings 
may be clearly beneficial to the patient (e.g., the discovery of an ovarian tumor in a rou-
tine gynecological ultrasound examination), whereas other findings may be damaging 
(e.g., the finding of a genetic anomaly with uncertain clinical consequences). In the case 
of a prenatal finding of SCA, the child may benefit from early parental and professional 
guidance and may be damaged by stigmatization.
Our study shows that both the parents and the professionals which we interviewed 
consider the incidental prenatal finding of an SCA a benefit  in terms of early treatment 
and support options. As our study had a qualitative design, the results are indicative 
rather than conclusive. These results may contribute to the discussion whether testing 
procedures that include a potential incidental diagnosis of a fetal SCA indeed constitute 
good medical care. 
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Considering that the parents and experts in our study favored including the sex 
chromosomes in prenatal testing, it seems important to continue detecting SCAs and 
to improve pre- and post-test information. The finding of an SCA in prenatal testing 
should no longer be considered an incidental finding, and pre-test counseling should 
adequately inform parents about it.
Pre-test counseling
The incidence of SCAs is 1 in 300 in prenatal tests for advanced maternal age (AMA) or 
a positive first-trimester screening test result, which is comparable to the incidence of 
Down syndrome.1,2 Overall, the incidence of SCA findings at birth is 1 in 400.3 Parents 
should be informed beforehand that SCAs can be found in routine prenatal testing; this 
issue has been addressed in earlier reports.4-6 
 Choosing full-scale prenatal testing by traditional karyotyping, micro-array, 
next generation sequencing (NGS) or rapid aneuploidy detection (RAD) for selected 
most common chromosomal aneuploidies, depending on the reason for testing and the 
parents’ preference.7,8 This choice is of topical and ethical interest in terms of the parents’ 
autonomous “right to know versus not to know” genetic information about the unborn 
child. Our first study has shown that, if full-scale testing were available to low-risk preg-
nant women as part of invasive diagnostics, they would not accept it unquestioningly. 
Low educational level and limited knowledge of genetic defects may play a role in their 
choices (Chapter 2).
Pre-test counseling concerning prenatal diagnostic testing covers the purposes of the 
tests and the risks. It should be non-directive in nature,9 tailored to the circumstances, 
and preferably with both parents participating.10 All prenatal tests carry the risk of find-
ing a genetic or structural fetal anomaly for which the parents were possibly unprepared, 
and its clinical significance is not always clear. Since the prenatal finding of an SCA is 
not uncommon, we propose that it should be discussed with the parents in pre-test 
counseling. 
screening and diagnostic prenatal tests
Parents consider fetal ultrasound to be the first pleasant encounter with their unborn 
child.11,12 Ultrasound imaging may reassure most pregnant women, yet it is a diagnostic 
tool that can detect a fetal anomaly.  It can miss or falsely detect an anomaly, and it 
can detect fetal physiology variations with unclear clinical significance (e.g., choroid 
plexus cysts or echogenic bowel.13,14 The possibility of finding a major anomaly like 
anencephaly, or a minor anomaly like a soft marker, is not always discussed beforehand. 
A similar situation may occur concerning the completeness of the pre-test counseling 
in invasive diagnostic testing, as increasingly high resolution DNA technology such as 
micro-array and soon NGS will be applied in prenatal testing. Parents need appropriate 
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pre-test  counseling which means that counselors verify that patients have read and 
understand the disclosures of the test. In the future, pre-test counseling will be even 
more challenging.
Mosaicism
The co-existence of more than one cell line in one person influences the phenotype 
and the prognosis. The co-existence of a normal cell line has a positive impact, and the 
co-existence of another aneuploidy has a clearly negative impact on the postnatal qual-
ity of life. Mosaicisms are common in all SCAs and are especially associated with 45,X.4 
This is an important complicating factor in the post-test counseling as mosaicisms may 
have important health consequences. Growth, onset of puberty, fertility, behavior, and 
general health may be quite normal in the presence of a normal 46,XX cell line.4,15,16 This 
is also true of mosaicisms of 47,XXY or 47,XXX combined with a normal cell line.17 The 
estimated percentage of Y-chromosome mosaicism in 45,X is 5.5%18-20 and is associated 
with hyperandrogenism, virilization, and gonadal tumors.21-23 
Because of the large variability of co-existing X- or Y-chromosome cell lines, it is virtu-
ally impossible to predict the postnatal phenotype of a 45,X fetus, whereas the presence 
of fetal ultrasound abnormalities is a clear negative prognostic factor.24-27 
One has to realize that, even if a normal fetal karyotype is found in prenatal invasive 
testing, there may still be a co-existing aneuploidic cell line that remained undetected in 
the test. This fact is not usually discussed in pre- or post-test counseling, but the person 
concerned is diagnosed later in life because of health problems.28 The huge variability 
and complexity of the clinical impact of mosaicism in SCAs make it impossible to discuss 
all the options in pre-test counseling, but counselors can inform parents about the 
existence of mosaicism by guiding them to specific websites that explain the subject in 
an understandable way. 
 A specific back-up marker set should be used to confirm any initial QF-PCR 
results indicative of (mosaicism) sex-chromosome aneuploidy. This back-up set includes 
extra markers and primers to amplify chromosome-specific sequences of the paralogous 
gene TAF9L. This gene has a high degree of sequence identity between chromosome 
3 and X, making a relative quantification between chromosome 3 and chromosome X 
possible. See Figure 1.
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Post-test counseling
Meeting patients’ expectations for information and explanations in genetic pre- and 
post-test counseling is an issue that earlier studies have discussed.29,30 The results of our 
study show that parents were generally shocked by the finding of a fetal SCA, but they 
were glad to know about the syndrome to better decide whether to continue the preg-
nancy. They would have preferred to quietly learn about these syndromes beforehand, 
and pre-test counseling would certainly have been more satisfactory. Other studies of 
the prenatal diagnosis of SCA have discussed this issue.4,5 
In our study, most parents complained about the way this unexpected test result was 
communicated to them, at an unexpected moment, sometimes in an awkward place. 
They had an appointment with one or more counselors in the days after the disclosure 
figure 1. Detection of X chromosome aneuploidies by QF-PCR analysis of TAF9L
 
45,X 
46,XX 
47,XXX 
0.7 : 1 
1 : 1 
2 : 1 
-  X monosomy (Turner Syndrome) is determined by the double dose of chromosome 3-specific product compared to the 
X. 
- Two peaks of equal fluorescent intensity (ratio 1:1) indicate the presence of two X chromosomes. 
- Skewed ratio (0,7:1) in favor of the X specific product indicates the presence of three X chromosomes
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of the finding for an explanation of the syndrome. Not all counselors gave comparable 
information, a known fact in post-test counseling of SCA,31-34 which made them feel 
insecure, and they reported  spending much time in uncertainty and worry (Chapter 4).
Patients increasingly use the Internet to obtain health information. This may affect the 
patient–health-professional relationship.35 Searching for additional information about 
syndromes or diseases without the aid of a medical professional provides a certain risk 
of getting incorrect or incomplete data, or even misunderstanding information.36 In 
the case of the prenatal diagnosis of SCA, anxious parents inevitably visit websites with 
much positive information coming from parental contact groups, but they also find uni-
lateral negative information regarding the prognosis of the full-blown syndromes. One 
of the results of our study is that some parents were shocked by the amount of negative 
information, but at the same time other parents found the information too positively 
colored; it all depended on the concern they had for their child’s future quality of life. 
Our review of the SCA literature shows that an incidental prenatal diagnosis usually 
leads to a less affected or more normal postnatal phenotype (Chapter 3), and this infor-
mation is generally unavailable on the Internet SCA sites. Reliable information including 
these specific facts should be available on the Internet; they should adequately inform 
anxious parents who are faced with an incidental prenatal finding of SCA. Linden et 
al.6 have discussed a suggestion for more adequately informing parents about the vari-
ability and imprecise prognoses of SCAs.
Parental decision-making
Parents generally found the information they received from the professional counselors 
satisfactory. This finding confirms the conclusions of other reports.29,37,38 All the partici-
pating couples were able to make a satisfactory decision to continue or terminate their 
pregnancy. They all stated they would do the same again, and they were content with 
the procedure and their decision. Parents who terminated confirmed that they appreci-
ated neutral medical information about the syndrome and appeared to be rather au-
tonomous in their termination decision, whereas parents who continued the pregnancy 
asked for more guidance from medical advisors.
non-response
In our study of the parental perspectives of the decision to terminate after the incidental 
prenatal finding of SCA, the parents generally had decided to do so in such a case before 
the actual diagnostic testing (Chapter 5). The parents whom we invited to participate 
in the interviews and who were willing to talk about the events and their perspectives 
again formed a minority (29%). Other studies show that the usual non-response rate 
is 30%, with peaks to 50%, so that those who refused to take part were probably not 
a random sub-set of the population to be investigated.39 We can only speculate about 
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the reasons for the large proportion of non-responders in our study (71%). Termination 
of a desired pregnancy has been described as a “major life event”, and the grief for the 
self-chosen loss of a child is associated with feelings of relief, guilt, doubt, and loss of 
self-esteem.40 More than 95% of the parents decide to terminate when they receive a 
prenatal diagnosis of Down syndrome,41 a fact that is now socially and legally accepted. 
If the parents acknowledged the possibility of finding a prenatal SCA, they would prob-
ably be less shocked when confronted with one, and it might be easier for them to 
reflect on their perspectives and decision again.
experts´ opinions
We asked professionals in the field of counseling and treatment of people with SCA 
about the usefulness of a prenatal diagnosis of SCA. They stated that they considered it 
a benefit to the child and the parents because of the early prevention and treatment op-
tions. This is in line with earlier reports.4,17,42,43 The experts acknowledged that the child 
might be stigmatized and that the parents might decide to terminate the pregnancy. 
After analysis of all the answers, the professionals concluded that the advantages of 
prenatal SCA detection largely outweigh the disadvantages (Chapter 6).
literature
Parents who are confronted with an incidental prenatal diagnosis of SCA in the absence 
of fetal ultrasound abnormalities need different counseling and certainly different ad-
ditional information than the parents of a child with a postnatal diagnosis of an SCA 
because of phenotypic problems. Our literature review (Chapter 3) shows that these 
incidental prenatal findings are associated with phenotypic problems that are much less 
serious in all domains (health, behavior, and fertility). The currently available informa-
tion leaflets and Internet websites all describe the condition of people with postnatally 
ascertained SCAs, and they may reliably report negative and positive aspects of the syn-
dromes. Nonetheless, people with incidentally and prenatally diagnosed SCAs do not 
fit in this category. These sources of information are thus inadequate and not useful for 
parents who want to obtain information after an incidental prenatal diagnosis of SCA.
standard inclusion of the sex chromosomes in prenatal tests
Molecular technologies such as multiplex ligation-dependent probe amplification 
(MLPA), quantitative fluorescence polymerase chain reaction (QF-PCR) are used for rapid 
aneuploidy detection (RAD) of the most common fetal aneuploidies (13, 18, 21, X and 
Y).44-47 Their implementation makes it possible to reduce certain unwanted findings. 
Excluding X and Y probes avoids finding a fetal SCA. The discussion whether or not to 
continue the standard inclusion of the X and Y probes in RAD is ongoing.48  The results 
of our study show that excluding the detection of SCAs might not be the best choice. 
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In conclusion, the results of the studies in this thesis show that both parents and 
professionals favor prenatal detection of SCAs, whether intended or not. This implies 
that pre- and post-test counseling deserves attention. Prenatal SCA findings are not 
uncommon, and this fact should be discussed with the parents before the testing. They 
can then calmly obtain reliable and neutral information and will then be better prepared 
for a possible SCA finding, which will increase their psychological adjustment. They will 
be less shocked by the disclosure of a finding that is unfamiliar to them. The prenatal 
diagnosis of an SCA should thus be considered a possibility in prenatal testing. 
8.2 ethiCal Considerations
the obligation to inform
Medical professionalism and the interpersonal doctor–patient relationship are sum-
marized and integrated in the Hippocratic Oath (classical or modified),49 which contains 
the generally accepted principles of moral values and ethics for physicians. Physicians 
promise not merely to avoid harm, but to act for the good of the patient.50 Physicians 
have a moral obligation to disclose all test information, prenatal or otherwise. 
Incidental diagnostic information is becoming common in many areas of medicine. 
Sometimes the clinical significance of the information remains unclear, but even then 
it cannot easily be ignored.51 Other prenatal incidental diagnoses are clearly beneficial, 
especially when the conditions are treatable or when the information helps parents 
decide whether to prevent the birth of a seriously handicapped child.52 However, some 
disorders are currently untreatable or may lead to late-onset disease (e.g., breast cancer 
mutations). Some consider that discussing these incidental findings may harm the par-
ents and the child by causing anxiety about a risk of future disease.
An incidental disclosure of a fetal SCA offers a unique opportunity for early prevention 
and management of SCA-related disease, the psychological issues for parents and chil-
dren, and the fertility issues in the later life of the child. These benefits are evident from 
the professional point of view,4,42,43,53 but they should be balanced against the possible 
negative impact of the unexpected diagnosis on the future child. Incidental prenatal 
diagnosis of an SCA may cause stigmatization, damage the child’s self-esteem, and/or 
distort the family’s perception of the child.54 In our studies, the problem of stigmatization 
did not appear to be an issue for concern (Chapter 4). Nonetheless, future genome-wide 
testing will likely reveal more genetic aberrations, at which time the clinical significance 
will not yet be clarified; stigmatization may then become a menace to the future child.55 
The term “incidental finding” has currently been replaced in some medical publications 
with “unsolicited finding”. One may discuss the use of the term “unsolicited” in the case 
of the prenatal finding of an SCA, as our studies have indicated that parents and experts 
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may find the incidental diagnosis of fetal SCA indeed useful and appreciate the informa-
tion. They all would want to be informed again in the event of another pregnancy. This 
shows that the professional obligation to inform parents about an “incidental” prenatal 
finding of an SCA is as much appreciated as the moral obligation to disclose a “solicited 
finding”.
the right to know and the right not to know
Genetic testing is distinct from testing for other conditions in that it potentially affects 
the family members as well as the person tested. For all genetic tests, patients must 
be adequately informed about the implications of genetic screening before they can 
provide informed consent.56 
In view of new technological developments, it is interesting to assess the parents’ 
preference, namely, whether women considered at high risk of having a child with 
Down syndrome and undergoing invasive testing (e.g., because of AMA), would opt 
for genome-wide genetic testing for other disorders for which they do not have an a 
priori increased risk (Chapter 2). Women referred because of an increased risk of Down 
syndrome can now choose between traditional karyotyping and RAD in some prenatal 
centers in Sweden and the Netherlands. About 70% of the women in Sweden and 60% 
in the Netherlands who had been offered this choice, preferred RAD.57,58 One should 
expect that incidental findings will thus be significantly reduced. The women’s prefer-
ence brings the right not to know to the fore. Women’s preferences to have a choice 
of one of these two prenatal testing techniques have recently been evaluated; most 
women preferred the choice option (Kooper 2012, data presented at ISPD Miami).7,8,59,60 
From the ethical point of view, the parents’ autonomous “right to know” versus “not to 
know” is of topical interest.61 Placing knowledge of genetic diseases or predispositions 
in a well-informed community with integrated clinical and social support systems 
optimizes its usefulness. These support systems should include counseling services for 
patients and their families,  Such circumstances can lead to better care and manage-
ment of the patient and ultimately improve the quality of life.55 If this is also true of 
conditions that can be diagnosed in fetuses, the question becomes how far the right not 
to know should be ascribed to the parents. If the quality of life of the future child will 
clearly benefit from disclosing certain information, a physicians’ dilemma arises. Both 
the pregnant woman and the unborn child are the physician’s patients, and they have 
the right to be cared for properly.59 The boundaries of the obligation to inform and the 
woman’s “right not to know” can conflict. Researchers are encouraged to consult with a 
clinical ethics committee regarding the existence of the participant’s right “not to know” 
about incidental findings.  
The new technologic advances in prenatal testing may provide genetic information with 
implications not only for the fetus who is being tested, but also for the parents, other 
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siblings, grandparents, and other relatives (Figure 2).52 Adequate, balanced counseling 
of the parents will lay the groundwork for well-informed choices of the type of prenatal 
tests. Techniques such as micro-arrays and NGS will oblige medical professionals to 
adequately assess the parental wish “to know or not to know”. The best time to give 
parents this information is most likely during pre-test counseling; the clarity of thought 
might not be optimal during post-test counseling when a fetal abnormality or disease 
has to be disclosed. 
the upcoming use of informed consent, and disclaimers
Informed consent and disclaimers have become customary items in prenatal practice 
when micro-array techniques are used. In addition, NGS in the near future, with ever 
figure 2.  Micro-array test result: an incidental finding unrelated to the initial indication for micro-
array testing (source:  Department of Human Genetics, Radboud University Nijmegen Medical Centre, 
Nijmegen, the Netherlands)
 
 Xp21 (DMD gene) Xq13.1 (DLG3 gene) 
child 
mother 
grandfather 
grandmother 
The index patient (child) shows a duplication on Xq13.1 of DLG3 gene: X-linked gene for non-syndromatic mental 
retardation.
The mother shows the same duplication as well as the grandmother. In addition, the mother shows a second mutation, 
an in-frame deletion of exons 3 – 9 in the Duchenne Muscular Dystrophy gene (Xp21).
The same deletion size was found in the grandfather of the index patient.  Because of the extremely large size of the 
DMD gene (nearly 2400kb), mutations in the DMD gene correlate between the size of the deletion and the severity of 
the Duchenne of Becker muscle dystrophia. The medical condition of the grandfather may be characterized by delayed 
walking.
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increasing probe coverage and resolution will increase the detection of small copy 
number changes.62 The challenges lie in interpreting the copy number variations (which 
exhibit reduced penetrance or variable expression), dealing with incidental findings that 
may be unrelated to the observed fetal anomalies, and handling unclassified variants 
of uncertain clinical significance. Thus more genetic information about the fetus may 
not always result in good patient care. Therefore, clinicians need to find a way to adopt 
policies and guidelines to manage test results that were not intentionally searched for.51 
The results described in this thesis show that both parents and experts appreciated 
the disclosure of an incidental prenatal finding of SCA. The increased amount of genetic 
information of unknown clinical significance or information about the risk of late-onset 
diseases may justify the legal protection of disclaimers. However, this never absolves us 
from providing adequate pre-test counseling tailored to the patient. 
8.3 future ProsPeCts 
new technologic advances in prenatal testing
Non-invasive prenatal diagnostics using next-generation sequencing (NGS) is rapidly 
being integrated into prenatal diagnostics and offers considerable potential benefits 
for the fetus at an unequalled detection level.63-65 However, NGS entails genome-wide 
testing of fetal DNA, and incidental findings may be encountered. This could be one of 
the most difficult obstacles. 
The complexity of finding and reporting genetic results which are incidental or unre-
lated to the reasons for which the test was initially ordered and the options clinicians 
and laboratories will face as genetic sequencing becomes more common are currently 
being discussed.66 To separate the fetal DNA from the mother’s, it is necessary to know 
the mother’s nucleotide sequence. This genetic information may also reveal information 
about family relationships and findings with great or possible net benefit. The proce-
dures are being tested for validation of the sensitivity and specificity in detecting fetal 
chromosomal aneuploidies, and they will be implemented in clinical prenatal practice 
soon.67-71 Both genome-wide testing and selective targeting of the most common 
aneuploidies 13, 18, 21, X, and Y are possible, and this includes the diagnosis of fetal 
SCAs.67,70,72,73 
The diagnostic tests for fetal genetic anomalies in maternal serum samples carry no 
risk of pregnancy loss, but regulations are needed to respect the parental wish not to 
know about genetic conditions in what they consider to be unwelcome information. 
Next-generation sequencing has been discussed as a complex medical test with the 
power to help, harm, and confuse. Medical professionals have a long-established ob-
General discussion and future prospects 147
ligation to “first, do no harm.” That sentiment applies in the discussion about genomic 
testing as much as in other medical contexts.74 
Counselors need to learn what patients would want to know about their genome, and 
management guidelines for counseling patients about incidental genetic findings are 
necessary. This applies particularly to the new prenatal testing technologies, such as 
NGS of fetal DNA in maternal plasma. 
improvement of the quality of life for people with sCa
Early recognition of the syndrome and its associated problems in the domains of health, 
behavior, and fertility offers an opportunity to provide early prevention programs.42,43,75,76 
Besides the problems of gonadal dysgenesis and aberrant stature, some people with 
SCA have a reduced life expectancy because of certain well-defined health hazards. A 
diversity and co-existence of factors may influence their quality of life. Early screening 
and treatment improves health and behavior, and technological advances in fertility 
treatment offer possibilities of procreation to people with SCA.4,17,42,43,53,77-80 
Freriks42 has shown that about one-third of the 45,X population lacks any form of on-
going specialist care. A large proportion of patients with an SCA may not be diagnosed 
because of the substantial variation of the clinical phenotype;4,81 still, they have certain 
health and psychosocial risks. A prenatal diagnosis may be a benefit in terms of early 
support options.
The information parents receive greatly influences their decision about whether to 
continue the pregnancy after the incidental prenatal finding of an SCA. It has been 
shown that there is an association between the amount of negative information parents 
are given about SCA and the decision to terminate the affected pregnancy.33 Further, 
there is a clear influence of the specialty and the knowledge of the counselor on parents’ 
perceptions of the expected disability of the future.6,31,32,38,82 
Our study shows that some parents expected poor quality of life for their child on 
the basis of the additional information they found on the Internet. These parents were 
more inclined to terminate the pregnancy, as they had no faith in the options to improve 
the quality of life through early treatment programs and they feared these programs 
would be a burden to their family (Chapter 5). An incidental prenatal finding of SCA may 
result in the birth of a child with a mild clinical phenotype or no apparent phenotypical 
problems. The parental fears for the child’s future poor quality of life may be unjustified, 
as has been shown in earlier reports of the mild clinical phenotype of people with SCA 
after an incidental prenatal diagnosis (Chapter 4).
 Improving the quality of life of children with an incidentally prenatally diag-
nosed SCA may require little effort from the parents, and the early recognition of even 
a small problem in health or behavior may still be beneficial.4,43,81,83 Early explanation 
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of future fertility problems and a joint search for possible solutions, such as fertility 
preservation or gamete-donation, would most certainly improve the quality of life.84-87 
tailored information about sCa for expecting parents: the internet and 
hospital brochures
In countries where prenatal screening is routinely offered, some women use testing 
without considering its consequences.4,88-90 Early fetal assessment may produce find-
ings that may have important medical or social implications unrelated to the reason for 
the testing. These findings are beneficial in terms of increasing the parental autonomy 
in making a personal decision about continuing the pregnancy; for instance, when an 
important health-threatening fetal abnormality is diagnosed. In other cases, the clinical 
significance of the findings is unclear, which will lead to concern about the postnatal 
quality of life. 
As prenatal testing has become increasingly complicated because of technological 
advances in the last years, so will the counseling of the parents. During pre-test coun-
seling, parents should now receive information about the different testing procedures, 
the associated risks, and the possibility of intended or unintended findings in the tests 
that they choose. The counseling will be very time-consuming, and it is conceivable 
that parents will not completely understand all the technical or medical information 
they receive. Our study of parents’ preferences regarding full-scale genetic testing for 
disorders for which they do not have an a priori increased risk shows that they would 
not accept this unquestioningly. A low educational level was associated with a negative 
attitude towards genetic testing, which was inconsistent with the significantly positive 
attitude of these women towards full-scale testing (Chapter 2). Our data confirm that 
the general basic knowledge of prenatal testing appears to be positively linked with the 
educational level, which is in line with other studies about the lower rates of informed 
choice and the necessity of providing the women involved with extra information.91,92 
The Internet can be used for assistance in professionally guiding and counseling par-
ents. It may be helpful to the parents to have additional information after the counseling 
session and to have the counselor guide them to Internet websites with reliable, neutral, 
tailored, and accurate information. As Internet use broadens access to information, 
health professionals must be aware that this information is not always accurate.93 
In the Netherlands, prenatal screening for Down syndrome has become available to 
all pregnant women.94 Only licensed prenatal centers are registered to participate and 
it is a political choice that there should be no signal given that pregnant women should 
indeed ask for this test. It should be an individual well-informed choice, and attention 
is paid to guarantee women’s right of “not knowing”. Accurate information about this 
nation-wide screening for Down syndrome is available on government-approved web-
sites (www.erfocentrum.nl). However, information about incidental findings that have 
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an incidence similar to that of Down syndrome, such as SCAs, is not provided. They are 
not a part of the government-approved screening program, which applies to Down syn-
drome, recently Edwards and Patau syndrome have been added. Parents who have been 
confronted with such an incidental finding must resort to non-government-approved 
websites, and the information on these sites may be unhelpful and unreliable. It would 
be preferable to inform the parents just as accurately about findings that may no longer 
be considered incidental or unsolicited. 
The Internet successfully provides patients with additional and accurate information 
about diseases, testing, and treatment programs in other medical disciplines; nonethe-
less, professional guidance is advisable.36,93,95 Clear explanations can be given about the 
different types of prenatal tests which are available, the testing procedures, the associ-
ated risks, and the incidental findings in terms of treatable or untreatable disorders. The 
information can be printed as a hospital brochure and handed out to the parents after 
the pre-test counseling. The brochure should recommend reliable Internet websites 
(possibly including one set up by the hospital itself ) with adequate information consis-
tent with a prenatal diagnosis of the fetal abnormality in question. 
Parents should be informed that new technological advances in prenatal testing can 
now diagnose genetic abnormalities of unclear clinical significance. It is recommended 
that parents could choose to receive no elaborate whole-genome information, most 
importantly their choice should be consistent with their coping style. The results of this 
thesis show that the parents who participated in the studies did not know that SCAs 
existed and were shocked to hear about a finding of one. After a period of shock, grief, 
and anger, they all started an unguided Internet search and then decided whether to 
continue or terminate their pregnancy. They were content with their decisions, but they 
might have been spared an anxious time after the disclosure of the finding of SCA.
The variability in phenotypic outcome after a prenatal diagnosis of SCA seriously com-
plicates post-test counseling. Parents who have had a chance to read about SCA after 
pre-test counseling may be expected to be adequately informed about the likelihood of 
being confronted with these diagnoses and may have read about the large variability in 
phenotype. They may not have studied the subject in depth, but they have some idea 
of these genetic abnormalities. This makes post-test counseling more efficient and less 
frightening.
Because new technologic advances will result in even more genetic information in 
prenatal testing, it is of utmost importance that physicians adjust pre- and post-test 
counseling to the changing circumstances. Since the 1990s, expectant parents and 
worried patients have had access to an unlimited source of unreliable information: the 
World Wide Web. In the light of all the new medical diagnosing technologies (not only 
in the field of prenatal diagnosis), professional guidance of patients to reliable, tailored, 
and accurate information is essential.
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There are various reasons for prenatal diagnostic tests: to assess fetal viability, to deter-
mine the sex of the fetus, and to exclude a structural or genetic abnormality. Early fetal 
assessment risks incidental findings – findings unrelated to the reason for testing – that 
may have important medical or social implications. Sex chromosomal aneuploidies 
(SCAs) may be diagnosed as incidental findings in prenatal diagnostic testing proce-
dures. These SCAs cause syndromes little known to most parents, and their postnatal 
phenotypes are variable. 
In the light of technologic advances in prenatal testing, more genetic information 
about the fetus will become available, some of which may have uncertain clinical sig-
nificance. 
The studies in this thesis analyze and discuss the various aspects of parental attitudes 
and dilemmas, as well as professional opinions about the benefits or disadvantages of an 
incidental finding of a fetal SCA. We discuss how best to provide accurate and balanced 
pre-test information to parents and to guide them to secure additional information.
Chapter 1 describes the characteristics of sex chromosome disorders. In the variability 
of the phenotypic spectrum, we see that some individuals are very mildly affected and 
others have more significant physical and psychological features. The most common 
SCAs are 45,X (Turner syndrome), 47,XXY (Klinefelter syndrome), and 47,XXX (Triple X 
syndrome). For better understanding, we briefly describe the phenotypic features of the 
three most common SCAs. Women with Turner syndrome generally have ovarian failure, 
subfertility or infertility, short adult height, and increased morbidity and mortality 
(mainly because of complications from congenital heart disease). Men with Klinefelter 
syndrome generally present with hypogonadism, subfertility or infertility, are taller than 
expected, and have small, firm testes. Some have gynecomastia and increased morbid-
ity (due to increased cancer risk or autoimmune, metabolic, or other disease). Women 
with Triple X syndrome often have tall stature and hypotonia; premature ovarian failure 
and other SCA-associated diseases may occur. All three types of SCA may lead to psycho-
social problems and speech or learning difficulties. 
Due to a high rate of fetal demise, the postnatal incidence of 45,X is 1 in 2000 to 2500 
newborn girls, resulting in a worldwide prevalence of 1.5 million Turner women. The in-
cidence of diagnosis of Turner syndrome in prenatal testing depends on the presence of 
fetal ultrasound abnormalities and the indication for the testing procedure. The 47,XXY 
abnormality occurs with an incidence of 1 in 500 to 1000 newborn boys; many Klinefel-
ter individuals remain undiagnosed. Prenatally, the incidence of 47,XXY diagnosis  is 1 
in 650 fetuses; it includes 25% of all chromosomal abnormalities after invasive prenatal 
testing. The postnatal incidence of 47,XXX is 1 in 1000 newborn girls, the same incidence 
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as in prenatal testing. Prenatally, the syndrome is diagnosed in 0.1% of all chromosomal 
abnormalities, generally as an incidental finding. The addition of more than one extra sex 
chromosome is rare; the prevalence of other X–Y aneuploidies is estimated at 1 in 18,000 
or less. The incidence of SCA diagnosis after prenatal invasive testing shows no direct 
causality to maternal age. In prenatal testing for advanced maternal age, the incidence 
of fetal SCA findings appears to be comparable to the incidence of Down syndrome. 
Various facets of the diagnosis and some typical pre- and post-natal phenotypic aspects 
of SCA are described. 
The second part of the chapter describes the emergence of SCA and explains the 
mechanism underlying embryonic folding, along with some basic elements of genet-
ics and the complexity of the counseling. Counseling after a prenatal diagnosis of SCA 
provides the parents with information about the very broad scale of the postnatal 
phenotype of these individuals. One end of the scale shows a normal, self-supporting 
person without any health or behavior problems who may ultimately discover the ge-
netic anomaly in the medical search for the cause of his or her infertility. The other end of 
the scale shows a person with SCA who may have many health and behavior problems, 
and even very serious metabolic, autoimmune, or psychiatric disorders.
 The third part of the chapter names all the currently available screening and diag-
nostic prenatal tests: the non-invasive first-trimester screening test, second-trimester 
ultrasound screening, diagnostic ultrasound assessment, and the invasive procedures 
for karyotyping the fetus, such as chorion villus biopsy and amniocentesis. The available 
choices for rapid aneuploidy detection (RAD) or genome-wide testing using micro-array 
technology or next-generation sequencing are weighed. 
The fourth part discusses the difficulties of informing the parents about the incidental 
findings and addresses some ethical issues.
Chapter 2 describes the attitudes of women in low-risk pregnancies towards full-scale 
genetic testing and explores relationships between demographic characteristics and 
the level of interest. Except for educational level, no significant relationships were 
noted between the demographic variables and the wish to opt for full-scale testing. A 
low educational level was significantly related to the interest in full-scale testing. The 
conclusion of this pilot study was that low-risk pregnant women had little interest in 
full-scale genetic testing, and their interest further diminished as pregnancy progressed. 
Educational level appeared to affect their views.
Chapter 3 reports a literature review of the diagnostic relevance of incidental prenatal 
findings of SCAs. Publications about postnatally diagnosed SCAs from 2006 to 2011 as 
well as publications about incidentally prenatally diagnosed SCAs  from 1980 to 2011 
were systematically screened. Incidental prenatal diagnosis of SCAs is associated with 
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normal to mildly affected phenotypes. This contrasts sharply with postnatal diagnoses 
of SCAs and highlights the importance of this ascertainment bias towards the prognos-
tic value of diagnosis of fetal SCAs. Although it seems rather obvious that the outcome 
of a child with an incidental discovery of a sex chromosome abnormality is better than 
one who is diagnosed postnatally on clinical grounds, this review of the literature since 
1980 shows that counselors may reassure the parents in the knowledge that indeed all 
the currently available studies support this conclusion.
Chapter 4 describes the parental perspectives of being confronted with an unforeseen 
fetal SCA in light of the fact that RAD can avoid this incidental finding. Parents were un-
prepared for incidental findings in routine prenatal diagnostics, and all of them started 
an unguided Internet search. Parents reported having faith in good quality of life for 
their child. Most participants reported that they appreciated knowing about the syn-
drome and would choose the same procedure again in the event of another pregnancy. 
This fact is important in discussing the option of excluding the X and Y probes from RAD. 
The parents’ perspectives may serve as major contributors to research into the question 
whether  including the X and Y probes in RAD should be standard. 
Chapter 5 shows the parental perspectives of being confronted with an unforeseen 
SCA and their considerations regarding termination of their pregnancy. Again, parents 
were unprepared for incidental findings in routine prenatal diagnostics and started an 
unguided Internet search. They appreciated knowing about the syndrome, and they had 
many concerns about the child’s future health and socio-psychological wellness. The 
parents gave their advice for professionals and stated their preference of including the 
probes for the sex chromosomes again in a future test. The main reason for terminating 
a pregnancy appeared to be the negative perspective from which the parents judged 
the child’s future. The percentage of respondents was 31.2. This high percentage of 
selective non-responders might reflect parents’ inner feelings and thoughts about their 
terminated pregnancy.
Chapter 6 describes experts’ opinions of the advantages and disadvantages of an in-
cidental prenatal diagnosis of an SCA. Most of the experts, who were clinicians in the 
field of counseling and treatment of people with SCA (87.5%), and clinical geneticists 
(76.9%) stated that an incidental prenatal diagnosis of SCA was a benefit for the child 
and the parents. They acknowledged the possibility of parental decisions to terminate 
pregnancy. Experts favored an incidental prenatal diagnosis of SCA, despite the complex 
counseling issues and their acknowledgment of possible parental decisions to terminate 
pregnancy. They believed that the benefits greatly outweigh the disadvantages.
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Chapter 7 shows our letter to the editor of Genetics in Medicine and the reply from Jeon 
and colleagues. Their letter is a reflection on a review article Decision to abort after a 
prenatal diagnosis of sex chromosome abnormality: a systematic review of the literature, 
which was published in October 2011. We concluded that some main points were not 
addressed in the review: (i) the reason for referral (e.g., fetal ultrasound abnormality); (ii) 
the increasingly important role of the Internet in providing additional, but sometimes 
confusing, medical information to anxious parents; and (iii) the significant contribution 
geneticists can make to parents’ decision-making to continue or abort their pregnancy. 
Our letter to the editor commenting on the review was published in the May 2012 issue 
of Genetics in Medicine, together with the reply from the authors of the review. 
Chapter 8 discusses considerations regarding the incidental prenatal finding of SCA 
and the central study question of this thesis: whether an incidental finding of a fetal 
SCA creates diagnostic benefits or diagnostic damage. Our study shows that both the 
parents and the professionals who were interviewed considered the incidental prenatal 
finding of an SCA a benefit in terms of early treatment and support options. As the 
study design is qualitative, the results are indicative rather than conclusive. The results 
may contribute to the discussion whether testing procedures that include a possible 
incidental diagnosis of a fetal SCA is indeed constitutes good medical care. The com-
plexity of pre- and post-test counseling, the problem of mosaicisms, aspects of parental 
decision-making, the problem of non-responders, the opinion of experts in the field 
of SCAs, and the issue of providing additional and secure information are addressed. 
Parents and experts favored the prenatal detection of SCA, whether intended or not. 
Ethical considerations are discussed: the moral obligation of physicians to inform and 
the right of the patient “to know” or “not to know” as well as the rights of the fetus. The 
upcoming use of informed consent and disclaimers in genetic testing and the inevitable 
increase of the number of incidental findings using genome-wide technologies with 
high resolution in prenatal testing are addressed. A prenatal diagnosis may positively 
influence the quality of life because it provides an opportunity for early prevention and 
treatment programs. Tailored information about possible findings for expecting parents 
is needed, and pre- and post-test counseling should involve the Internet as a very useful 
way to provide reliable and accurate information.
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Prenatale diagnostische testen worden uitgevoerd om verschillende redenen: om de le-
vensvatbaarheid van de foetus te beoordelen, voor geslachtsbepaling of om een foetale 
structurele of genetische afwijking uit te sluiten. Vroege foetale beoordeling heeft het 
potentiële risico van het doen van incidentele bevindingen, losstaand van de reden voor 
het testen, deze bevindingen kunnen belangrijke medische of sociale gevolgen hebben. 
Geslachtschromosomale aneuploïdieën (SCA) kunnen worden gediagnosticeerd als 
incidentele bevindingen in procedures van prenatale diagnostiek. Deze chromosomale 
afwijkingen veroorzaken syndromen die niet goed bekend zijn bij de meeste ouders en 
hun postnatale fenotype is variabel. 
In het licht van de technologische ontwikkelingen in de prenatale testen, zal meer 
genetische informatie van de foetus beschikbaar komen, waarvan soms de klinische 
betekenis nog niet zeker is. 
De studies in dit proefschrift analyseren en bespreken de verschillende aspecten van 
de ouderlijke gevoelens en dilemma’s, alsook de professionele opinie over het nut of 
nadeel van een incidentele vondst van een foetale SCA. De beste manier van accurate en 
evenwichtige pre-test informatie aan de ouders en het begeleiden van hen naar veilige 
aanvullende informatie wordt besproken.
hoofdstuk 1 beschrijft de eigenschappen van de geslachtschromosomale aandoenin-
gen. Er is variabiliteit van het fenotypisch spectrum, waarbij sommigen zeer weinig zijn 
aangedaan en anderen meer fysieke en psychologische afwijkingen vertonen. De meest 
voorkomende geslachtschromosomale aneuploïdieën zijn: 45,X (syndroom van Turner), 
47,XXY (syndroom van Klinefelter) en 47,XXX (Triple X syndroom). Voor een beter begrip 
wordt hier een korte beschrijving van de drie meest voorkomende SCAs gegeven. 
Vrouwen met het syndroom van Turner hebben over het algemeen ovariëel falen, zijn 
onvruchtbaar, hebben een korte volwassen lengte en een verhoogde morbiditeit en 
mortaliteit (vooral als gevolg van complicaties van aangeboren hartafwijkingen). Man-
nen met het Klinefelter syndroom hebben vaak hypogonadisme, zijn sterk verminderd 
vruchtbaar of onvruchtbaar, hebben kleine vaste testikels, soms borstontwikkeling 
en een verhoogde morbiditeit (verhoogd kanker risico of auto-immune, metabole en 
andere aandoeningen). Vrouwen met het Triple X syndroom hebben vaak een grote 
gestalte en hypotonie, prematuur ovariëel falen kan optreden, evenals een aantal met 
het syndroom samenhangende aandoeningen. Bij alle drie de vormen van SCA, kunnen 
zich psychosociale problemen voordoen, evenals spraak- of leermoeilijkheden.
Door een hoog percentage aan foetaal overlijden, is de postnatale incidentie van Turner 
syndroom 1 op de 2000-2500 meisjes, wat resulteert in een wereldwijde prevalentie 
van 1.5 miljoen Turner vrouwen. De incidentie van de diagnose Turner syndroom in 
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prenatale testen wordt beïnvloed door de aanwezigheid van echoscopische foetale 
afwijkingen en de indicatie voor de testprocedure. Klinefelter syndroom komt voor met 
een incidentie van 1 op 500-1000 pasgeboren jongens; veel Klinefelter mannen wor-
den nooit gediagnosticeerd. Prenataal is de incidentie van Triple X syndroom 1 op de 
650 foetus, dit is 25% van alle chromosomale afwijkingen die worden gevonden bij 
invasieve prenatale testen. De postnatale incidentie van Triple X syndroom is in op de 
1000 pasgeboren meisjes, dezelfde incidentie als gevonden wordt bij prenatale testen. 
Prenataal wordt Triple X syndroom vastgesteld in 0.1% van alle chromosoomafwijkin-
gen, in het algemeen als een incidentele bevinding. De toevoeging van meer dan een 
extra geslachtschromosoom is zeldzaam; de prevalentie van andere X-Y aneuploïdieën 
wordt geschat op 1 op de 18.000 of minder. Er is geen direct causaal verband met de 
moederlijke leeftijd; in prenatale onderzoeken op indicatie van verhoogde moederlijke 
leeftijd, was de incidentie van de diagnose foetale SCA vergelijkbaar met de incidentie 
van het syndroom van Down. Verschillende aspecten van de diagnose en enkele typi-
sche pre- en postnatale fenotypische aspecten van SCA worden beschreven. 
Het tweede deel van dit hoofdstuk beschrijft het ontstaan van SCA en verklaart het 
embryologische mechanisme. Een aantal basiselementen betreffende de genetica en de 
complexiteit van de voorlichting worden beschreven. Counseling na een prenatale di-
agnose SCA behelst het informeren van de ouders over het zeer brede spectrum van het 
postnatale fenotype van personen met een dergelijk syndroom. Aan de ene kant van het 
spectrum is er een normaal persoon die voor zichzelf kan zorgen zonder gezondheids- of 
gedragsproblemen, maar die uiteindelijk de genetische afwijking kan ontdekken in een 
medische zoektocht naar de oorzaak van onvruchtbaarheid. Aan de andere kant van het 
spectrum, kan een persoon met SCA vele gezondheids- en gedragsproblemen ervaren 
en zelfs ernstige stofwisselings-, auto-immuun of psychiatrische stoornissen hebben.
Het derde deel van het hoofdstuk vermeldt alle screenings en diagnostische prenatale 
onderzoeksprocedures die momenteel beschikbaar zijn: de niet-invasieve eerste trimes-
ter screeningstest, de tweede trimester echo screening, diagnostiek door echoscopische 
beoordeling en de invasieve procedures voor karyotypering van de foetus, zoals de 
chorion villus biopsie (vlokkentest) en de amniocentesis (vruchtwaterpunctie), alsmede 
de keuzemogelijkheden voor gerichte of genoom-brede testen. 
Het vierde deel gaat in op de complexiteit van het inlichten van de ouders over de 
incidentele bevindingen en wordt een aantal ethische kwesties besproken.
hoofdstuk 2 beschrijft de interesse van zwangere vrouwen in laagrisico zwangerschap-
pen betreffende genetisch testen van het volledige genoom en onderzoekt de relaties 
tussen hun demografische kenmerken en de mate van interesse. Met uitzondering van 
het opleidingsniveau, werden geen significante relaties gezien tussen de demografische 
variabelen en de keuze voor genetisch onderzoek van het volledige genoom. Een laag 
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opleidingsniveau bleek significant gerelateerd aan de interesse in deze uitgebreide 
testen. De conclusie van deze pilotstudie was dat de meeste zwangeren met een laag 
risico weinig interesse hebben in genetische testen waarbij het volledige genoom wordt 
onderzocht. Hun interesse verminderde naarmate de zwangerschap verder was gevor-
derd. Het opleidingsniveau bleek van invloed op hun mening.
hoofdstuk 3 rapporteert een review van de literatuur over de diagnostische relevantie 
van incidentele prenatale bevindingen van SCA. Publicaties over postnataal gediagnos-
ticeerde SCAs van 2006-2011 en de publicaties over incidenteel prenataal gediagnosti-
ceerde SCAs van 1980-2011 werden systematisch beoordeeld. Een incidentele prenatale 
diagnose SCA is geassocieerd met een normaal tot licht aangedaan fenotype. Dit staat in 
schril contrast met het fenotype van postnataal gediagnosticeerde SCA en dit feit bena-
drukt het vertekende beeld betreffende de prognostische waarde van een diagnose van 
foetale SCA. Hoewel het nogal voor de hand lijkt te liggen dat de prognose van een kind 
waarbij een incidentele bevinding van een geslachtschromosomale aneuploïdie wordt 
gedaan, beter is dan bij iemand waarbij dit na de geboorte op klinische gronden wordt 
vastgesteld, laat dit overzicht van de literatuur vanaf 1980 zien dat behandelaars de 
ouders kunnen geruststellen, aangezien inderdaad alle studies tot nu toe deze conclusie 
ondersteunen. 
hoofdstuk 4 beschrijft de perspectieven van ouders die werden geconfronteerd 
met een incidentele bevinding van een foetale SCA, in het licht van het feit dat deze 
toevallige bevinding kan worden vermeden door snelle aneuploïdie detectie (rapid 
aneuploidy detection: RAD). De ouders waren niet voorbereid op incidentele bevindin-
gen en begonnen een onbegeleide zoektocht op het internet. Deze ouders gaven aan 
dat zij vertrouwen hadden in een goede kwaliteit van leven voor hun kind. De meeste 
deelnemers rapporteerden dat zij het prettig vonden om op de hoogte te zijn van het 
bestaan van het syndroom en dat zij wederom dezelfde procedure zouden kiezen als er 
een volgende zwangerschap zou optreden. Dit aspect is een belangrijke bevinding bij 
de bespreking van de mogelijkheid van uitsluiting van de X en Y probes met RAD, de 
perspectieven van de ouders kunnen een belangrijke bijdrage leveren in het onderzoek 
naar de vraag of de X en Y probes standaard opgenomen moeten blijven bij gebruikma-
king van RAD.
hoofdstuk 5 toont de ouderlijke perspectieven wanneer zij worden geconfronteerd met 
een onvoorziene SCA en de verkenning van hun overwegingen om de zwangerschap te 
beëindigen. Wederom waren de ouders niet voorbereid op incidentele bevindingen in 
het routine prenatale onderzoek en ook zij begonnen een onbegeleide zoektocht op 
het internet. Zij vonden het prettig om op de hoogte te zijn van het bestaan van het syn-
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droom en zij hadden veel zorgen over de toekomstige gezondheid en het sociaalpsycho-
logische welzijn van het kind. De ouders gaven adviezen aan de professionals en zouden 
opnieuw de probes voor de geslachtschromosomen includeren in een toekomstige test. 
De belangrijkste reden om te termineren bleek het negatieve perspectief van waaruit 
de ouders de toekomst van het kind beoordeelden. Het percentage respondenten was 
31.2, het hoge percentage selectieve non-responders zou een reflectie kunnen zijn van 
hun innerlijke gevoelens en gedachten betreffende de beëindigde zwangerschap.
hoofdstuk 6 beschrijft de mening van experts betreffende hun mening van het voor- 
en nadeel van een incidentele prenatale bevinding SCA. Het merendeel van de experts, 
clinici op het gebied van begeleiding en behandeling van mensen met SCA (87.5%) 
en klinisch genetici (76.9%) verklaarden dat een incidentele prenatale diagnose SCA 
een voordeel is voor het kind en de ouders. Zij erkenden de mogelijkheid dat ouders 
zouden kunnen besluiten tot het beëindigen van de zwangerschap. De experts waren 
voorstanders van een incidentele prenatale diagnose SCA, ondanks de complexiteit van 
de voorlichting en de mogelijkheid dat ouders zouden besluiten tot zwangerschapsbe-
eindiging. Zij geloofden dat de voordelen sterk opwegen tegen de nadelen.
hoofdstuk 7 toont onze ingezonden brief aan de hoofdredacteur van het tijdschrift 
“Genetics in Medicine”, gevolgd door het antwoord van de auteurs op onze overwegin-
gen. De brief is een reflectie op een overzichtsartikel van Jeon et al.:”Decision to abort 
after a prenatal diagnosis of sex chromosome abnormality: a systematic review of the 
literature”, welke werd gepubliceerd in oktober 2011. Wij concludeerden dat een aantal 
belangrijke aspecten niet aan bod kwamen in dit review: (i) de reden voor verwijzing 
(bv foetale echoscopische afwijkingen); (ii) de steeds belangrijkere rol van het internet 
in het verstrekken van aanvullende, maar soms verwarrende medische informatie aan 
bezorgde ouders; (iii) de belangrijke bijdrage die genetici kunnen leveren aan de be-
sluitvorming van de ouders om de zwangerschap te continueren of te beëindigen. 
Onze ingezonden brief aan de hoofdredacteur met het commentaar op het review is 
gepubliceerd in de mei 2012 editie, tezamen met het antwoord van de auteurs van het 
review waarop we commentaar gaven.
hoofdstuk 8 behandelt diverse aspecten betreffende een incidentele prenatale bevin-
ding van SCA en de centrale onderzoeksvraag van dit proefschrift: of een incidentele 
diagnose van een foetale SCA beschouwd moet worden als diagnostische winst of als 
diagnostische schade. Onze studie toonde aan dat de incidentele prenatale bevinding 
van een SCA door zowel de ouders als de professionals die werden geïnterviewd, werd 
beschouwd als een voordeel voor wat betreft de mogelijkheden tot vroege behandeling 
en ondersteuning. Aangezien onze studie een kwalitatief ontwerp had, zijn de resulta-
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ten vooral indicatief en niet zozeer doorslaggevend. De resultaten kunnen bijdragen 
aan de discussie, of gebruikmaking van test procedures waarin de mogelijkheid bestaat 
tot een incidentele bevinding van een foetale SCA, ook werkelijk goede medische zorg 
is. De complexiteit van de pre- en post-test counseling, het probleem van mosaïcisme, 
aspecten betreffende ouderlijke besluitvorming, het probleem van non-responders, 
de mening van experts op het gebied van SCA en ook de kwestie van het verstrekken 
van aanvullende en veilige informatie wordt behandeld. Ouders en deskundigen waren 
voorstanders van een prenatale detectie van SCA, of deze nu bedoeld is of niet. Ethi-
sche overwegingen worden besproken, de morele plicht van artsen om patiënten te 
informeren, tevens het recht van de patiënt om “te weten” of “niet te weten” alsook het 
recht van de foetus. Het toekomstige gebruik van informed consent en disclaimers bij 
gebruikmaking van genetische testen en de onvermijdelijke toename van het aantal 
incidentele bevindingen met behulp van genoom-brede technologieën met een hoge 
resolutie in prenataal onderzoek wordt besproken. De kwaliteit van leven kan positief 
worden beïnvloed door een prenatale diagnose, want dit biedt de mogelijkheid tot 
vroege preventie en behandel programma’s. Informatie op maat voor alle aanstaande 
ouders over mogelijke bevindingen is nodig en het internet zou betrokken moeten wor-
den bij de pre- en post-test counseling als een zeer bruikbare manier om betrouwbare 
en nauwkeurige informatie te verstrekken.

Authors and their affiliations 169
authors and their affiliations
From the Department of Human Genetics 
Radboud University Medical Centre Nijmegen, The Netherlands: 
A.P.T. Smits, A. Geurts van Kessel, A.J.A. Kooper
From the Department of Obstetrics and Gynecology 
Radboud University Medical Centre Nijmegen, The Netherlands:
D.D.M. Braat and A.J. Eggink
From the Department of Medical Psychology 
Radboud University Medical Centre Nijmegen, The Netherlands: 
C.M. Verhaak
From the Department IQ Healthcare, Section Medical Ethics 
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands:
E. van Leeuwen
From the Department of Pediatrics 
Radboud University Medical Centre Nijmegen, The Netherlands:
B.J. Otten
From the Department of Epidemiology, Biostatistics and Health Technology Assessment
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands:
T.B. Feuth
From the Department of Medical Psychology and Neuropsychology
Tilburg School of Social and Behavioral Sciences, The Netherlands:
J. de Vries
From the Department of Clinical Genetics
Erasmus Medical Centre Rotterdam, The Netherlands:
R.J.H. Galjaard 
170
danKwoord
Het werk waaruit dit proefschrift is voortgekomen werd met groot enthousiasme 
begeleidt door medewerkers van het UMC St Radboud. 
Ik ben in het bijzonder de ouderparen, die bereid waren met mij in gesprek te gaan, zeer 
erkentelijk voor hun vertrouwen en hun moed om de emotionele besluiten van destijds 
met mij te delen. De adviezen die zij mij gaven tijdens de gesprekken zijn terug te vinden 
in dit proefschrift.
Graag wil ik in dit dankwoord een aantal mensen met name noemen. 
Professor Didi Braat, hoofd van de afdeling Verloskunde en Gynaecologie, plaatsvervan-
gend hoofd pijler Voortplantingsgeneeskunde en opleider. Direct nadat ik aangaf te willen 
promoveren zette jij de deuren open om mij te faciliteren, gebruikmakend van je grote 
netwerk. Jij hebt me met enthousiasme en optimisme begeleid in dit traject, waarvoor 
veel dank.
Dr. Arie Smits, voormalig hoofd van het laboratorium Prenatale Cytogenetica. Jij was een 
ware mentor. Je hebt mij op afstand gecoacht met een onuitputtelijke energie tot in de 
vroege uurtjes (!). Ik heb zeer veel geleerd van onze discussies en ik voel me bevoorrecht 
dat ik dit proefschrift heb mogen voorbereiden met jouw positieve steun. 
Professor Evert van Leeuwen, hoofd van de afdeling IQ Healthcare, sectie Ethiek, Filoso-
fie en Geschiedenis van de Geneeskunde. Jij hebt mij geleerd om de bevindingen uit het 
onderzoek steeds onder een zuivere loep te beoordelen. Ik wil je danken voor de begelei-
ding die ik kreeg bij het doen van kwalitatief onderzoek en analyse, een hele aparte tak 
van sport. 
Dr. Chris Verhaak, hoofd sectie Kinderen en Jeugdigen afdeling Medische Psychologie. 
Graag wil ik je bedanken voor je hulp bij het voorbereiden en nadien analyseren van de 
interviews. Je hebt me gestimuleerd om open te staan voor alle informatie, iets waar ik in 
de kliniek elke dag profijt van heb.
Ik ben de manuscriptcommissie: professor Ad Geurts van Kessel, professor Ad Hermus 
en professor Jan van Lith zeer erkentelijk voor de tijd die ze hebben vrijgemaakt om het 
manuscript te beoordelen. 
De medische professionals, die als experts op het gebied van de genetica of als behan-
delaars van patiënten met een geslachtschromosomale afwijking hebben deelgenomen 
aan de expert studie (hoofdstuk 6), wil ik van harte bedanken voor de tijd die zij hebben 
vrijgemaakt en voor hun waardevolle informatie.
Ik heb veel ondersteuning ontvangen vanuit de afdeling Cytogenetica en Genetica. 
Ik wil graag met name noemen Dr. Angelique Kooper academisch klinisch medewerker 
en nauw betrokken bij het onderzoek vanaf het begin. Ik heb veel gehad aan onze in-
houdelijke discussies en ik bedank je voor de nauwgezette precisie bij het schrijven van 
een aantal gemeenschappelijke publicaties. Dr. Dominique Smeets, huidig themahoofd 
Dankwoord 171
Fertiliteit en Zwangerschap van de afdeling Genetica, dank ik voor de deskundige bij-
drage bij het schrijven van de genetische paragraaf van de inleiding. Dr. Nicole de Leeuw, 
themahoofd Mentale Retardatie en Multipele Congenitale Afwijkingen wil ik bedanken 
voor het verstrekken van de array resultaten en staflid Dr. Rolph Pfundt dank ik voor de 
gedetailleerde en deskundige uitleg bij de interpretatie van deze onderzoeksgegevens. 
Ik bedank Guillaume van de Zande, operationeel manager, voor de begeleiding van de 
stage op het laboratorium.  Monique Kuipers, medisch secretaresse van de afdeling, heeft 
mij zeer ondersteund en heeft alle interviews verbatim uitgewerkt. De arts-echoscopisten 
van de Afdeling Prenatale Diagnostiek hebben mij voorzien van enkele informatieve 
echoplaatjes.  Danielle Voskuilen, maatschappelijk werker, wil ik bedanken, zij heeft mij 
regelmatig geadviseerd. Zij kende de ouderparen goed en nam soms als eerste contact op 
met hen. De gynaecologen, verbonden aan het Netwerk Prenatale Diagnostiek Nijmegen 
(NPDN) die actief zich hebben ingespannen om ouderparen te benaderen voor een inter-
view ben ik dank verschuldigd, met name: Dr. Aad Huisman, Dr. Jozien Brons en Annette 
ter Haar.
Om een breder beeld te kunnen schetsen, heb ik ook buiten de Nijmeegse regio in-
terviews gehouden. Hierbij heb ik steun ontvangen van Dr. Robert-Jan Galjaard, hoofd 
van het laboratorium Prenatale Diagnostiek, verbonden aan de afdeling Genetica van het 
Erasmus Medisch Centrum Rotterdam; tevens van Dr. Lieve Page-Christiaens en Dr. Carla 
van Oppen, beiden gynaecoloog -perinatoloog in het Utrechts Medisch Centrum. Graag 
bedank ik hen voor de inspanningen om patiënten te vragen deel te willen nemen aan de 
interview studie.
Mijn eerste artikel (hoofdstuk 2), de eerste stap op weg naar de promotie, is tot stand 
gekomen in samenwerking met professor Jolanda de Vries, medisch psycholoog aan de 
Universiteit van Tilburg en haar student Meeke Hoedjes. Graag wil ik hen bedanken voor 
de leerzame samenwerking en voor de mogelijkheid om op deze wijze een bijdrage te 
hebben mogen leveren aan het onderwijs aan studenten medische psychologie en enkele 
afstudeerscripties. 
Ik heb uitstekende ondersteuning gehad in het redigeren en omzetten in correct Engels 
van meerdere stukken door Sylvia van Roosmalen, beëdigd vertaler uit Maastricht, het-
geen soms resulteerde in expliciete complimenten van de reviewers.
Mijn beide vriendinnen Dr. Hedda van Ravenswaay Claasen (klinisch patholoog) en Dr. 
Marja Laine (tandarts universitair docent parodontologie) wil ik graag bedanken voor hun 
goede voorbeeld, onze jarenlange vriendschap en het feit dat ze paranimf willen zijn bij 
de promotie. Mijn ouders zijn mijn inspiratie en voorbeeld, beiden zijn mij voorgegaan 
in een druk en ambitieus leven op gebied van wetenschap en maatschappij. Ik ben hen 
dankbaar voor hun stimulerende ondersteuning. 
Jaap en jongens, jullie zijn mijn basis. Ik ben trots en zeer gelukkig dat jullie altijd naast 
me staan.
172
PuBliCations
Experts’ opinions on the benefit of an incidental prenatal diagnosis of sex chromosomal 
aneuploidy: a qualitative interview survey
JJPM Pieters, CM Verhaak, DDM Braat, E van Leeuwen and APT Smits 
Prenatal Diagnosis 2012 Oct;32:1-7
Why Do Parents Prefer to Know The Fetal Sex as Part Of Invasive Prenatal Testing?
Angelique JA Kooper, Jacqueline JPM Pieters, Alex J Eggink, Ton B Feuth, Ilse Feenstra, 
Lia DE Wijnberger, Robbert JP Rijnders, Rik WP Quartero, Peter F. Boekkooi, John MG van 
Vugt and Arie PT Smits
ISRN Obstetrics and Gynecology 2012; in press
Considering factors affecting the parental decision to abort after a prenatal diagnosis of 
a sex chromosome abnormality
JJPM Pieters, AJA Kooper, TB Feuth, APT Smits 
Genetics in Medicine 2012 May; 14:558-9
Is routine karyotyping required in prenatal samples with a molecular or metabolic refer-
ral?
Kooper AJ, Pieters JJ, Faas BH, Hoefsloot LH, van der Burgt I, Zondervan HA, Smits AP.
Mol Cytogenet. 2012 Jan 27;5(1):7
Parents’ perspectives on the unforeseen finding of a fetal sex chromosomal aneuploidy
JJPM Pieters, AJA Kooper, AJ Eggink, CM Verhaak, BJ Otten, DDM Braat, APT Smits and 
E van Leeuwen 
Prenatal Diagnosis 2011 Mar;31(3):286-92
Incidental prenatal diagnosis of sex chromosome aneuploidies: health, behaviour and 
fertility. A systematic descriptive review
JJPM Pieters, AJA Kooper, A Geurts van Kessel, DDM Braat, APT Smits
ISRN Obstetrics and Gynecology 2011:807106
Domestic violence in the gynecological and obstetrical practice, discussion of the Dutch 
approach
Pieters JJ, Vos MC, Paarlberg KM
Chapter I.2 
Textbook edited by the Katholieke Universiteit Leuven: “Partner Violence, if love is a battle”. 
ISBN 978-90-334-7930-4 Dutch
Publications 173
Parents’ attitudes towards full-scale prenatal testing for genetic disorders
JJPM Pieters, AJA. Kooper, APT Smits, J de Vries
Journal of Psychosomatic Obstetrics & Gynecology 2009 Mar;30(1):42-7.
Huiselijk geweld in de gynaecologische en obstetrische praktijk.
Pieters JJ, Vos MC, Paarlberg KM
Nederlands Tijdschrift voor Obstetrie en Gynaecologie; 2008 Sept;(121):223-5 
Limited uterine artery embolization for leiomyomas with tris-acryl gelatin microspheres: 
1-year follow-up.
Lohle PN, Boekkooi FP, Smeets AJ, Pieters JJ, Vervest HA, Lampmann LE, Sluzewski M
J Vasc Interv Radiol. 2006 Feb;17(2 Pt 1):283-7
Embolization as treatment for symptomatic uterus myomata. 
Lohle PN, Lampmann LE, Boekkooi PF, Vervest HA, Pieters JJ
Ned Tijdschr Geneeskd. 2001 Apr 21;145(16):791-4 Dutch
Foetale biometrie en placentameting in het tweede trimester van de graviditeit als 
parameter voor vroege predictie van intra- en extra-uteriene groeiproblemen. JJPM 
Pieters, SJ Nienhuis, I Ravelink, M Kessels, CJ Ruissen, L Volowitz, HJ Hoogland. 
Nederlands Tijdschrift voor Obstetrie en Gynaecologie; 1993 Febr;(106):67-9
174
CurriCuluM vitae
Jacqueline Pieters werd geboren in Zuid-Limburg en verhuisde op 12-jarige leeftijd 
met haar ouders naar Brussel. Zij bezocht daar de Europese School; het eindexamen 
Gymnasium Bèta deed zij aan het Stedelijk Lyceum te Maastricht. Zij startte haar me-
dische studie aan de Vrije Universiteit te Brussel in oktober 1979. Na het behalen van het 
kandidaatsexamen in juni 1982 heeft zij haar studie voortgezet aan de Rijksuniversiteit 
Leiden. Het artsexamen werd behaald in 1987 en in 1988 is zij gestart met het acade-
mische deel van de opleiding tot gynaecoloog in Maastricht (Prof. J. de Haan). Na drie 
jaar heeft ze het perifere deel van de opleiding gedaan in het Reinier de Graaf Gasthuis 
te Delft (Dr O. van Hemel). In januari 1993 werd zij geregistreerd in het BIG-register als 
gynaecoloog, destijds de jongste van Nederland. Zij is een jaar chef de clinique geweest 
in Delft en was vervolgens ruim een jaar als staflid high-risk obstetrie verbonden aan 
het toenmalige Dijkzigt Ziekenhuis, nu Erasmus MC, te Rotterdam (Prof. H. Wallenburg). 
Van 1996 tot 2005 maakte zij deel uit van de maatschap gynaecologen in het Elisabeth 
Ziekenhuis te Tilburg. In deze periode was zij medeoprichter van het Centrum voor 
Prenatale Diagnostiek Tilburg en ontstond de eerste samenwerking met Nijmegen in 
een netwerk van prenatale satellietcentra, later het Netwerk Prenatale Diagnostiek 
Nijmegen (NPDN) geheten. Zij is meeverhuisd met haar echtgenoot naar Noordwijk 
en heeft twee jaar deel uitgemaakt van de vakgroep gynaecologen in het Kennemer 
Gasthuis te Haarlem met als aandachtsgebied echoscopie en fertiliteit. Ook hier heeft 
zij meegewerkt aan het opzetten van een samenwerkingsverband voor Prenatale Diag-
nostiek met het VUMC. Sinds 2008 is zij als gynaecoloog verbonden aan het volledig op 
fertiliteit gespecialiseerde zelfstandig behandelcentrum Medisch Centrum Kinderwens 
te Leiderdorp en sinds een jaar maakt zij ook deel uit van het management en vervult de 
functie van adjunct-directeur. Zij is met het MCK als eerste centrum in Nederland gestart 
met een embryodonatie-programma, een initiatief waar collega en directeur Rien Crooij 
al in 2007 mee naar buiten trad. Sinds 2005 is zij als bestuurslid actief geweest in de 
Werkgroep Psychosomatische Obstetrie en Gynaecologie van de NVOG, een functie 
waarvan zij dit jaar afscheid neemt. Zij is getrouwd en heeft drie zonen.


